Announcements

10 April 2024
Meet Us at the 48th FEBS Congress, 29 June–3 July 2024, Milan, Italy


Conference:
The 48th FEBS Congress
Date: 29 June–3 July 2024
Location: Milan, Italy

MDPI will be attending the 48th FEBS Congress at Booth #30, and we welcome researchers from different backgrounds to visit us and share their latest ideas.

The Italian Society of Biochemistry and Molecular Biology (SIB), founded in 1951, will host the event. The 48th FEBS Congress—“Mining biochemistry for human health and well-being”—welcomes scientists from Europe and other parts of the world.

The 48th FEBS Congress will present a broad-spectrum and ground-breaking scientific program in a fruitful collaboration with FEBS journals and representatives from FEBS Constituent Societies. The SIB and biochemical community are focusing on human health and well-being through molecular and cellular science approaches; this is a key social issue amid ongoing global transitions. Besides presenting the latest and emerging developments in biochemical sciences, the Congress will include dedicated education-oriented sessions, symposia organized by young biochemists, and biochemistry-related economic discussions. Industry representatives will also give presentations on the latest advances in commercial instrumentation.

The following MDPI journals will be represented:

If you plan to attend this conference, please start an online conversation with us. Our delegates look forward to meeting you in person and answering your questions. For more information about the conference, please visit the following website: https://2024.febscongress.org/.

9 April 2024
Cancers | Editor’s Choice Articles from 2022–2023 Related to Cancer Causes, Screening and Diagnosis


Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles related to cancer causes, screening and diagnosis, a curated list of high-quality articles from 2022 to 2023 in Cancers (ISSN: 2072-6694). The list of relevant papers can be seen below. The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice.

“An Effective Method for Lung Cancer Diagnosis from CT Scan Using Deep Learning-Based Support Vector Network”
by Imran Shafi, Sadia Din, Asim Khan, Isabel De La Torre Díez, Ramón del Jesús Palí Casanova, Kilian Tutusaus Pifarre and Imran Ashraf
Cancers 2022, 14(21), 5457; https://doi.org/10.3390/cancers14215457
Available online: https://www.mdpi.com/2072-6694/14/21/5457

“Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma”
by Borghild Ljokjel, Hilde Haave, Stein Lybak, Olav Karsten Vintermyr, Lars Helgeland and Hans Jørgen Aarstad
Cancers 2022, 14(6), 1508; https://doi.org/10.3390/cancers14061508
Available online: https://www.mdpi.com/2072-6694/14/6/1508

“Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection”
by Alessandro Allegra, Alessandro Tonacci, Raffaele Sciaccotta, Sara Genovese, Caterina Musolino, Giovanni Pioggia and Sebastiano Gangemi
Cancers 2022, 14(3), 606; https://doi.org/10.3390/cancers14030606
Available online: https://www.mdpi.com/2072-6694/14/3/606

“Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells”
by Timothy Crook, Robert Leonard, Kefah Mokbel, Alastair Thompson, Michael Michell, Raymond Page, Ashok Vaid, Ravi Mehrotra, Anantbhushan Ranade, Sewanti Limaye et al.
Cancers 2022, 14(14), 3341; https://doi.org/10.3390/cancers14143341
Available online: https://www.mdpi.com/2072-6694/14/14/3341

“Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial”
by Dolorès Pourette, Amber Cripps, Margaux Guerrien, Caroline Desprès, Eric Opigez, Marc Bardou and Alexandre Dumont
Cancers 2022, 14(6), 1380; https://doi.org/10.3390/cancers14061380
Available online: https://www.mdpi.com/2072-6694/14/6/1380

“Slip versus Slop: A Head-to-Head Comparison of UV-Protective Clothing to Sunscreen”
by Elizabeth G. Berry, Joshua Bezecny, Michael Acton, Taylor P. Sulmonetti, David M. Anderson, Haskell W. Beckham, Rebecca A. Durr, Takahiro Chiba, Jennifer Beem, Douglas E. Brash et al.
Cancers 2022, 14(3), 542; https://doi.org/10.3390/cancers14030542
Available online: https://www.mdpi.com/2072-6694/14/3/542

“Changes in the Number of Gastrointestinal Cancers and Stage at Diagnosis with COVID-19 Pandemic in Japan: A Multicenter Cohort Study”
by Kento Kuzuu, Noboru Misawa, Keiichi Ashikari, Shigeki Tamura, Shingo Kato, Kunihiro Hosono, Masato Yoneda, Takashi Nonaka, Shozo Matsushima, Tatsuji Komatsu et al.
Cancers 2023, 15(17), 4410; https://doi.org/10.3390/cancers15174410
Available online: https://www.mdpi.com/2072-6694/15/17/4410

“Innovation in Actinic Keratosis Assessment: Artificial Intelligence-Based Approach to LC-OCT PRO Score Evaluation”
by Fabia Daxenberger, Maximilian Deußing, Quirine Eijkenboom, Charlotte Gust, Janis Thamm, Daniela Hartmann, Lars E. French, Julia Welzel, Sandra Schuh and Elke C. Sattler
Cancers 2023, 15(18), 4457; https://doi.org/10.3390/cancers15184457
Available online: https://www.mdpi.com/2072-6694/15/18/4457

“Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma”
by Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola Annels and Adam E. Frampton
Cancers 2023, 15(17), 4265; https://doi.org/10.3390/cancers15174265
Available online: https://www.mdpi.com/2072-6694/15/17/4265

“Dietary Interventions in Cancer Treatment and Response: A Comprehensive Review”
by Benjamin D. Mercier, Eemon Tizpa, Errol J. Philip, Qianhua Feng, Ziyi Huang, Reeny M. Thomas, Sumanta K. Pal, Tanya B. Dorff and Yun R. Li
Cancers 2022, 14(20), 5149; https://doi.org/10.3390/cancers14205149
Available online: https://www.mdpi.com/2072-6694/14/20/5149

“Brain Functional Connectivity in Low- and High-Grade Gliomas: Differences in Network Dynamics Associated with Tumor Grade and Location”
by Luca Pasquini, Mehrnaz Jenabi, Onur Yildirim, Patrick Silveira, Kyung K. Peck and Andrei I. Holodny
Cancers 2022, 14(14), 3327; https://doi.org/10.3390/cancers14143327
Available online: https://www.mdpi.com/2072-6694/14/14/3327

“Current Trend of Artificial Intelligence Patents in Digital Pathology: A Systematic Evaluation of the Patent Landscape”
by Muhammad Joan Ailia, Nishant Thakur, Jamshid Abdul-Ghafar, Chan Kwon Jung and Kwangil Yim and Yosep Chong
Cancers 2022, 14(10), 2400; https://doi.org/10.3390/cancers14102400
Available online: https://www.mdpi.com/2072-6694/14/10/2400

“CT-Based Radiomics Analysis to Predict Histopathological Outcomes Following Liver Resection in Colorectal Liver Metastases”
by Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Federica De Muzio, Federica Dell’ Aversana, Carmen Cutolo, Lorenzo Faggioni, Vittorio Miele, Francesco Izzo and Antonella Petrillo
Cancers 2022, 14(7), 1648; https://doi.org/10.3390/cancers14071648
Available online: https://www.mdpi.com/2072-6694/14/7/1648

“Radiolabeled Antibodies for Cancer Imaging and Therapy”
by Sagun Parakh, Sze Ting Lee, Hui K. Gan and Andrew M. Scott
Cancers 2022, 14(6), 1454; https://doi.org/10.3390/cancers14061454
Available online: https://www.mdpi.com/2072-6694/14/6/1454

“Metabolomic Phenotyping of Gliomas: What Can We Get with Simplified Protocol for Intact Tissue Analysis?”
by Paulina Zofia Goryńska, Kamila Chmara, Bogumiła Kupcewicz, Krzysztof Goryński, Karol Jaroch, Dariusz Paczkowski, Jacek Furtak, Marek Harat and Barbara Bojko
Cancers 2022, 14(2), 312; https://doi.org/10.3390/cancers14020312
Available online: https://www.mdpi.com/2072-6694/14/2/312

“Clinical Significance and Regulation of ERK5 Expression and Function in Cancer”
by Matilde Monti, Jacopo Celli, Francesco Missale, Francesca Cersosimo, Mariapia Russo, Elisa Belloni, Anna Di Matteo, Silvia Lonardi, William Vermi, Claudia Ghigna et al.
Cancers 2022, 14(2), 348; https://doi.org/10.3390/cancers14020348
Available online: https://www.mdpi.com/2072-6694/14/2/348

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

8 April 2024
Meet Us at the 2024 ASCO Annual Meeting, 31 May–4 June 2024, Chicago, IL, USA


The 2024 ASCO Annual Meeting will take you to discover state-of-the-art research, groundbreaking treatments, and visionary insights, igniting your passion for oncology. This year's program will feature over 200 sessions, complementing Dr. Lynn Schuchter’s Presidential theme “The Art and Science of Cancer Care: From Comfort to Cure”.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://conferences.asco.org/am/attend.

2 April 2024
Join Us for the 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), 10–13 June 2024, Rotterdam, the Netherlands


The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four-day congress engaged in basic, preclinical and translational cancer research across a myriad of topics that is aiming to spotlight, inspire and unite the cancer research community to innovate, build knowledge, and create collaborations.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to contact us online. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following link: https://2024.eacr.org/.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

1 April 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Pathophysiology”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Pathophysiology”. The list of relevant papers can be seen below.

“p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances”
by Lucas Geyer, Thibaut Wolf, Marie-Pierre Chenard, Helene Cebula, Roland Schott, Georges Noel, Eric Guerin, Erwan Pencreach, Damien Reita, Natacha Entz-Werlé et al.
Cancers 2023, 15(5), 1512; https://doi.org/10.3390/cancers15051512
Available online: https://www.mdpi.com/2072-6694/15/5/1512

“A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments”
by Irene Pérez-Díez, Zoraida Andreu, Marta R. Hidalgo, Carla Perpiñá-Clérigues, Lucía Fantín, Antonio Fernandez-Serra, María de la Iglesia-Vaya, José A. Lopez-Guerrero and Francisco García-García
Cancers 2023, 15(11), 2887; https://doi.org/10.3390/cancers15112887
Available online: https://www.mdpi.com/2072-6694/15/11/2887

“In Situ Imaging of O-Linked β-N-Acetylglucosamine Using On-Tissue Hydrolysis and MALDI Mass Spectrometry”
by Edwin E. Escobar, Erin H. Seeley, Jesús E. Serrano-Negrón, David J. Vocadlo and Jennifer S. Brodbelt
Cancers 2023, 15(4), 1224; https://doi.org/10.3390/cancers15041224
Available online: https://www.mdpi.com/2072-6694/15/4/1224

“Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies”
by Valentina Schiavoni, Roberto Campagna, Valentina Pozzi, Monia Cecati, Giulio Milanese, Davide Sartini, Eleonora Salvolini, Andrea Benedetto Galosi and Monica Emanuelli
Cancers 2023, 15(12), 3207; https://doi.org/10.3390/cancers15123207
Available online: https://www.mdpi.com/2072-6694/15/12/3207

“HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases”
by Alessia Garufi, Valerio D’Orazi, Giuseppa Pistritto, Mara Cirone and Gabriella D’Orazi
Cancers 2023, 15(5), 1566; https://doi.org/10.3390/cancers15051566
Available online: https://www.mdpi.com/2072-6694/15/5/1566

“SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer”
by Lóránd Váncza, Anna Horváth, Lee Seungyeon, András Rókusz, Katalin Dezső, Andrea Reszegi, Gábor Petővári, Martin Götte, Ilona Kovalszky and Kornélia Baghy
Cancers 2023, 15(7), 2037; https://doi.org/10.3390/cancers15072037
Available online: https://www.mdpi.com/2072-6694/15/7/2037

“Natural Products for the Prevention, Treatment and Progression of Breast Cancer”
by Fabiano Svolacchia, Sergio Brongo, Alessia Catalano, Agostino Ceccarini, Lorenzo Svolacchia, Alessandro Santarsiere, Carmen Scieuzo, Rosanna Salvia, Francesca Finelli, Luigi Milella et al.
Cancers 2023, 15(11), 2981; https://doi.org/10.3390/cancers15112981
Available online: https://www.mdpi.com/2072-6694/15/11/2981

“Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers”
by Sangeeth Pillai, Jan C. Kwan, Fares Yaziji, Hanwen Yu and Simon D. Tran
Cancers 2023, 15(15), 3894; https://doi.org/10.3390/cancers15153894
Available online: https://www.mdpi.com/2072-6694/15/15/3894

“Connection of Cancer Exosomal LncRNAs, Sponging miRNAs, and Exosomal Processing and Their Potential Modulation by Natural Products”
by Ya-Ting Chuang, Jun-Ping Shiau, Jen-Yang Tang, Ammad Ahmad Farooqi, Fang-Rong Chang, Yi-Hong Tsai, Ching-Yu Yen and Hsueh-Wei Chang
Cancers 2023, 15(8), 2215; https://doi.org/10.3390/cancers15082215
Available online: https://www.mdpi.com/2072-6694/15/8/2215

“A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma”
by Steffen Spoerl, Ramona Erber, Michael Gerken, Juergen Taxis, Nils Ludwig, Felix Nieberle, Niklas Biermann, Carol Immanuel Geppert, Tobias Ettl, Arndt Hartmann et al.
Cancers 2023, 15(3), 675; https://doi.org/10.3390/cancers15030675
Available online: https://www.mdpi.com/2072-6694/15/3/675

“Pediatric Rhabdomyosarcomas of the Genitourinary Tract”
by Jennifer T. Castle, Brittany E. Levy, Derek B. Allison, David A. Rodeberg and Eric J. Rellinger
Cancers 2023, 15(10), 2864; https://doi.org/10.3390/cancers15102864
Available online: https://www.mdpi.com/2072-6694/15/10/2864

“A High MCM6 Proliferative Index in Atypical Meningioma Is Associated with Shorter Progression Free and Overall Survivals”
by Guillaume Gauchotte, Charles Bédel, Emilie Lardenois, Sébastien Hergalant, Laura Cuglietta, Robin Pflaum, Stéphanie Lacomme, Héloïse Pina, Mathilde Treffel, Fabien Rech et al.
Cancers 2023, 15(2), 535; https://doi.org/10.3390/cancers15020535
Available online: https://www.mdpi.com/2072-6694/15/2/535

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

1 April 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Pathophysiology


We are delighted to share some highly viewed papers on cancer pathophysiology that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma”
by Rosa Maria Paragliola, Francesco Torino, Agnese Barnabei, Giovanni Maria Iannantuono, Andrea Corsello, Pietro Locantore and Salvatore Maria Corsello
Cancers 2023, 15(2), 529; https://doi.org/10.3390/cancers15020529
Available online: https://www.mdpi.com/2072-6694/15/2/529

“Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease—From Early Cancer Detection to Individualized Cancer Treatment”
by Paul David, Anke Mittelstädt, Dina Kouhestani, Anna Anthuber, Christoph Kahlert, Kai Sohn and Georg F. Weber
Cancers 2023, 15(7), 1924; https://doi.org/10.3390/cancers15071924
Available online: https://www.mdpi.com/2072-6694/15/7/1924

“RadWise: A Rank-Based Hybrid Feature Weighting and Selection Method for Proteomic Categorization of Chemoirradiation in Patients with Glioblastoma”
by Erdal Tasci, Sarisha Jagasia, Ying Zhuge, Mary Sproull, Theresa Cooley Zgela, Megan Mackey, Kevin Camphausen and Andra Valentina Krauze
Cancers 2023, 15(10), 2672; https://doi.org/10.3390/cancers15102672
Available online: https://www.mdpi.com/2072-6694/15/10/2672

“Biosynthesis and Significance of Fatty Acids, Glycerophospholipids, and Triacylglycerol in the Processes of Glioblastoma Tumorigenesis”
by Jan Korbecki, Mateusz Bosiacki, Izabela Gutowska, Dariusz Chlubek and Irena Baranowska-Bosiacka
Cancers 2023, 15(7), 2183; https://doi.org/10.3390/cancers15072183
Available online: https://www.mdpi.com/2072-6694/15/7/2183

“Classification of Pancreatic Ductal Adenocarcinoma Using MALDI Mass Spectrometry Imaging Combined with Neural Networks”
by Frederic Kanter, Jan Lellmann, Herbert Thiele, Steve Kalloger, David F. Schaeffer, Axel Wellmann, and Oliver Klein
Cancers 2023, 15(3), 686; https://doi.org/10.3390/cancers15030686
Available online: https://www.mdpi.com/2072-6694/15/3/686

“Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer”
by Victória Bombarda-Rocha, Dany Silva, Allal Badr-Eddine, Patrícia Nogueira, Jorge Gonçalves and Paula Fresco
Cancers 2023, 15(15), 4013; https://doi.org/10.3390/cancers15154013
Available online: https://www.mdpi.com/2072-6694/15/15/4013

Special Issues:

Lipids and Small Metabolites in Cancer
Edited by Dr. Zsolt Balogi and Dr. Laszlo Vigh
Submission deadline: 30 March 2024

 

The Role of Tunneling Nanotubes in Intercellular Communication and Pathophysiology of Cancer
Edited by Dr. Emil Lou
Submission deadline: 25 April 2024

Advances in Breast Cancer: From Pathogenesis to Therapy
Edited by Prof. Dr. Ana Isabel Torres-Suárez and Dr. Ana Isabel Fraguas-Sánchez
Submission deadline: 31 May 2024

New Insights in Molecular Pathology of Cancers: From Biomarkers to Therapeutic Targets
Edited by Dr. Hisham Bahmad
Submission deadline: 30 June 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

29 March 2024
Meet Us at the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024), 16–20 June 2024, Osaka, Japan


MDPI will be attending the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024) held in Osaka, Japan, from 16 to 20 June 2024. The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. This is the third time that the conference will be held in Japan, following the 2005 and 2014 conferences held in Tsuruoka. We look forward to welcoming the metabolomics community, building strong connections, and discussing world-class research in a relaxed collegial environment. Let us build on the momentum of the incredible Niagara Falls and Valencia conferences that brought us back together in person, and make it the best meeting of 2024 together!

During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest views and research with us.

The following MDPI journals will be represented:

  • Metabolites;
  • Biomolecules;
  • Plants;
  • IJMS;
  • Life;
  • Cells;
  • Agronomy;
  • Nutrients;
  • Cancers;
  • CIMB;
  • Genes;
  • Antioxidants.

If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: https://www.metabolomics2024.org/.

27 March 2024
Cancers | Selected Papers in 2023 in the Section “Infectious Agents and Cancer”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Infectious Agents and Cancer”. The paper list is as follows:

“The Role of the Microbiota in Esophageal Cancer”
by Clara Moreira, Ceu Figueiredo and Rui Manuel Ferreira
Cancers 2023, 15(9), 2576; https://doi.org/10.3390/cancers15092576
Available online: https://www.mdpi.com/2072-6694/15/9/2576

“Increased IL-17A Serum Levels and Gastric Th17 Cells in Helicobacter pylori-Infected Patients with Gastric Premalignant Lesions”
by Chiara Della Bella, Sofia D’Elios, Sara Coletta, Marisa Benagiano, Annalisa Azzurri, Fabio Cianchi, Marina de Bernard and Mario Milco D’Elios
Cancers 2023, 15(6), 1662; https://doi.org/10.3390/cancers15061662
Available online: https://www.mdpi.com/2072-6694/15/6/1662

“The Lack of Standardized Outcomes for Surgical Salvage of HPV-Positive Recurrent Oropharyngeal Squamous Cell Carcinoma: A Systematic Scoping Review”
by April N. Taniguchi, Sarah R. Sutton, Shaun A. Nguyen, Alexandra E. Kejner and William G. Albergotti
Cancers 2023, 15(10), 2832; https://doi.org/10.3390/cancers15102832
Available online: https://www.mdpi.com/2072-6694/15/10/2832

“Harnessing the Microbiome to Reduce Pancreatic Cancer Burden”
by Ana Raquel Bastos, Joana Pereira-Marques, Rui Manuel Ferreira and Ceu Figueiredo
Cancers 2023, 15(9), 2629; https://doi.org/10.3390/cancers15092629
Available online: https://www.mdpi.com/2072-6694/15/9/2629

“HPV Type Distribution in Benign, High-Grade Squamous Intraepithelial Lesions and Squamous Cell Cancers of the Anus by HIV Status”
by Sona Chowdhury, Teresa M. Darragh, J. Michael Berry-Lawhorn, Maria G. Isaguliants, Maxim S. Vonsky, Joan F. Hilton, Ann A. Lazar and Joel M. Palefsky
Cancers 2023, 15(3), 660; https://doi.org/10.3390/cancers15030660
Available online: https://www.mdpi.com/2072-6694/15/3/660

“Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients”
by Jennifer Schieber, Miranda Pring, Andy Ness, Zhiwei Liu, Wan-Lun Hsu, Nicole Brenner, Julia Butt, Tim Waterboer and Julia Simon
Cancers 202315(9), 2578; https://doi.org/10.3390/cancers15092578
Available online: https://www.mdpi.com/2072-6694/15/9/2578

“Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV”
by Lauren Greenberg, Lene Ryom, Elzbieta Bakowska, Ferdinand Wit, Heiner C. Bucher, Dominique L. Braun, Andrew Phillips, Caroline Sabin, Antonella d’Arminio Monforte, Robert Zangerle et al.
Cancers 202315(14), 3640; https://doi.org/10.3390/cancers15143640
Available online: https://www.mdpi.com/2072-6694/15/14/3640

“Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas”
by Benoît Pilmis, Yousra Kherabi, Pauline Huriez, Jean-Ralph Zahar and Djamel Mokart
Cancers 2023, 15(7), 1989; https://doi.org/10.3390/cancers15071989
Available online: https://www.mdpi.com/2072-6694/15/7/1989

“The Interaction between Gut Microbiota and Host Amino Acids Metabolism in Multiple Myeloma”
by Qin Yang, Yumou Wei, Yinghong Zhu, Jiaojiao Guo, Jingyu Zhang, Yanjuan He, Xin Li, Jing Liu and Wen Zhou
Cancers 2023, 15(7), 1942; https://doi.org/10.3390/cancers15071942
Available online: https://www.mdpi.com/2072-6694/15/7/1942

“Alarming Upward Trend in Multidrug-Resistant Bacteria in a Large Cohort of Immunocompromised Children: A Four-Year Comparative Study”
by Ana-Raluca Mihalcea, Nathalie Garnier, Cécile Faure-Conter, Nicolas Rama, Cécile Renard, Sarah Benezech, Yves Bertrand, Christine Fuhrmann and Carine Domenech
Cancers 2023, 15(3), 938; https://doi.org/10.3390/cancers15030938
Available online: https://www.mdpi.com/2072-6694/15/3/938

“Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia”
by Saki Matsumoto, Paulina Biniecka, Axel Bellotti, Michel A. Duchosal and Aimable Nahimana
Cancers 2023, 15(3), 787; https://doi.org/10.3390/cancers15030787
Available online: https://www.mdpi.com/2072-6694/15/3/787

“Upregulation of Cell Surface Glycoproteins in Correlation with KSHV LANA in the Kaposi Sarcoma Tumor Microenvironment”
by Sara R. Privatt, Owen Ngalamika, Jianshui Zhang, Qinsheng Li, Charles Wood and John T. West
Cancers 2023, 15(7), 2171; https://doi.org/10.3390/cancers15072171
Available online: https://www.mdpi.com/2072-6694/15/7/2171

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

27 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Drug Development”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Drug Development”. The list of relevant papers can be seen below.

“Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment”
by Hiroyoshi Y. Tanaka, Takuya Nakazawa, Atsushi Enomoto, Atsushi Masamune and Mitsunobu R. Kano
Cancers 2023, 15(3), 724; https://doi.org/10.3390/cancers15030724
Available online: https://www.mdpi.com/2072-6694/15/3/724

“Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers”
by Shoaib Shoaib, Farheen Badrealam Khan, Meshari A. Alsharif, M. Shaheer Malik, Saleh A. Ahmed, Yahya F. Jamous, Shahab Uddin, Ching Siang Tan, Chrismawan Ardianto, Saba Tufail et al.
Cancers 2023, 15(8), 2390; https://doi.org/10.3390/cancers15082390
Available online: https://www.mdpi.com/2072-6694/15/8/2390

“Multi-Fold Computational Analysis to Discover Novel Putative Inhibitors of Isethionate Sulfite-Lyase (Isla) from Bilophila wadsworthia: Combating Colorectal Cancer and Inflammatory Bowel Diseases”
by Muhammad Waqas, Sobia Ahsan Halim, Atta Ullah, Assim Alaa Mohammed Ali, Asaad Khalid, Ashraf N. Abdalla, Ajmal Khan and Ahmed Al-Harrasi
Cancers 2023, 15(3), 901; https://doi.org/10.3390/cancers15030901
Available online: https://www.mdpi.com/2072-6694/15/3/901

“Precision Medicine: Disease Subtyping and Tailored Treatment”
by Richard C. Wang and Zhixiang Wang
Cancers 2023, 15(15), 3837; https://doi.org/10.3390/cancers15153837
Available online: https://www.mdpi.com/2072-6694/15/15/3837

“Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies”
by Dilipkumar Pal, Khushboo Raj, Shyam Sundar Nandi, Surajit Sinha, Abhishek Mishra, Arijit Mondal, Ricardo Lagoa, Jack T. Burcher and Anupam Bishayee
Cancers 2023, 15(10), 2808; https://doi.org/10.3390/cancers15102808
Available online: https://www.mdpi.com/2072-6694/15/10/2808

“microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer”
by Naotake Funamizu, Masahiko Honjo, Kei Tamura, Katsunori Sakamoto, Kohei Ogawa and Yasutsugu Takada
Cancers 2023, 15(4), 1230; https://doi.org/10.3390/cancers15041230
Available online: https://www.mdpi.com/2072-6694/15/4/1230

“Iridoid Derivatives as Anticancer Agents: An Updated Review from 1970–2022”
by Tanaka Ndongwe, Bwalya A. Witika, Nontobeko P. Mncwangi, Madan S. Poka, Phumzile P. Skosana, Patrick H. Demana, Beverley Summers and Xavier Siwe-Noundou
Cancers 2023, 15(3), 770; https://doi.org/10.3390/cancers15030770
Available online: https://www.mdpi.com/2072-6694/15/3/770

“Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors”
by Lucía Pérez-Lamas, Alejandro Luna, Concepción Boque, Blanca Xicoy, Pilar Giraldo, Raúl Pérez López, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Javier López Marín et al.
Cancers 2023, 15(4), 1045; https://doi.org/10.3390/cancers15041045
Available online: https://www.mdpi.com/2072-6694/15/4/1045

“An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models”
by Donald Poirier, Jenny Roy, René Maltais, Cindy Weidmann and Étienne Audet-Walsh
Cancers 2023, 15(11), 3033; https://doi.org/10.3390/cancers15113033
Available online: https://www.mdpi.com/2072-6694/15/11/3033

“α-Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells”
by Mirielle C. Nauman, Jong Hoon Won, Sakina M. Petiwala, Bhaskar Vemu, Hyun Lee, Maria Sverdlov and Jeremy J. Johnson
Cancers 2023, 15(7), 2118; https://doi.org/10.3390/cancers15072118
Available online: https://www.mdpi.com/2072-6694/15/7/2118

“Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance”
by Tapan K. Maity, Eun Young Kim, Constance M. Cultraro, Abhilash Venugopalan, Leena Khare, Ramulu Poddutoori, Sivapriya Marappan, Samiulla D. Syed, William G. Telford, Susanta Samajdar et al.
Cancers 2023, 15(8), 2263; https://doi.org/10.3390/cancers15082263
Available online: https://www.mdpi.com/2072-6694/15/8/2263

“Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds”
by Neeraj Choudhary, Sweta Bawari, Jack T. Burcher, Dona Sinha, Devesh Tewari and Anupam Bishayee
Cancers 2023, 15(15), 3980; https://doi.org/10.3390/cancers15153980
Available online: https://www.mdpi.com/2072-6694/15/15/3980

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

20 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Epidemiology and Prevention”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Epidemiology and Prevention”. The list of relevant papers can be seen below.

“Genetics and RNA Regulation of Uveal Melanoma”
by Cristina Barbagallo, Michele Stella, Giuseppe Broggi, Andrea Russo, Rosario Caltabiano and Marco Ragusa
Cancers 2023, 15(3), 775; https://doi.org/10.3390/cancers15030775
Available online: https://www.mdpi.com/2072-6694/15/3/775

“Anatomic Region of Cutaneous Melanoma Impacts Survival and Clinical Outcomes: A Population-Based Analysis”
by Christian M. Shannon, Neil K. Mehta, Hong Li, Shaun A. Nguyen, Sina Koochakzadeh, Dirk M. Elston, John M. Kaczmar and Terry A. Day
Cancers 2023, 15(4), 1229; https://doi.org/10.3390/cancers15041229
Available online: https://www.mdpi.com/2072-6694/15/4/1229

“Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats”
by Venkateshwar Madka, Jagan M. R. Patlolla, Karthikkumar Venkatachalam, Yuting Zhang, Gopal Pathuri, Nicole Stratton, Stanley Lightfoot, Naveena B. Janakiram, Altaf Mohammed and Chinthalapally V. Rao
Cancers 2023, 15(15), 4001; https://doi.org/10.3390/cancers15154001
Available online: https://www.mdpi.com/2072-6694/15/15/4001

“Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis”
by Elena Martinez-Garcia, Eva Coll-de la Rubia, Antoine Lesur, Gunnar Dittmar, Antonio Gil-Moreno, Silvia Cabrera and Eva Colas
Cancers 2023, 15(3), 911; https://doi.org/10.3390/cancers15030911
Available online: https://www.mdpi.com/2072-6694/15/3/911

“Ethanol Metabolism and Melanoma”
by Zili Zhai, Takeshi Yamauchi, Sarah Shangraw, Vincent Hou, Akiko Matsumoto and Mayumi Fujita
Cancers 2023, 15(4), 1258; https://doi.org/10.3390/cancers15041258
Available online: https://www.mdpi.com/2072-6694/15/4/1258

“MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis”
by Ranakul Islam, Lei Zhao, Xiujuan Zhang and Ling-Zhi Liu
Cancers 2023, 15(4), 1204; https://doi.org/10.3390/cancers15041204
Available online: https://www.mdpi.com/2072-6694/15/4/1204

“Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
by Joan Llach, Paula Aguilera, Ariadna Sánchez, Angels Ginès, Glòria Fernández-Esparrach, Guillem Soy, Oriol Sendino, Eva Vaquero, Sabela Carballal, Fabio Ausania et al.
Cancers 2023, 15(6), 1690; https://doi.org/10.3390/cancers15061690
Available online: https://www.mdpi.com/2072-6694/15/6/1690

“Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management”
by Yoshihiro Sato, Shingo Tsujinaka, Tomoya Miura, Yoh Kitamura, Hideyuki Suzuki and Chikashi Shibata
Cancers 2023, 15(16), 4154; https://doi.org/10.3390/cancers15164154
Available online: https://www.mdpi.com/2072-6694/15/16/4154

“Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk”
by Shaimaa A. Shehata, Eman A. Toraih, Ezzat A. Ismail, Abeer M. Hagras, Ekramy Elmorsy and Manal S. Fawzy
Cancers 2023, 15(18), 4525; https://doi.org/10.3390/cancers15184525
Available online: https://www.mdpi.com/2072-6694/15/18/4525

“Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations”
by Hye Won Lee, Whi-An Kwon, La Ngoc Thu Nguyen, Do Thanh Truc Phan and Ho Kyung Seo
Cancers 2023, 15(4), 1323; https://doi.org/10.3390/cancers15041323
Available online: https://www.mdpi.com/2072-6694/15/4/1323

“Body Shape Phenotypes and Breast Cancer Risk: A Mendelian Randomization Analysis”
by Laia Peruchet-Noray, Niki Dimou, Anja M. Sedlmeier, Béatrice Fervers, Isabelle Romieu, Vivian Viallon, Pietro Ferrari, Marc J. Gunter, Robert Carreras-Torres and Heinz Freisling
Cancers 2023, 15(4), 1296; https://doi.org/10.3390/cancers15041296
Available online: https://www.mdpi.com/2072-6694/15/4/1296

“Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK”
by Samuel Oxley, Ashwin Kalra, Michail Sideris, Nicole Itzkowitz, Olivia Evans, Emma Christine Atakpa, Adam R. Brentnall, Nina Dworschak, Faiza Gaba, Rhian Gabe et al.
Cancers 2023, 15(4), 1273; https://doi.org/10.3390/cancers15041273
Available online: https://www.mdpi.com/2072-6694/15/4/1273

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

19 March 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Pediatric Oncology


We are delighted to share some highly viewed papers on pediatric oncology that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience”
by Adriana Trabal, Amber Gibson, Jiasen He, David McCall, Michael Roth, Cesar Nuñez, Miriam Garcia, Meredith Buzbee, Laurie Toepfer, Aram Bidikian et al.
Cancers 2023, 15(7), 1983; https://doi.org/10.3390/cancers15071983
Available online: https://www.mdpi.com/2072-6694/15/7/1983

“Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals’ Perceptions of Barriers to Care and a Framework for Action”
by Paula A. Ospina, Lesley Pritchard, David D. Eisenstat and Margaret L. McNeely
Cancers 2023, 15(3), 693; https://doi.org/10.3390/cancers15030693
Available online: https://www.mdpi.com/2072-6694/15/3/693

“Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma”
by Silvia Pomella, Sara G. Danielli, Rita Alaggio, Willemijn B. Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S. Walters, Beat W. Schäfer, Rossella Rota et al.
Cancers 2023, 15(10), 2823; https://doi.org/10.3390/cancers15102823
Available online: https://www.mdpi.com/2072-6694/15/10/2823

“Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma”
by Yujia Chen, Chao Zhao, Shenglun Li, Jun Wang and Hongwei Zhang
Cancers 2023, 15(3), 602; https://doi.org/10.3390/cancers15030602
Available online: https://www.mdpi.com/2072-6694/15/3/602

“Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature”
by Louisa Taylor, Philippa K. Wade, James E. C. Johnson, Macha Aldighieri, Sonia Morlando, Gianpiero Di Leva, Ian D. Kerr and Beth Coyle
Cancers 2023, 15(4), 1086; https://doi.org/10.3390/cancers15041086
Available online: https://www.mdpi.com/2072-6694/15/4/1086

“Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma”
by Daniela Di Carlo, Julia Chisholm, Anna Kelsey, Rita Alaggio, Gianni Bisogno, Veronique Minard-Colin, Meriel Jenney, Raquel Dávila Fajardo, Johannes H. M. Merks, Janet M. Shipley et al.
Cancers 2023, 15(6), 1644; https://doi.org/10.3390/cancers15061644
Available online: https://www.mdpi.com/2072-6694/15/6/1644

 Pediatric Cancer: From Molecular Targets to Effective Therapies
Edited by: Dr. Raushan Kurmasheva
Submission deadline: 29 February 2024
 Pediatric and AYA Sarcoma and Intermediate Tumors
Edited by: Prof. Dr. Yoshihiro Nishida
Submission deadline: 25 March 2024
 Updates on Management and Clinical Trials in Pediatric Oncology
Edited by: Dr. Atsushi Makimoto, Dr. Yasuhiro Okamoto and Dr. Yuki Yuza
Submission deadline: 15 April 2024
 Challenges and New Strategies in the Management of Pediatric Brain Tumors
Edited by: Dr. Semi B. Harrabi and Prof. Dr. Adilia Hormigo
Submission deadline: 31 May 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

19 March 2024
Cancers | Selected Papers in 2023 in the Section “Pediatric Oncology”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Pediatric Oncology”. The paper list is as follows:

The list of relevant papers can be seen below:

1. “Experiences of Female Childhood Cancer Patients and Survivors Regarding Information and Counselling on Gonadotoxicity Risk and Fertility Preservation at Diagnosis: A Systematic Review”
by Nikita H. Z. Clasen, M. E. Madeleine van der Perk, Sebastian J. C. M. M. Neggers, Annelies M. E. Bos and Marry M. van den Heuvel-Eibrink
Cancers 2023, 15(7), 1946; https://doi.org/10.3390/cancers15071946
Available online: https://www.mdpi.com/2072-6694/15/7/1946

2. “Hyperleukocytosis in Childhood Acute Leukemia: Early Complications and Survival Outcomes”
by Sirinthip Kittivisuit, Nichanan Jongthitinon, Pornpun Sripornsawan, Natsaruth Songthawee, Shevachut Chavananon, Chompoonut Limratchapong, Edward B. McNeil and Thirachit Chotsampancharoen
Cancers 2023, 15(12), 3072; https://doi.org/10.3390/cancers15123072
Available online: https://www.mdpi.com/2072-6694/15/12/3072

3. “Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes”
by Juan Pablo Muñoz, Cristina Larrosa, Saray Chamorro, Sara Perez-Jaume, Margarida Simao, Nazaret Sanchez-Sierra, Amalia Varo, Maite Gorostegui, Alicia Castañeda, Moira Garraus et al.
Cancers 2023, 15(19), 4837; https://doi.org/10.3390/cancers15194837
Available online: https://www.mdpi.com/2072-6694/15/19/4837

4. “Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated”
by Alexandra McLean Stevens, Eric S. Schafer, Minhua Li, Maci Terrell, Raushan Rashid, Hana Paek, Melanie B. Bernhardt, Allison Weisnicht, Wesley T. Smith, Noah J. Keogh et al.
Cancers 2023, 15(4), 1344; https://doi.org/10.3390/cancers15041344
Available online: https://www.mdpi.com/2072-6694/15/4/1344

5. “Targeting the Hedgehog Pathway in Rhabdomyosarcoma”
by Patricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, Gabriela Guillén, Gabriel Gallo-Oller, Guillem Pons, Julia Sansa-Girona, Miguel F. Segura, Josep Sánchez de Toledo, Lucas Moreno et al.
Cancers 2023, 15(3), 727; https://doi.org/10.3390/cancers15030727
Available online: https://www.mdpi.com/2072-6694/15/3/727

6. “Co-Occurrence of Beckwith–Wiedemann Syndrome and Early-Onset Colorectal Cancer”
by Francesco Cecere, Laura Pignata, Bruno Hay Mele, Abu Saadat, Emilia D’Angelo, Orazio Palumbo, Pietro Palumbo, Massimo Carella, Gioacchino Scarano, Giovanni Battista Rossi et al.
Cancers 2023, 15(7), 1944; https://doi.org/10.3390/cancers15071944
Available online: https://www.mdpi.com/2072-6694/15/7/1944

7. “Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients”
by K. L. Juliëtte Schmidt, Noël M. M. Dautzenberg, Peter M. Hoogerbrugge, Caroline A. Lindemans, Stefan Nierkens, Gaby Smits, Rob S. Van Binnendijk, Louis J. Bont and Wim J. E. Tissing
Cancers 2023, 15(9), 2562; https://doi.org/10.3390/cancers15092562
Available online: https://www.mdpi.com/2072-6694/15/9/2562

8. “The Battlefield of Chemotherapy in Pediatric Cancers”
by Letao Bo, Youyou Wang, Yidong Li, John N. D. Wurpel, Zoufang Huang and Zhe-Sheng Chen
Cancers 2023, 15(7), 1963; https://doi.org/10.3390/cancers15071963
Available online: https://www.mdpi.com/2072-6694/15/7/1963

9. “Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals’ Perceptions of Barriers to Care and a Framework for Action”
by Paula A. Ospina, Lesley Pritchard, David D. Eisenstat and Margaret L. McNeely
Cancers 2023, 15(3), 693; https://doi.org/10.3390/cancers15030693
Available online: https://www.mdpi.com/2072-6694/15/3/693

10. “Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma”
by Silvia Pomella, Sara G. Danielli, Rita Alaggio, Willemijn B. Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S. Walters, Beat W. Schäfer, Rossella Rota et al.
Cancers 2023, 15(10), 2823; https://doi.org/10.3390/cancers15102823
Available online: https://www.mdpi.com/2072-6694/15/10/2823

11. “STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo”
by Kyle A. Rohrer, Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J. Wilder, Erin M. McIntyre, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino et al.
Cancers 2023, 15(8), 2239; https://doi.org/10.3390/cancers15082239
Available online: https://www.mdpi.com/2072-6694/15/8/2239

12. “Safety, Feasibility and Efficacy of Lokomat® and Armeo®Spring Training in Deconditioned Paediatric, Adolescent and Young Adult Cancer Patients”
by Morgan Atkinson, Angela Tully, Carol A. Maher, Christopher Innes-Wong, Ray N. Russo and Michael P. Osborn
Cancers 2023, 15(4), 1250; https://doi.org/10.3390/cancers15041250
Available online: https://www.mdpi.com/2072-6694/15/4/1250

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

14 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Immunology and Immunotherapy”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Immunology and Immunotherapy”. The list of relevant papers can be seen below.

“Recent Advances in Molecular Mechanisms of Cancer Immunotherapy”
by Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, Summya Rashid, Muhammad Omer Iqbal, Renata Kontek, Muhanad A. Abdulsamad and Abdulmutalib A. Allaq
Cancers 2023, 15(10), 2721; https://doi.org/10.3390/cancers15102721
Available online: https://www.mdpi.com/2072-6694/15/10/2721

“Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials”
by Bin Li, Juan Jin, Duancheng Guo, Zhonghua Tao and Xichun Hu
Cancers 2023, 15(10), 2858; https://doi.org/10.3390/cancers15102858
Available online: https://www.mdpi.com/2072-6694/15/10/2858

“Chasing Immune Checkpoint Inhibitors in Ovarian Cancer: Novel Combinations and Biomarker Discovery”
by Ilaria Colombo, Katherine Karakasis, Sneha Suku and Amit M. Oza
Cancers 2023, 15(12), 3220; https://doi.org/10.3390/cancers15123220
Available online: https://www.mdpi.com/2072-6694/15/12/3220

“Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment”
by Almog Shalit, Panagiotis Sarantis, Evangelos Koustas, Eleni-Myrto Trifylli, Dimitris Matthaios and Michalis V. Karamouzis
Cancers 2023, 15(2), 375; https://doi.org/10.3390/cancers15020375
Available online: https://www.mdpi.com/2072-6694/15/2/375

“The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?”
by Alaa Alsalloum, Julia A. Shevchenko and Sergey Sennikov
Cancers 2023, 15(6), 1779; https://doi.org/10.3390/cancers15061779
Available online: https://www.mdpi.com/2072-6694/15/6/1779

“Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma”
by Masahiro Morita, Naoshi Nishida, Tomoko Aoki, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima and Masatoshi Kudo
Cancers 2023, 15(8), 2311; https://doi.org/10.3390/cancers15082311
Available online: https://www.mdpi.com/2072-6694/15/8/2311

“Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma”
by Carmelo Laface, Girolamo Ranieri, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Michele Ammendola, Marigia Laterza, Gerardo Cazzato, Riccardo Memeo, Giovanni Mastrandrea et al.
Cancers 2023, 15(3), 654; https://doi.org/10.3390/cancers15030654
Available online: https://www.mdpi.com/2072-6694/15/3/654

“The Immunology of DLBCL”
by Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki and Akira Satou
Cancers 2023, 15(3), 835; https://doi.org/10.3390/cancers15030835
Available online: https://www.mdpi.com/2072-6694/15/3/835

“Ready for Prime Time? Dendritic Cells in High-Grade Gliomas”
by Claire A. Conarroe and Timothy N. J. Bullock
Cancers 2023, 15(11), 2902; https://doi.org/10.3390/cancers15112902
Available online: https://www.mdpi.com/2072-6694/15/11/2902

“The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy”
by Hasti Gholami, John A. Chmiel, Jeremy P. Burton and Saman Maleki Vareki
Cancers 2023, 15(4), 1300; https://doi.org/10.3390/cancers15041300
Available online: https://www.mdpi.com/2072-6694/15/4/1300

“Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism”
by Marcelo S. F. Pereira, Kinnari Sorathia, Yasemin Sezgin, Aarohi Thakkar, Colin Maguire, Patrick L. Collins, Bethany L. Mundy-Bosse, Dean A. Lee and Meisam Naeimi Kararoudi
Cancers 2023, 15(3), 705; https://doi.org/10.3390/cancers15030705
Available online: https://www.mdpi.com/2072-6694/15/3/705

“Immunotherapy through the Lens of Non-Small Cell Lung Cancer”
by Robyn Stanley, Saoirse Flanagan, David O’ Reilly, Ella Kearney, Jarushka Naidoo and Catríona M. Dowling
Cancers 2023, 15(11), 2996; https://doi.org/10.3390/cancers15112996
Available online: https://www.mdpi.com/2072-6694/15/11/2996

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

13 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Biomarkers”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Biomarkers”. The list of relevant papers can be seen below.

“Liquid Biopsies in Lung Cancer”
by Marcel Kemper, Carolin Krekeler, Kerstin Menck, Georg Lenz, Georg Evers, Arik Bernard Schulze and Annalen Bleckmann
Cancers 2023, 15(5), 1430; https://doi.org/10.3390/cancers15051430  
Available online: https://www.mdpi.com/2072-6694/15/5/1430

“HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept”
by Yanjun Hou, Hiroaki Nitta and Zaibo Li
Cancers 2023, 15(10), 2664; https://doi.org/10.3390/cancers15102664  
Available online: https://www.mdpi.com/2072-6694/15/10/2664

“Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma”
by Ricardo Errazquin, Estela Carrasco, Sonia Del Marro, Anna Suñol, Jorge Peral, Jessica Ortiz, Juan Carlos Rubio, Carmen Segrelles, Marta Dueñas, Alicia Garrido-Aranda et al.
Cancers 2023, 15(6), 1871; https://doi.org/10.3390/cancers15061871  
Available online: https://www.mdpi.com/2072-6694/15/6/1871

“The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer”
by Ana Regina de Abreu, Ken Op de Beeck, Pierre Laurent-Puig, Valerie Taly and Leonor Benhaim
Cancers 2023, 15(4), 1284; https://doi.org/10.3390/cancers15041284  
Available online: https://www.mdpi.com/2072-6694/15/4/1284

“A Novel Blood Proteomic Signature for Prostate Cancer”
by Ammara Muazzam, Matt Spick, Olivier N. F. Cexus, Bethany Geary, Fowz Azhar, Hardev Pandha, Agnieszka Michael, Rachel Reed, Sarah Lennon, Lee A. Gethings et al.
Cancers 2023, 15(4), 1051; https://doi.org/10.3390/cancers15041051  
Available online: https://www.mdpi.com/2072-6694/15/4/1051

Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors”
by Tina Draškovič, Nina Zidar and Nina Hauptman
Cancers 2023, 15(3), 859; https://doi.org/10.3390/cancers15030859 
Available online: https://www.mdpi.com/2072-6694/15/3/859

“Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma”
by Long-Bin Jeng, Wen-Ling Chan and Chiao-Fang Teng
Cancers 2023, 15(4), 1005, https://doi.org/10.3390/cancers15041005  
Available online: https://www.mdpi.com/2072-6694/15/4/1005

“Canine-Inspired Chemometric Analysis of Volatile Organic Compounds in Urine Headspace to Distinguish Prostate Cancer in Mice and Men”
by Mark Woollam, Amanda P. Siegel, Adam Munshi, Shengzhi Liu, Sunil Tholpady, Thomas Gardner, Bai-Yan Li, Hiroki Yokota and Mangilal Agarwal
Cancers 2023, 15(4), 1352; https://doi.org/10.3390/cancers15041352  
Available online: https://www.mdpi.com/2072-6694/15/4/1352

“Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis”
by Juan P. Rodrigo, Mario Sánchez-Canteli, Asterios Triantafyllou, Remco de Bree, Antti A. Mäkitie, Alessandro Franchi, Henrik Hellquist, Nabil F. Saba, Göran Stenman, Robert P. Takes et al.
Cancers 2023, 15(3), 802; https://doi.org/10.3390/cancers15030802  
Available online: https://www.mdpi.com/2072-6694/15/3/802

“Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma”
by Anna Brandt, Benjamin Thiele, Christoph Schultheiß, Eveline Daetwyler and Mascha Binder
Cancers 2023, 15(7), 2051; https://doi.org/10.3390/cancers15072051  
Available online: https://www.mdpi.com/2072-6694/15/7/2051

“Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment”
by Sergio Antonio Oropeza-de Lara, Idalia Garza-Veloz, Bertha Berthaud-González and Margarita L. Martinez-Fierro
Cancers 2023, 15(10), 2686; https://doi.org/10.3390/cancers15102686  
Available online: https://www.mdpi.com/2072-6694/15/10/2686

Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy”
by Dung-Tsa Chen, Andreas N. Saltos, Trevor Rose, Zachary J. Thompson, Ram Thapa, Alberto Chiappori and Jhanelle E. Gray
Cancers 2023, 15(9), 2521; https://doi.org/10.3390/cancers15092521 
Available online: https://www.mdpi.com/2072-6694/15/9/2521

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

13 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Causes, Screening and Diagnosis”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Causes, Screening and Diagnosis”. The list of relevant papers can be seen below.

“Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping”
by Álvaro Díaz-González, Elvira Mora, Gayane Avetisyan, Santiago Furió, Rosalía De la Puerta, José Vicente Gil, Alessandro Liquori, Eva Villamón, Carmen García-Hernández, Marta Santiago et al. Cancers 2023, 15(11), 3039; https://doi.org/10.3390/cancers15113039
Available online: https://www.mdpi.com/2072-6694/15/11/3039

“Differentiating Thyroid Follicular Adenoma from Follicular Carcinoma via G-Protein Coupled Receptor-Associated Sorting Protein 1 (GASP-1)”
by Yuan Rong, Cesar Torres-Luna, George Tuszynski, Richard Siderits and Frank N. Chang
Cancers 2023, 15(13), 3404; https://doi.org/10.3390/cancers15133404
Available online: https://www.mdpi.com/2072-6694/15/13/3404

“Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients”
by Akram Al-Ibraheem, Ula Al-Rasheed, Noor Mashhadani, Ahmed Saad Abdlkadir, Dhuha Ali Al-Adhami, Saad Ruzzeh, Feras Istatieh, Areen Mansour, Basem Hamdan, Reem Kheetan et al.
Cancers 2023, 15(16), 4102; https://doi.org/10.3390/cancers15164102
Available online: https://www.mdpi.com/2072-6694/15/16/4102

“Biomarker Reproducibility Challenge: A Review of Non-Nucleotide Biomarker Discovery Protocols from Body Fluids in Breast Cancer Diagnosis”
by Fatemeh Safari, Cheka Kehelpannala, Azadeh Safarchi, Amani M. Batarseh and Fatemeh Vafaee
Cancers 2023, 15(10), 2780; https://doi.org/10.3390/cancers15102780
Available online: https://www.mdpi.com/2072-6694/15/10/2780

“Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis”
by Faiza Gaba, Oleg Blyuss, Alex Tan, Daniel Munblit, Samuel Oxley, Khalid Khan, Rosa Legood and Ranjit Manchanda
Cancers 2023, 15(5), 1625; https://doi.org/10.3390/cancers15051625
Available online: https://www.mdpi.com/2072-6694/15/5/1625

“Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies”
by Katharina Lucas, Nathaniel Melling, Anastasios D. Giannou, Matthias Reeh, Oliver Mann, Thilo Hackert, Jakob R. Izbicki, Daniel Perez and Julia K. Grass
Cancers 2023, 15(12), 3196; https://doi.org/10.3390/cancers15123196
Available online: https://www.mdpi.com/2072-6694/15/12/3196

“Primary Cutaneous Anaplastic Large Cell Lymphoma—A Review of Clinical, Morphological, Immunohistochemical, and Molecular Features”
by Carlos Ortiz-Hidalgo and Sergio Pina-Oviedo
Cancers 2023, 15(16), 4098; https://doi.org/10.3390/cancers15164098
Available online: https://www.mdpi.com/2072-6694/15/16/4098

“Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma”
by Arthur, Cecilia, Cecilia Jylhä, Teresita Díaz de Ståhl, Alia Shamikh, Johanna Sandgren, Richard Rosenquist, Magnus Nordenskjöld, Arja Harila, Gisela Barbany, Ulrika Sandvik et al.
Cancers 2023, 15(7), 1972; https://doi.org/10.3390/cancers15071972  
Available online: https://www.mdpi.com/2072-6694/15/7/1972

“Proposal and Definition of an Intelligent Clinical Decision Support System Applied to the Screening and Early Diagnosis of Breast Cancer”
by Manuel Casal-Guisande, Antía Álvarez-Pazó, Jorge Cerqueiro-Pequeño, José-Benito Bouza-Rodríguez, Gustavo Peláez-Lourido and Alberto Comesaña-Campos
Cancers 2023, 15(6), 1711; https://doi.org/10.3390/cancers15061711
Available online: https://www.mdpi.com/2072-6694/15/6/1711

“Mast Cell Leukemia: An Update with a Practical Review”
by Magda Zanelli, Martina Quintini, Salvatore Magnasco, Lara Aprile, Andrea Palicelli, Maurizio Zizzo, Francesca Sanguedolce, Stefano Ricci, Saverio Pancetti, Valeria Zuccalà et al.
Cancers 2023, 15(6), 1664; https://doi.org/10.3390/cancers15061664
Available online: https://www.mdpi.com/2072-6694/15/6/1664

“Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore”
by Brandon Chua, Li Min Lim, Joseph Soon Yau Ng, Yan Ma, Hwee Lin Wee and J. Jaime Caro
Cancers 2023, 15(6), 1812; https://doi.org/10.3390/cancers15061812
Available online: https://www.mdpi.com/2072-6694/15/6/1812

“Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Concepts”
by Katrin S. Kurz, Michaela Ott, Sabrina Kalmbach, Sophia Steinlein, Claudia Kalla, Heike Horn, German Ott and Annette M. Staiger
Cancers 2023, 15(8), 2285; https://doi.org/10.3390/cancers15082285
Available online: https://www.mdpi.com/2072-6694/15/8/2285

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

13 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Survivorship and Quality of Life”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Survivorship and Quality of Life”. The list of relevant papers can be seen below.

“Prostate Cancer in Sexual Minorities: Epidemiology, Screening and Diagnosis, Treatment, and Quality of Life”
by Omid Yazdanpanah, David J. Benjamin and Arash Rezazadeh Kalebasty
Cancers 2023, 15(9), 2654; https://doi.org/10.3390/cancers15092654
Available online: https://www.mdpi.com/2072-6694/15/9/2654

“Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram”
by Gabriela Oses, Eduard Mension, Claudia Pumarola, Helena Castillo, León Francesc, Inés Torras, Isaac Cebrecos, Xavier Caparrós, Sergi Ganau, Belén Ubeda et al.
Cancers 2023, 15(8), 2392; https://doi.org/10.3390/cancers15082392
Available online: https://www.mdpi.com/2072-6694/15/8/2392

“Symptom Clusters in Survivorship and Their Impact on Ability to Work among Cancer Survivors”
by Joanna E. Fardell, Sim Yee (Cindy) Tan, Kim Kerin-Ayres, Haryana M. Dhillon and Janette L. Vardy
Cancers 2023, 15(21), 5119; https://doi.org/10.3390/cancers15215119
Available online: https://www.mdpi.com/2072-6694/15/21/5119

“Psychosocial Impact of Virtual Cancer Care through Technology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
by Caterina Caminiti, Maria Antonietta Annunziata, Paola Di Giulio, Luciano Isa, Paola Mosconi, Maria Giulia Nanni, Michela Piredda, Claudio Verusio, Francesca Diodati, Giuseppe Maglietta et al.
Cancers 2023, 15(7), 2090; https://doi.org/10.3390/cancers15072090
Available online: https://www.mdpi.com/2072-6694/15/7/2090

“Real-World Evidence: How Long Do Our Patients Fast?—Results from a Prospective JAGO-NOGGO-Multicenter Analysis on Perioperative Fasting in 924 Patients with Malignant and Benign Gynecological Disease”
by Maximilian Heinz Beck, Derya Balci-Hakimeh, Florian Scheuerecker, Charlotte Wallach, Hannah Lena Güngor, Marlene Lee, Ahmed Farouk Abdel-Kawi, Jacek Glajzer, Jekaterina Vasiljeva, Karol Kubiak et al.
Cancers 2023, 15(4), 1311; https://doi.org/10.3390/cancers15041311
Available online: https://www.mdpi.com/2072-6694/15/4/1311

“Caring for Adolescents and Young Adults (AYA) with Cancer: A Scoping Review into Caregiver Burdens and Needs”
by Milou J. P. Reuvers, Asiye Gedik, Kirsty M. Way, Sanne M. Elbersen-van de Stadt, Winette T. A. van der Graaf and Olga Husson
Cancers 2023, 15(12), 3263; https://doi.org/10.3390/cancers15123263
Available online: https://www.mdpi.com/2072-6694/15/12/3263

“Associations between Lifestyle Factors and Neurocognitive Impairment among Chinese Adolescent and Young Adult (AYA) Survivors of Sarcoma”
by Yin Ting Cheung, Chung Tin Ma, Michael Can Heng Li, Keary Rui Zhou, Herbert Ho Fung Loong, Agnes Sui Yin Chan, Kwok Chuen Wong and Chi Kong Li
Cancers 2023, 15(3), 799; https://doi.org/10.3390/cancers15030799
Available online: https://www.mdpi.com/2072-6694/15/3/799

“Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence”
by Flavio Milana, Michela Anna Polidoro, Simone Famularo, Ana Lleo, Renzo Boldorini, Matteo Donadon and Guido Torzilli
Cancers 2023, 15(2), 508; https://doi.org/10.3390/cancers15020508
Available online: https://www.mdpi.com/2072-6694/15/2/508

“Quality of End-of-Life Care during the COVID-19 Pandemic at a Comprehensive Cancer Center”
by Yvonne Heung, Donna Zhukovsky, David Hui, Zhanni Lu, Clark Andersen and Eduardo Bruera
Cancers 2023, 15(8), 2201; https://doi.org/10.3390/cancers15082201
Available online: https://www.mdpi.com/2072-6694/15/8/2201

“Associations of Age and Sex with the Efficacy of Inpatient Cancer Rehabilitation: Results from a Longitudinal Observational Study Using Electronic Patient-Reported Outcomes”
by Jens Lehmann, David Riedl, Alain Nickels, Gabriele Sanio, Marco Hassler, Gerhard Rumpold, Bernhard Holzner and Thomas Licht
Cancers 2023, 15(6), 1637; https://doi.org/10.3390/cancers15061637
Available online: https://www.mdpi.com/2072-6694/15/6/1637

“Accuracy of Delirium Screening Tools in Older People with Cancer—A Systematic Review”
by Francisco Miguel Martínez-Arnau, Andrea Puchades-García and Pilar Pérez-Ros
Cancers 2023, 15(10), 2807; https://doi.org/10.3390/cancers15102807
Available online: https://www.mdpi.com/2072-6694/15/10/2807

“Best Practices for Providing Patient-Centered Tele-Palliative Care to Cancer Patients”
by Grecia Lined Aldana, Onyinyechi Vanessa Evoh and Akhila Reddy
Cancers 2023, 15(6), 1809; https://doi.org/10.3390/cancers15061809   
Available online: https://www.mdpi.com/2072-6694/15/6/1809

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

 

13 March 2024
Cancers | Selected Papers in 2023 in the Section “Systematic Review or Meta-Analysis in Cancer Research”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Systematic Review or Meta-Analysis in Cancer Research”. The list of relevant papers can be seen below.

“Malignant Neoplasms Arising in the Cardiac Pacemaker Cavity: A Systematic Review”
by Francisco Cezar Aquino de Moraes, Lucca Dal Moro, Fernando Rocha Pessoa, Ellen Sabrinna dos Remédios Passos, Raul Antônio Lopes Silva Campos, Dilma do Socorro Moraes de Souza, Danielle Feio, Rommel Mario Rodríguez Burbano, Marianne Rodrigues Fernandes and Ney Pereira Carneiro dos Santos
Cancers 2023, 15(21), 5206; https://doi.org/10.3390/cancers15215206
Available online: https://www.mdpi.com/2072-6694/15/21/5206

“The Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer: A Systematic Literature Review”
by Doris K. Hansen, Yi-Hsuan Liu, Sandip Ranjan, Hitesh Bhandari, Ravi Potluri, Lindsay McFarland, Kevin C. De Braganca and Stephen Huo
Cancers 2023, 15(24), 5746; https://doi.org/10.3390/cancers15245746
Available online: https://www.mdpi.com/2072-6694/15/24/5746

“Chordoma: A Comprehensive Systematic Review of Clinical Trials”
by Sonja Chen, Ruben Ulloa, Justin Soffer, Roberto J. Alcazar-Felix, Carl H. Snyderman, Paul A. Gardner, Vijay A. Patel and Sean P. Polster
Cancers 2023, 15(24), 5800; https://doi.org/10.3390/cancers15245800
Available online: https://www.mdpi.com/2072-6694/15/24/5800

“Predictive Factors for Chemoradiation-Induced Oral Mucositis and Dysphagia in Head and Neck Cancer: A Scoping Review”
by Alexander J. Nicol, Jerry C. F. Ching, Victor C. W. Tam, Kelvin C. K. Liu, Vincent W. S. Leung, Jing Cai and Shara W. Y. Lee
Cancers 2023, 15(23), 5705; https://doi.org/10.3390/cancers15235705
Available online: https://www.mdpi.com/2072-6694/15/23/5705

“A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population”
by Cynthia Mbuya-Bienge, Nora Pashayan, Cornelia D. Kazemali, Julie Lapointe, Jacques Simard and Hermann Nabi
Cancers 2023, 15(22), 5380; https://doi.org/10.3390/cancers15225380
Available online: https://www.mdpi.com/2072-6694/15/22/5380

“The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis”
by Yu-Cheng Chang, Junmin Song, Yu Chang, Chin-Hsuan Huang, Aarushi Sudan, Pei-Chin Chen and Kuan-Yu Chi
Cancers 2023, 15(21), 5133; https://doi.org/10.3390/cancers15215133
Available online: https://www.mdpi.com/2072-6694/15/21/5133

“A Systematic Review of the Current Status of Magnetic Resonance–Ultrasound Images Fusion Software Platforms for Transperineal Prostate Biopsies”
by Nahuel Paesano, Violeta Catalá, Larisa Tcholakian, Enric Trilla and Juan Morote
Cancers 2023, 15(13), 3329; https://doi.org/10.3390/cancers15133329
Available online: https://www.mdpi.com/2072-6694/15/13/3329

“The Relationship between Thyrotropin Serum Concentrations and Thyroid Carcinoma”
by Xueqi Zhang, Lijun Tian, Di Teng and Weiping Teng
Cancers 2023, 15(20), 5017; https://doi.org/10.3390/cancers15205017
Available online: https://www.mdpi.com/2072-6694/15/20/5017

“Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials”
by Gartrell C. Bowling, Piragash Swargaloganathan, Carly Heintz, Ravi A. Madan, Binil Eldhose, Albert Dobi and Gregory T. Chesnut
Cancers 2023, 15(19), 4904; https://doi.org/10.3390/cancers15194904
Available online: https://www.mdpi.com/2072-6694/15/19/4904

“A Systematic Review of Population-Based Studies of Chronic Bowel Symptoms in Cancer Survivors following Pelvic Radiotherapy”
by Adam Biran, Iakov Bolnykh, Ben Rimmer, Anthony Cunliffe, Lisa Durrant, John Hancock, Helen Ludlow, Ian Pedley, Colin Rees and Linda Sharp
Cancers 2023, 15(16), 4037; https://doi.org/10.3390/cancers15164037
Available online: https://www.mdpi.com/2072-6694/15/16/4037

“Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome—A Systematic Review”
by Francis S. P. L. Wens, Caroline C. C. Hulsker, Marta Fiocco, József Zsiros, Stephanie E. Smetsers, Ronald R. de Krijger, Alida F. W. van der Steeg, Ronald P. Zweemer, Inge O. Baas, Eva Maria Roes et al.
Cancers 2023, 15(15), 3749; https://doi.org/10.3390/cancers15153794
Available online: https://www.mdpi.com/2072-6694/15/15/3794

“Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies”
by Andrealuna Ucciero, Federico Pagnoni, Lorenza Scotti, Alessia Pisterna, Francesco Barone-Adesi, Gianluca Gaidano, Andrea Patriarca and Monia Lunghi
Cancers 2023, 15(18), 4618; https://doi.org/10.3390/cancers15184618
Available online: https://www.mdpi.com/2072-6694/15/18/4618

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

13 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Therapy”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Therapy”. The list of relevant papers can be seen below.

“The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited”
by Kevin Dzobo, Dimakatso A. Senthebane and Collet Dandara
Cancers 2023, 15(2), 376; https://doi.org/10.3390/cancers15020376
Available online: https://www.mdpi.com/2072-6694/15/2/376

“Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches”
by Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik and Viktor Grünwald
Cancers 2023, 15(2), 461; https://doi.org/10.3390/cancers15020461
Available online: https://www.mdpi.com/2072-6694/15/2/461

“Application Prospects of Triphenylphosphine-Based Mitochondria-Targeted Cancer Therapy”
by Xiaoxia Cheng, Dong Feng, Junyu Lv, Xiaoman Cui, Yichen Wang, Qun Wang and Lei Zhang
Cancers 2023, 15(3), 666; https://doi.org/10.3390/cancers15030666
Available online: https://www.mdpi.com/2072-6694/15/3/666

“Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer”
by Houssein Chhouri, David Alexandre and Luca Grumolato
Cancers 2023, 15(2), 504; https://doi.org/10.3390/cancers15020504
Available online: https://www.mdpi.com/2072-6694/15/2/504

“Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)”
by Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat, Isabel Rubio, Jana de Boniface, Nina Ditsch, Güldeniz Karadeniz Cakmak, Andreas Karakatsanis, Rajiv Dave, Markus Hahn et al.
Cancers 2023, 15(4), 1173; https://doi.org/10.3390/cancers15041173
Available online: https://www.mdpi.com/2072-6694/15/4/1173

“Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities”
by Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, Roberto Cairoli, Marco Montillo and Alessandra Tedeschi
Cancers 2023, 15(5), 1504; https://doi.org/10.3390/cancers15051504
Available online: https://www.mdpi.com/2072-6694/15/5/1504

“Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer”
by Vivek P. Chavda,  Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K. Singla, Avinash Khadela, Lalitkumar Vora and Vladimir N. Uversky
Cancers 2023, 15(4), 1023. https://doi.org/10.3390/cancers15041023
Available online: https://www.mdpi.com/2072-6694/15/4/1023

“Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer”
by Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies and Rajesh Singh
Cancers 2023, 15(3), 1320; https://doi.org/10.3390/cancers15041324
Available online: https://www.mdpi.com/2072-6694/15/4/1320

“Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis”
by Jerry C. Lee and Aaron C. Logan
Cancers 2023, 15(6), 1839; https://doi.org/10.3390/cancers15061839
Available online: https://www.mdpi.com/2072-6694/15/6/1839

“The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer”
by Melanie Kirkby, Alyanna M. Popatia, Jessie R. Lavoie and Lisheng Wang
Cancers 2023, 15(19), 4702; https://doi.org/10.3390/cancers15194702
Available online: https://www.mdpi.com/2072-6694/15/19/4702

“Current Perioperative Care in Pancreatoduodenectomy: A Step-by-Step Surgical Roadmap from First Visit to Discharge”
by Tommaso Giuliani, Giampaolo Perri, Ravinder Kang and Giovanni Marchegiani
Cancers 2023, 15(9), 2499. https://doi.org/10.3390/cancers15092499
Available online: https://www.mdpi.com/2072-6694/15/9/2499

“Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis”
by Seong Eun Bak, Hanwool Kim, Jung Yoon Ho, Eun-Hae Cho, Junnam Lee, Sung Min Youn, Seong-Woo Park, Mi-Ryung Han, Soo Young Hur, Sung Jong Lee et al.
Cancers 2023, 15(2), 530; https://doi.org/10.3390/cancers15020530
Available online: https://www.mdpi.com/2072-6694/15/2/530

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

11 March 2024
Cancers | Selected Papers in 2023 in the Section “Molecular Cancer Biology”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Molecular Cancer Biology”. The paper list is as follows:

“PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma”
by Viola Hedrich, Kristina Breitenecker, Gregor Ortmayr, Franziska Pupp, Heidemarie Huber, Doris Chen, Sarthak Sahoo, Mohit Kumar Jolly and Wolfgang Mikulits
Cancers 2023, 15(9), 2415; https://doi.org/10.3390/cancers15092415
Available online: https://www.mdpi.com/2072-6694/15/9/2415

“Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution”
by Federica Giugliano, Ambra Carnevale Schianca, Chiara Corti, Mariia Ivanova, Nadia Bianco, Silvia Dellapasqua, Carmen Criscitiello, Nicola Fusco, Giuseppe Curigliano and Elisabetta Munzone
Cancers 2023, 15(5), 1538; https://doi.org/10.3390/cancers15051385
Available online: https://www.mdpi.com/2072-6694/15/5/1385

“Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies”
by Yuliya Kitsel, Timothy Cooke, Vlasios Sotirchos and Constantinos T. Sofocleous
Cancers 2023, 15(6), 1679; https://doi.org/10.3390/cancers15061679
Available online: https://www.mdpi.com/2072-6694/15/6/1679

“The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond”
by Meghan E. McLean, Maya R. MacLean, Hannah F. Cahill, Raj Pranap Arun, Olivia L. Walker, Marie-Claire D. Wasson, Wasundara Fernando, Jaganathan Venkatesh and Paola Marcato
Cancers 2023, 15(2), 492; https://doi.org/10.3390/cancers15020492
Available online: https://www.mdpi.com/2072-6694/15/2/492

“Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review”
by Graziantonio Lauria, Rosita Curcio, Paola Lunetti, Stefano Tiziani, Vincenzo Coppola, Vincenza Dolce, Giuseppe Fiermonte and Amer Ahmed
Cancers 2023, 15(2), 411; https://doi.org/10.3390/cancers15020411
Available online: https://www.mdpi.com/2072-6694/15/2/411

“Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma”
by Gary Brierly, Antonio Celentano, Omar Breik, Elham Moslemivayeghan, Romeo Patini, Michael McCullough and Tami Yap
Cancers 2023, 15(6), 1841; https://doi.org/10.3390/cancers15061841
Available online: https://www.mdpi.com/2072-6694/15/6/1841

“Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy”
by Hafiza Padinharayil, Vikrant Rai and Alex George
Cancers 2023, 15(4), 1070; https://doi.org/10.3390/cancers15041070
Available online: https://www.mdpi.com/2072-6694/15/4/1070

“Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects”
by Vaikunthavasan Thiruchenthooran, Elena Sánchez-López and Anna Gliszczyńska
Cancers 2023, 15(2), 475; https://doi.org/10.3390/cancers15020475
Available online: https://www.mdpi.com/2072-6694/15/2/475

“An Image-Based Identification of Aggressive Breast Cancer Circulating Tumor Cell Subtypes”
by Mohamed Kamal, Yiru Jess Wang, Sarai Plummer, Amber Dickerson and Min Yu
Cancers 2023, 15(10), 2669; https://doi.org/10.3390/cancers15102669
Available online: https://www.mdpi.com/2072-6694/15/10/2669

“Rapamycin-Induced Feedback Activation of eIF4E-EIF4A Dependent mRNA Translation in Pancreatic Cancer”
by Trang Uyen Nguyen, Harrison Hector, Eric Nels Pederson, Jianan Lin, Zhengqing Ouyang, Hans-Guido Wendel and Kamini Singh
Cancers 2023, 15(5), 1444; https://doi.org/10.3390/cancers15051444
Available online: https://www.mdpi.com/2072-6694/15/5/1444

“Unraveling the Role of Epithelial–Mesenchymal Transition in Adenoid Cystic Carcinoma of the Salivary Glands: A Comprehensive Review”
by Cosima C. Hoch, Fabian Stögbauer and Barbara Wollenberg
Cancers 2023, 15(11), 2886; https://doi.org/10.3390/cancers15112886
Available online: https://www.mdpi.com/2072-6694/15/11/2886

“Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines”
by Juan De los Santos-Jiménez, Tracy Rosales, Bookyung Ko, José A. Campos-Sandoval, Francisco J. Alonso, Javier Márquez, Ralph J. DeBerardinis and José M. Matés
Cancers 2023, 15(2), 531; https://doi.org/10.3390/cancers15020531
Available online: https://www.mdpi.com/2072-6694/15/2/531

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

11 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Metastasis”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Metastasis”. The list of relevant papers can be seen below.

“Experimental Murine Models for Colorectal Cancer Research”
by Íris Neto, João Rocha, Maria Manuela Gaspar and Catarina P. Reis
Cancers 2023, 15(9), 2570; https://doi.org/10.3390/cancers15092570
Available online: https://www.mdpi.com/2072-6694/15/9/2570

“Efficacy of Tango Argentino for Cancer-Associated Fatigue and Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial”
by Friedemann Schad, Thomas Rieser, Sarah Becker, Jessica Groß, Harald Matthes, Shiao Li Oei and Anja Thronicke
Cancers 2023, 15(11), 2920; https://doi.org/10.3390/cancers15112920
Available online: https://www.mdpi.com/2072-6694/15/11/2920

“Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers”
by Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung et al.
Cancers 2023, 15(4), 1326; https://doi.org/10.3390/cancers15041326
Available online: https://www.mdpi.com/2072-6694/15/4/1326

“Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges”
by Carlo Sorrentino and Emma Di Carlo
Cancers 2023, 15(11), 2885; https://doi.org/10.3390/cancers15112885
Available online: https://www.mdpi.com/2072-6694/15/11/2885

“Irreversible Electroporation for Liver Metastases from Colorectal Cancer: A Systematic Review”
by Harry V. M. Spiers, Francesco Lancellotti, Nicola de Liguori Carino, Sanjay Pandanaboyana, Adam E. Frampton, Santhalingam Jegatheeswaran, Vinotha Nadarajah and Ajith K. Siriwardena
Cancers 2023, 15(9), 2428; https://doi.org/10.3390/cancers15092428
Available online: https://www.mdpi.com/2072-6694/15/9/2428

“Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature Review”
by Simona Gaito, Giulia Marvaso, Ramon Ortiz, Adrian Crellin, Marianne C. Aznar, Daniel J. Indelicato, Shermaine Pan, Gillian Whitfield, Filippo Alongi, Barbara Alicja Jereczek-Fossa et al.
Cancers 2023, 15(9), 2489; https://doi.org/10.3390/cancers15092489
Available online: https://www.mdpi.com/2072-6694/15/9/2489

“Epigenetic Rewiring of Metastatic Cancer to the Brain: Focus on Lung and Colon Cancers”
by Annamaria Morotti, Francesco Gentile, Gianluca Lopez, Giulia Passignani, Luca Valenti, Marco Locatelli, Manuela Caroli, Claudia Fanizzi, Stefano Ferrero and Valentina Vaira
Cancers 2023, 15(7), 2145; https://doi.org/10.3390/cancers15072145
Available online: https://www.mdpi.com/2072-6694/15/7/2145

“Efficacy of Thermal Ablation for Small-Size (0–3 cm) versus Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)”
by Madelon Dijkstra, Susan van der Lei, Robbert S. Puijk, Hannah H. Schulz, Danielle J. W. Vos, Florentine E. F. Timmer, Hester J. Scheffer, Tineke E. Buffart, M. Petrousjka van den Tol, Birgit I. Lissenberg-Witte et al.
Cancers 2023, 15(17), 4346; https://doi.org/10.3390/cancers15174346
Available online: https://www.mdpi.com/2072-6694/15/17/4346

“Breast Cancer: How Hippotherapy Bridges the Gap between Healing and Recovery—A Randomized Controlled Clinical Trial”
by Hélène Viruega, Corinne Galy, Célia Loriette, Stéphane Jacquot, Jean Louis Houpeau and Manuel Gaviria
Cancers 2023, 15(4), 1317; https://doi.org/10.3390/cancers15041317
Available online: https://www.mdpi.com/2072-6694/15/4/1317

“Re-Evaluating the Role of PTHrP in Breast Cancer”
by Jeremy F. Kane and Rachelle W. Johnson
Cancers 2023, 15(10), 2670; https://doi.org/10.3390/cancers15102670
Available online: https://www.mdpi.com/2072-6694/15/10/2670

“PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer”
by Edoardo Pastorello, Luca Nicosia, Francesco Cuccia, Laura Olivari, Matilde Fiorini, Niccolò Giaj Levra, Rosario Mazzola, Francesco Ricchetti, Michele Rigo, Paolo Ravelli et al.
Cancers 2023, 15(10), 2800; https://doi.org/10.3390/cancers15102800
Available online: https://www.mdpi.com/2072-6694/15/10/2800

“Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases”
by Camilo E. Fadul, Guneet Sarai, Joseph A. Bovi, Alissa A. Thomas, Wendy Novicoff, Roger Anderson, Ryan F. Amidon, Samantha Schuetz, Rohit Singh, Amy Chang et al.
Cancers 2023, 15(12), 3255; https://doi.org/10.3390/cancers15123255
Available online: https://www.mdpi.com/2072-6694/15/12/3255

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

11 March 2024
Cancers | Colorectal Cancer Awareness Month


Globally, colorectal cancer is the third most diagnosed cancer and ranks second in cancer-related deaths overall. Its screening and early detection have led to improvements in the survival of patients, especially those with early-stage disease; however, for patients who are diagnosed with unresectable metastatic colorectal cancer, the outlook remains grim. In the past decade, developments in targeted therapies have improved patient survival, but the benefits are still modest. While immunotherapies are effective and result in durable responses in a subset of patients, effective therapies for most patients are still required. Additionally, increases in patients with early-onset colorectal cancer present an area of major concern. The roles of liquid biopsies, targeted drug therapies, immunotherapies, and less- as well as non-invasive treatments are some of the evolving horizons in managing and combating this terrible disease.

March is designated as Colorectal Cancer Awareness Month, with various global activities highlighting the importance of screening for colorectal cancer and increasing awareness of colorectal cancer for research support and development.

We would like to take this opportunity to appreciate all the researchers who have contributed to the fight against this disease. In particular, we would like to highlight several topics in this field: early detection, promising therapeutic targets, new therapeutic strategies, the biology of colorectal tumors, and early-onset colorectal cancer. We hope this announcement will provide useful information for basic and translational researchers and help improve clinical practice.

The list of relevant papers can be seen below:

“Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities”
by Himani Pandey, Daryl W. T. Tang, Sunny H. Wong and Devi Lal
Cancers 2023, 15(3), 866; https://doi.org/10.3390/cancers15030866
Available online: https://www.mdpi.com/2072-6694/15/3/866

“Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer”
by Rong He, Heping Zhang, Huaxin Zhao, Xiaolan Yin, Jingyi Lu, Cheng Gu, Jie Gao and Qing Xu
Cancers 2023, 15(2), 387; https://doi.org/10.3390/cancers15020387
Available online: https://www.mdpi.com/2072-6694/15/2/387

“Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape”
by Núria Mulet-Margalef, Jenniffer Linares, Jordi Badia-Ramentol, Mireya Jimeno, Carolina Sanz Monte, José Luis Manzano Mozo and Alexandre Calon
Cancers 2023, 15(4), 1022; https://doi.org/10.3390/cancers15041022
Available online: https://www.mdpi.com/2072-6694/15/4/1022

“Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells”
by Annalisa Contursi, Rosa Fullone, Paulina Szklanna-Koszalinska, Simone Marcone, Paola Lanuti, Francesco Taus, Alessandra Meneguzzi, Giulia Turri, Melania Dovizio, Annalisa Bruno et al.
Cancers 2023, 15(2), 350; https://doi.org/10.3390/cancers15020350
Available online: https://www.mdpi.com/2072-6694/15/2/350

“A Review of Translational Research for Targeted Therapy for Metastatic Colorectal Cancer”
by Samantha M. Ruff and Timothy M. Pawlik
Cancers 2023, 15(5), 1395; https://doi.org/10.3390/cancers15051395
Available online: https://www.mdpi.com/2072-6694/15/5/1395

“Libertellenone T, a Novel Compound Isolated from Endolichenic Fungus, Induces G2/M Phase Arrest, Apoptosis, and Autophagy by Activating the ROS/JNK Pathway in Colorectal Cancer Cells”
by Chathurika D. B. Gamage, Jeong-Hyeon Kim, Yi Yang, İsa Taş, So-Yeon Park, Rui Zhou, Sultan Pulat, Mücahit Varlı, Jae-Seoun Hur, Sang-Jip Nam et al.
Cancers 2023, 15(2), 489; https://doi.org/10.3390/cancers15020489
Available online: https://www.mdpi.com/2072-6694/15/2/489

“Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review”
by Yasmin Cura, Cristina Pérez-Ramírez, Almudena Sánchez-Martín, Cristina Membrive-Jimenez, María Isabel Valverde-Merino, Encarnación González-Flores and Alberto Jiménez Morales
Cancers 2023, 15(6), 1821; https://doi.org/10.3390/cancers15061821
Available online: https://www.mdpi.com/2072-6694/15/6/1821

“The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers”
by Simon Manuel Tria, Matthew E. Burge and Vicki L. J. Whitehall
Cancers 2023, 15(8), 2375; https://doi.org/10.3390/cancers15082375
Available online: https://www.mdpi.com/2072-6694/15/8/2375

“Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal Cancer”
by Zehua Wu, Yi Cheng, Huaiming Wang, Dian Liu, Xiaoxing Qi, Chao Wang, Yuanzhe Zhang, Yuting Zhang, Runkai Cai, Hong Huo et al.
Cancers 2023, 15(2), 554; https://doi.org/10.3390/cancers15020554
Available online: https://www.mdpi.com/2072-6694/15/2/554

“Targeted Therapy in the Palliative Setting of Colorectal Cancer—Survival and Medical Costs”
by Kamuran Inci, Bengt Nilsson, Lars Ny, Ulf Strömberg, Nils Wilking, Stefan Lindskog and Daniel Giglio
Cancers 2023, 15(11), 3022; https://doi.org/10.3390/cancers15113022
Available online: https://www.mdpi.com/2072-6694/15/11/3022

“Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis”
by Jurgis Alvikas, Winifred Lo, Samer Tohme and David A. Geller
Cancers 2023, 15(4), 1179; https://doi.org/10.3390/cancers15041179
Available online: https://www.mdpi.com/2072-6694/15/4/1179

“Stereotactic Body Radiotherapy versus Surgery for Lung Metastases from Colorectal Cancer: Single-Institution Results”
by Nagore Garcia-Exposito, Ricard Ramos, Valentin Navarro-Perez, Kevin Molina, Maria Dolores Arnaiz, Susana Padrones, Jose Carlos Ruffinelli, Cristina Santos, Ferran Guedea and Arturo Navarro-Martin
Cancers 2023, 15(4), 1195; https://doi.org/10.3390/cancers15041195
Available online: https://www.mdpi.com/2072-6694/15/4/1195

You are welcome to submit relevant papers to the Special Issue “Colorectal Cancer Awareness Month”. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office

9 March 2024
Cancers | Selected Papers in 2023 in the Section “Clinical Research of Cancer”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Clinical Research of Cancer”. The list of relevant papers can be seen below.

“The Use of Artificial Intelligence (AI) in the Radiology Field: What Is the State of Doctor–Patient Communication in Cancer Diagnosis?”
by Alexandra Derevianko, Silvia Francesca Maria Pizzoli, Filippo Pesapane, Anna Rotili, Dario Monzani, Roberto Grasso, Enrico Cassano and Gabriella Pravettoni
Cancers 2023, 15(2), 470; https://doi.org/10.3390/cancers15020470
Available online: https://www.mdpi.com/2072-6694/15/2/470

“Lung Cancer as a Leading Cause among Paraneoplastic Non-Bacterial Thrombotic Endocarditis: A Meta-Analysis of Individual Patients’ Data”
by Mohamed Rahouma, Sherif Khairallah, Anas Dabsha, Ismail A. M. H. Elkharbotly, Massimo Baudo, Amr Ismail, Omnia M. Korani, Mohamed Hossny, Arnaldo Dimagli, Leonard N. Girardi et al.
Cancers 2023, 15(6), 1848; https://doi.org/10.3390/cancers15061848
Available online: https://www.mdpi.com/2072-6694/15/6/1848

“Recent Advances in Optimizing Radiation Therapy Decisions in Early Invasive Breast Cancer”
by Nazia Riaz, Tiffany Jeen, Timothy J. Whelan and Torsten O. Nielsen
Cancers 2023, 15(4), 1260; https://doi.org/10.3390/cancers15041260
Available online: https://www.mdpi.com/2072-6694/15/4/1260

“Advances in PARP Inhibitors for Prostate Cancer”
by Steven Tisseverasinghe, Boris Bahoricm, Maurice Anidjar, Stephan Probst and Tamim Niazi
Cancers 2023, 15(6), 1849; https://doi.org/10.3390/cancers15061849
Available online: https://www.mdpi.com/2072-6694/15/6/1849

“Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions”
by John Michael Bryant, Joseph Weygand, Emily Keit, Ruben Cruz-Chamorro, Maria L. Sandoval, Ibrahim M. Oraiqat, Jacqueline Andreozzi, Gage Redler, Kujtim Latifi, Vladimir Feygelman et al.
Cancers 2023, 15(7), 2081; https://doi.org/10.3390/cancers15072081
Available online: https://www.mdpi.com/2072-6694/15/7/2081

“Robotic versus Laparoscopic Partial Nephrectomy in the New Era: Systematic Review”
by Estefanía Ruiz Guerrero, Ana Victoria Ojeda Claro, María José Ledo Cepero, Manuel Soto Delgado and José Luis Álvarez-Ossorio Fernández
Cancers 2023, 15(6), 1793; https://doi.org/10.3390/cancers15061793
Available online: https://www.mdpi.com/2072-6694/15/6/1793

“Emotional, Behavioral, and Physical Health Consequences in Caregivers of Children with Cancer: A Network Analysis Differentiation in Mothers’ and Fathers’ Reactivity”
by Dorella Scarponi, Pierfrancesco Sarti, Veronica Rivi, Chiara Colliva, Elisa Marconi, Andrea Pession and Johanna M. C. Blom
Cancers 2023, 15(13), 3496; https://doi.org/10.3390/cancers15133496
Available online: https://www.mdpi.com/2072-6694/15/13/3496

“From Head and Neck Tumour and Lymph Node Segmentation to Survival Prediction on PET/CT: An End-to-End Framework Featuring Uncertainty, Fairness, and Multi-Region Multi-Modal Radiomics”
by Zohaib Salahuddin, Yi Chen, Xian Zhong, Henry C. Woodruff, Nastaran Mohammadian Rad, Shruti Atul Mali and Philippe Lambin
Cancers 2023, 15(7), 1932; https://doi.org/10.3390/cancers15071932
Available online: https://www.mdpi.com/2072-6694/15/7/1932

“Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm”
by Muhammet Ozer, Charan Thej Reddy Vegivinti, Masood Syed, Morgan E. Ferrell, Cyndi Gonzalez Gomez, Svea Cheng, Jennifer Holder-Murray, Tullia Bruno, Anwaar Saeed and Ibrahim Halil Sahin
Cancers 2023, 15(15), 3833; https://doi.org/10.3390/cancers15153833
Available online: https://www.mdpi.com/2072-6694/15/15/3833

“Systematic Review of Nutrition Interventions to Improve Short Term Outcomes in Head and Neck Cancer Patients”
by Claire Leis, Anna E. Arthur, Xin Chen, Michael W. Greene and Andrew D. Frugé
Cancers 2023, 15(3), 822; https://doi.org/10.3390/cancers15030822
Available online: https://www.mdpi.com/2072-6694/15/3/822

“The Role of Intratumor Microbiomes in Cervical Cancer Metastasis”
by Lu Jiang, Baofeng Duan, Peng Jia, Yan Zhang and Xin Yan
Cancers 2023, 15(2), 509; https://doi.org/10.3390/cancers15020509
Available online: https://www.mdpi.com/2072-6694/15/2/509

“The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells”
by Yuri Tozaki, Hiromasa Aoki, Rina Kato, Kohki Toriuchi, Saki Arame, Yasumichi Inoue, Hidetoshi Hayashi, Eiji Kubota, Hiromi Kataoka and Mineyoshi Aoyama
Cancers 2023, 15(3), 735; https://doi.org/10.3390/cancers15030735
Available online: https://www.mdpi.com/2072-6694/15/3/735

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

8 March 2024
Cancers | Myeloma Awareness Month


March is designated as Myeloma Awareness Month, with various global activities that highlight and increase awareness of myeloma for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of myeloma, which were published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant papers can be seen below.

“Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study”
by Normann Steiner, Georg Göbel, Leonie Mauser, Lena Mühlnikel, Marie Fischinger, Tina Künz, Wolfgang Willenbacher, Gabriele Hetzenauer, Jakob Rudzki, Walter Nussbaumer et al.
Cancers 2021, 13(3), 608; https://doi.org/10.3390/cancers15030608
Available online: https://www.mdpi.com/2072-6694/15/3/608

“Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice”
by Danai Dima, Fauzia Ullah, Sandra Mazzoni, Louis Williams, Beth Faiman, Austin Kurkowski, Chakra Chaulagain, Shahzad Raza, Christy Samaras, Jason Valent et al.
Cancers 2021, 13(7), 2160; https://doi.org/10.3390/cancers15072160
Available online: https://www.mdpi.com/2072-6694/15/7/2160

“Single-Stage versus Multi-Stage Intramedullary Nailing for Multiple Synchronous Long Bone Impending and Pathologic Fractures in Metastatic Bone Disease and Multiple Myeloma”
by Aditya V. Maheshwari, Andriy Kobryn, Juhayer S. Alam and Mikhail Tretiakov
Cancers 2021, 13(4), 1227; https://doi.org/10.3390/cancers15041227
Available online: https://www.mdpi.com/2072-6694/15/4/1227

“Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance”
by Philip Weir, David Donaldson, Mary Frances McMullin and Lisa Crawford
Cancers 2021, 13(6), 1682; https://doi.org/10.3390/cancers15061682
Available online: https://www.mdpi.com/2072-6694/15/6/1682

“Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy”
by Shebli Atrash, Aytaj Mammadzadeh, Fulei Peng, Omar Alkharabsheh, Aimaz Afrough, Wei Cui, Zahra Mahmoudjafari, Al-Ola Abdallah and Hamza Hashmi
Cancers 2021, 13(11), 2891; https://doi.org/10.3390/cancers15112891
Available online: https://www.mdpi.com/2072-6694/15/11/2891

“Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity”
by Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Maria Teresa Petrucci, Francesca Fazio, Stefania Intoppa, Maria Laura Milani, Lucy Kirkham-McCarthy, Robert Henderson, Dawn Swan et al.
Cancers 2021, 13(7), 2154; https://doi.org/10.3390/cancers15072154
Available online: https://www.mdpi.com/2072-6694/15/7/2154

“New Strategies for the Treatment of Older Myeloma Patients”
by Alessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, Benedetto Bruno and Sara Bringhen
Cancers 2021, 13(10), 2693; https://doi.org/10.3390/cancers15102693
Available online: https://www.mdpi.com/2072-6694/15/10/2693

“Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma”
by Abdul Aziz, Haiqin Wang, Yanpeng Wang, Zhenzhen Li, Chaoying Yang, Zekang Ma, Xiaojuan Xiao and Jing Liu
Cancers 2021, 13(5), 1526; https://doi.org/10.3390/cancers15051526
Available online: https://www.mdpi.com/2072-6694/15/5/1526

“Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma”
by Cédric Gillich, Dilara Akhoundova, Michael Hayoz, Yolanda Aebi, Carlo R. Largiadèr, Katja Seipel, Michael Daskalakis, Ulrike Bacher  and Thomas Pabst
Cancers 2021, 13(10), 2699; https://doi.org/10.3390/cancers15102699
Available online: https://www.mdpi.com/2072-6694/15/10/2699

“Understanding DNA Damage Response and DNA Repair in Multiple Myeloma”
by Cole Petrilla, Joshua Galloway, Ruchi Kudalkar, Aya Ismael and Francesca Cottini
Cancers 2021, 13(16), 4155; https://doi.org/10.3390/cancers15164155
Available online: https://www.mdpi.com/2072-6694/15/16/4155

“The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age”
by Agata Tyczyńska, Marcela Krzysława Krzempek, Alexander Jorge Cortez, Artur Jurczyszyn, Katarzyna Godlewska, Hanna Ciepłuch, Edyta Subocz, Janusz Hałka, Anna Kulikowska de Nałęcz and Anna Wiśniewska
Cancers 2021, 13(13), 3469; https://doi.org/10.3390/cancers15133469
Available online: https://www.mdpi.com/2072-6694/15/13/3469

“Intramedullary Nailing with and without the Use of Bone Cement for Impending and Pathologic Fractures of the Humerus in Multiple Myeloma and Metastatic Disease”
by Andriy Kobryn, Patrick Nian, Joydeep Baidya, Tai L. Li and Aditya V. Maheshwari
Cancers 2021, 13(14), 3601; https://doi.org/10.3390/cancers15143601
Available online: https://www.mdpi.com/2072-6694/15/14/3601

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

8 March 2024
Cancers | Selected Papers in 2023 in the Section “Methods and Technologies Development”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Methods and Technologies Development”. The paper list is as follows:

“Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives”
by Daniel M. Girardi, Lara P. Sousa, Thiago A. Miranda, Fernanda N. C. Haum, Gabriel C. B. Pereira and Allan A. L. Pereira
Cancers 2023, 15(6), 1680; https://doi.org/10.3390/cancers15061680
Available online: https://www.mdpi.com/2072-6694/15/6/1680

“Endoscopic Management of Large Non-Pedunculated Colorectal Polyps”
by Oliver Cronin and Michael J. Bourke
Cancers 2023, 15(15), 3805; https://doi.org/10.3390/cancers15153805
Available online: https://www.mdpi.com/2072-6694/15/15/3805

“Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis”
by Anthony-Joe Nassour, Anika Jain, Nicholas Hui, George Siopis, James Symons and Henry Woo
Cancers 2023, 15(2), 506; https://doi.org/10.3390/cancers15020506
Available online: https://www.mdpi.com/2072-6694/15/2/506

“An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4”
by Lavanya Varier, Mohana Sundaram, Naisarg Gamit and Sudha Warrier
Cancers 2023, 15(4), 1275; https://doi.org/10.3390/cancers15041275
Available online: https://www.mdpi.com/2072-6694/15/4/1275

“MR-Class: A Python Tool for Brain MR Image Classification Utilizing One-vs-All DCNNs to Deal with the Open-Set Recognition Problem”
by Patrick Salome, Francesco Sforazzini, Gianluca Brugnara, Andreas Kudak, Matthias Dostal, Christel Herold-Mende, Sabine Heiland, Jürgen Debus, Amir Abdollahi and Maximilian Knoll
Cancers 2023, 15(6), 1820; https://doi.org/10.3390/cancers15061820
Available online: https://www.mdpi.com/2072-6694/15/6/1820

“Artificial Intelligence in Lung Cancer Screening: The Future Is Now”
by Michaela Cellina, Laura Maria Cacioppa, Maurizio Cè, Vittoria Chiarpenello, Marco Costa, Zakaria Vincenzo, Daniele Pais, Maria Vittoria Bausano, Nicolò Rossini, Alessandra Bruno et al.
Cancers 2023, 15(17), 4344; https://doi.org/10.3390/cancers15174344
Available online: https://www.mdpi.com/2072-6694/15/17/4344

“Development of a Novel Intra-Operative Score to Record Diseases’ Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence”
by Alexandros Laios, Evangelos Kalampokis, Racheal Johnson, Sarika Munot, Amudha Thangavelu, Richard Hutson, Tim Broadhead, Georgios Theophilou, David Nugent and Diederick De Jong
Cancers 2023, 15(3), 966; https://doi.org/10.3390/cancers15030966
Available online: https://www.mdpi.com/2072-6694/15/3/966

“Prostate Cancer and Its Mimics—A Pictorial Review”
by Anna Żurowska, Rafał Pęksa, Michał Bieńkowski, Katarzyna Skrobisz, Marek Sowa, Marcin Matuszewski, Wojciech Biernat and Edyta Szurowska
Cancers 2023, 15(14), 3682; https://doi.org/10.3390/cancers15143682
Available online: https://www.mdpi.com/2072-6694/15/14/3682

“Artificial Intelligence Applied to Colonoscopy: Is It Time to Take a Step Forward?”
by Antonio Z. Gimeno-García, Anjara Hernández-Pérez, David Nicolás-Pérez and Manuel Hernández-Guerra
Cancers 2023, 15(8), 2193; https://doi.org/10.3390/cancers15082193
Available online: https://www.mdpi.com/2072-6694/15/8/2193

“Chimp Optimization Algorithm Influenced Type-2 Intuitionistic Fuzzy C-Means Clustering-Based Breast Cancer Detection System”
by Prasanalakshmi Balaji, Vasanthi Muniasamy, Syeda Meraj Bilfaqih, Anandhavalli Muniasamy, Sridevi Tharanidharan, Devi Mani and Linda Elzubir Gasm Alsid
Cancers 2023, 15(4), 1131; https://doi.org/10.3390/cancers15041131
Available online: https://www.mdpi.com/2072-6694/15/4/1131

“Sutureless Purely Off-Clamp Robot-Assisted Partial Nephrectomy: Avoiding Renorrhaphy Does Not Jeopardize Surgical and Functional Outcomes”
by Aldo Brassetti, Leonardo Misuraca, Umberto Anceschi, Alfredo Maria Bove, Manuela Costantini, Maria Consiglia Ferriero, Salvatore Guaglianone, Riccardo Mastroianni, Giulia Torregiani, Marco Covotta et al.
Cancers 2023, 15(3), 698; https://doi.org/10.3390/cancers15030698
Available online: https://www.mdpi.com/2072-6694/15/3/698

“Deep Learning Model Based on Contrast-Enhanced Computed Tomography Imaging to Predict Postoperative Early Recurrence after the Curative Resection of a Solitary Hepatocellular Carcinoma”
by Masahiko Kinoshita, Daiju Ueda, Toshimasa Matsumoto, Hiroji Shinkawa, Akira Yamamoto, Masatsugu Shiba, Takuma Okada, Naoki Tani, Shogo Tanaka, Kenjiro Kimura et al.
Cancers 2023, 15(7), 2140; https://doi.org/10.3390/cancers15072140
Available online: https://www.mdpi.com/2072-6694/15/7/2140

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

7 March 2024
Cancers | Selected Papers in 2023 in the Section “Cancer Informatics and Big Data”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Informatics and Big Data”. The list of relevant papers can be seen below.

“Transcriptomic Maps of Colorectal Liver Metastasis: Machine Learning of Gene Activation Patterns and Epigenetic Trajectories in Support of Precision Medicine”
by Ohanes Ashekyan, Nerses Shahbazyan, Yeva Bareghamyan, Anna Kudryavzeva, Daria Mandel, Maria Schmidt, Henry Loeffler-Wirth, Mohamed Uduman, Dhan Chand, Dennis Underwood et al.
Cancers 2023, 15(15), 3835; https://doi.org/10.3390/cancers15153835
Available online: https://www.mdpi.com/2072-6694/15/15/3835

“Computational Methods Summarizing Mutational Patterns in Cancer: Promise and Limitations for Clinical Applications”
by Andrew Patterson, Abdurrahman Elbasir, Bin Tian and Noam Auslander
Cancers 2023, 15(7), 1958; https://doi.org/10.3390/cancers15071958
Available online: https://www.mdpi.com/2072-6694/15/7/1958

“Comparing Detection Schemes for Adversarial Images against Deep Learning Models for Cancer Imaging”
by Marina Z. Joel, Arman Avesta, Daniel X. Yang, Jian-Ge Zhou, Antonio Omuro, Roy S. Herbst, Harlan M. Krumholz and Sanjay Aneja
Cancers 2023, 15(5), 1548; https://doi.org/10.3390/cancers15051548
Available online: https://www.mdpi.com/2072-6694/15/5/1548

“Machine Learning Algorithms to Predict Breast Cancer Recurrence Using Structured and Unstructured Sources from Electronic Health Records”
by Lorena González-Castro, Marcela Chávez, Patrick Duflot, Valérie Bleret, Alistair G. Martin, Marc Zobel, Jama Nateqi, Simon Lin, José J. Pazos-Arias, Guilherme Del Fiol et al.
Cancers 2023, 15(10), 2741; https://doi.org/10.3390/cancers15102741
Available online: https://www.mdpi.com/2072-6694/15/10/2741

“Identification of a Novel Model for Predicting the Prognosis and Immune Response Based on Genes Related to Cuproptosis and Ferroptosis in Ovarian Cancer”
by Ying Li, Tian Fang, Wanying Shan and Qinglei Gao
Cancers 2023, 15(3), 579; https://doi.org/10.3390/cancers15030579
Available online: https://www.mdpi.com/2072-6694/15/3/579

“Deep Learning Approach to Classify Cutaneous Melanoma in a Whole Slide Image”
by Meng Li, Makoto Abe, Shigeo Nakano and Masayuki Tsuneki
Cancers 2023, 15(6), 1907; https://doi.org/10.3390/cancers15061907
Available online: https://www.mdpi.com/2072-6694/15/6/1907

“Analyses of Genes Critical to Tumor Survival Reveal Potential ‘Supertargets’: Focus on Transcription”
by Darya Chetverina, Nadezhda E. Vorobyeva, Balazs Gyorffy, Alexander A. Shtil and Maksim Erokhin
Cancers 2023, 15(11), 3042; https://doi.org/10.3390/cancers15113042
Available online: https://www.mdpi.com/2072-6694/15/11/3042

“Prediction of the Molecular Subtype of IDH Mutation Combined with MGMT Promoter Methylation in Gliomas via Radiomics Based on Preoperative MRI”
by Yongjian Sha, Qianqian Yan, Yan Tan, Xiaochun Wang, Hui Zhang and Guoqiang Yang
Cancers 2023, 15(5), 1440; https://doi.org/10.3390/cancers15051440
Available online: https://www.mdpi.com/2072-6694/15/5/1440

“Bioinformatics Screen Reveals Gli-Mediated Hedgehog Signaling as an Associated Pathway to Poor Immune Infiltration of Dedifferentiated Liposarcoma”
by Erik P. Beadle, Natalie E. Bennett and Julie A. Rhoades
Cancers 2023, 15(13), 3360; https://doi.org/10.3390/cancers15133360
Available online: https://www.mdpi.com/2072-6694/15/13/3360

“Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma”
by Domenico D’Arca, Leda Severi, Stefania Ferrari, Luca Dozza, Gaetano Marverti, Fulvio Magni, Clizia Chinello, Lisa Pagani, Lorenzo Tagliazucchi, Marco Villani et al.
Cancers 2023, 15(2), 412; https://doi.org/10.3390/cancers15020412
Available online: https://www.mdpi.com/2072-6694/15/2/412

“Multi-Omic Analysis of CIC’s Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity”
by Yuka Takemon, Véronique G. LeBlanc, Jungeun Song, Susanna Y. Chan, Stephen Dongsoo Lee, Diane L. Trinh, Shiekh Tanveer Ahmad, William R. Brothers, Richard D. Corbett, Alessia Gagliardi et al.
Cancers 2023, 15(10), 2805; https://doi.org/10.3390/cancers15102805
Available online: https://www.mdpi.com/2072-6694/15/10/2805

“Revealing Prognostic and Immunotherapy-Sensitive Characteristics of a Novel Cuproptosis-Related LncRNA Model in Hepatocellular Carcinoma Patients by Genomic Analysis”
by Zhenzhen Mao, Ye Nie, Weili Jia, Yanfang Wang, Jianhui Li, Tianchen Zhang, Xinjun Lei, Wen Shi, Wenjie Song and Xiao Zhang
Cancers 2023, 15(2), 544; https://doi.org/10.3390/cancers15020544
Available online: https://www.mdpi.com/2072-6694/15/2/544

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

6 March 2024
Cancers | Selected Papers in 2023 in the Section “Tumor Microenvironment”


We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Tumor Microenvironment”. The paper list is as follows:

“Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment”
by Shouyi Zhang,Tao Shen and Yu Zeng
Cancers 2023, 15(8), 2243; https://doi.org/10.3390/cancers15082243
Available online: https://www.mdpi.com/2072-6694/15/8/2243

“Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma: A Review Based on a Consensus Organized by the Brazilian Association of Veterinary Oncology, ABROVET”
by Andrigo Barboza De Nardi, Cristina de Oliveira Massoco Salles Gomes, Carlos Eduardo Fonseca-Alves, Felipe Noleto de Paiva, Laís Calazans Menescal Linhares, Gabriel João Unger Carra, Rodrigo dos Santos Horta, Felipe Augusto Ruiz Sueiro, Paulo Cesar Jark, Adriana Tomoko Nishiya et al.
Cancers 2023, 15(7), 2025; https://doi.org/10.3390/cancers15072025
Available online: https://www.mdpi.com/2072-6694/15/7/2025

“Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and Resistance”
by Curtis A. Lachowiez, Courtney D. DiNardo and Sanam Loghavi
Cancers 2023, 15(5), 1617; https://doi.org/10.3390/cancers15051617
Available online: https://www.mdpi.com/2072-6694/15/5/1617

“Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages”
by Si-Yuan Li, Yong-Lin Guo, Jia-Wen Tian, He-Jing Zhang, Rui-Fang Li, Ping Gong and Zi-Li Yu
Cancers 2023, 15(10), 2717; https://doi.org/10.3390/cancers15102717
Available online: https://www.mdpi.com/2072-6694/15/10/2717

“Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer”
by Javad Alizadeh, Mahboubeh Kavoosi, Navjit Singh, Shahrokh Lorzadeh, Amir Ravandi, Biniam Kidane, Naseer Ahmed, Fatima Mraiche, Michael R. Mowat and Saeid Ghavami
Cancers 2023, 15(8), 2195; https://doi.org/10.3390/cancers15082195
Available online: https://www.mdpi.com/2072-6694/15/8/2195

“The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment”
by Giuseppina Augimeri, Marco Fiorillo, Catia Morelli, Salvatore Panza, Cinzia Giordano, Ines Barone, Stefania Catalano, Diego Sisci, Sebastiano Andò and Daniela Bonofiglio
Cancers 2023, 15(3), 819; https://doi.org/10.3390/cancers15030819
Available online: https://www.mdpi.com/2072-6694/15/3/819

“Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival”
by Chun-Yu Lin, Kaustuv Basu, Aino Ruusala, Inna Kozlova, Yan-Shuang Li, Spyridon S. Skandalis, Carl-Henrik Heldin and Paraskevi Heldin
Cancers 2023, 15(4), 1082; https://doi.org/10.3390/cancers15041082
Available online: https://www.mdpi.com/2072-6694/15/4/1082

“The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican”
by Aikaterini Berdiaki, Eirini-Maria Giatagana, George Tzanakakis and Dragana Nikitovic
Cancers 2023, 15(14), 3549; https://doi.org/10.3390/cancers15143549
Available online: https://www.mdpi.com/2072-6694/15/14/3549

“The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma”
by Martina Kleber, Ioannis Ntanasis-Stathopoulos and Evangelos Terpos
Cancers 2023, 15(24), 5829; https://doi.org/10.3390/cancers15245829
Available online: https://www.mdpi.com/2072-6694/15/24/5829

“Exploiting the DNA Damage Response for Prostate Cancer Therapy”
by Travis H. Stracker, Oloruntoba I. Osagie, Freddy E. Escorcia and Deborah E. Citrin
Cancers 2024, 16(1), 83; https://doi.org/10.3390/cancers16010083
Available online: https://www.mdpi.com/2072-6694/16/1/83

“NK3.3-Derived Extracellular Vesicles Penetrate and Selectively Kill Treatment-Resistant Tumor Cells”
by Allyson McCune and Jacki Kornbluth
Cancers 2024, 16(1), 90; https://doi.org/10.3390/cancers16010090
Available online: https://www.mdpi.com/2072-6694/16/1/90

“Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers”
by John J. Reiners, Jr., Patricia A. Mathieu, Mary Gargano, Irene George, Yimin Shen, John F. Callaghan, Richard F. Borch and Raymond R. Mattingly
Cancers 2024, 16(1), 89; https://doi.org/10.3390/cancers16010089
Available online: https://www.mdpi.com/2072-6694/16/1/89

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

6 March 2024
Cancers | Kidney Cancer Awareness Month


March is designated as “Kidney Cancer Awareness Month”, with various global activities that highlight and increase awareness of kidney cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of kidney cancer, which were published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant papers can be seen below.

“Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period”
by Pierluca Piselli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Nicola Bossini, Paola Todeschini, Maurizio Iaria, Franco Citterio et al.
Cancers 2023, 15(4), 1347; https://doi.org/10.3390/cancers15041347
Available online: https://www.mdpi.com/2072-6694/15/4/1347

“Protective Effects of Influenza Vaccine against Colorectal Cancer in Populations with Chronic Kidney Disease: A Nationwide Population-Based Cohort Study”
by Chun-Chao Chen, Wen-Rui Hao, Hong-Jye Hong, Kuan-Jie Lin, Chun-Chih Chiu, Tsung-Yeh Yang, Yu-Ann Fang, William Jian, Ming-Yao Chen, Min-Huei Hsu et al.
Cancers 2023, 15(8), 2398; https://doi.org/10.3390/cancers15082398
Available online: https://www.mdpi.com/2072-6694/15/8/2398

“Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century”
by Filip Tichanek, Asta Försti, Akseli Hemminki, Otto Hemminki and Kari Hemminki
Cancers 2023, 15(10), 2782; https://doi.org/10.3390/cancers15102782
Available online: https://www.mdpi.com/2072-6694/15/10/2782

“The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage”
by Annalisa Noce, Giulia Marrone, Manuela Di Lauro, Anna Paola Mitterhofer, Maria Josè Ceravolo, Nicola Di Daniele, Guglielmo Manenti and Antonino De Lorenzo
Cancers 2023, 15(8), 2254; https://doi.org/10.3390/cancers15082254
Available online: https://www.mdpi.com/2072-6694/15/8/2254

“Renal Cell Carcinoma in End-Stage Kidney Disease and the Role of Transplantation”
by Samuel Robinson, Alena Nag, Benjamin Peticca, Tomas Prudencio, Antonio Di Carlo and Sunil Karhadkar
Cancers 2024, 16(1), 3; https://doi.org/10.3390/cancers16010003
Available online: https://www.mdpi.com/2072-6694/16/1/3

“Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma”
by Alireza Ghoreifi, Reza Sari Motlagh and Gerhard Fuchs
Cancers 2023, 15(18), 4495; https://doi.org/10.3390/cancers15184495
Available online: https://www.mdpi.com/2072-6694/15/18/4495

“Kidney Cancer Diagnosis and Surgery Selection by Machine Learning from CT Scans Combined with Clinical Metadata”
by Sakib Mahmud, Tariq O. Abbas, Adam Mushtak, Johayra Prithula and Muhammad E. H. Chowdhury
Cancers 2023, 15(12), 3189; https://doi.org/10.3390/cancers15123189
Available online: https://www.mdpi.com/2072-6694/15/12/3189

“Predictive Risk Score for Acute Kidney Injury in Hematopoietic Stem Cell Transplant”
by Natacha Rodrigues, Mariana Fragão-Marques, Cláudia Costa, Carolina Branco, Filipe Marques, Pedro Vasconcelos, Carlos Martins, Adelino Leite-Moreira and José António Lopes
Cancers 2023, 15(14), 3720; https://doi.org/10.3390/cancers15143720
Available online: https://www.mdpi.com/2072-6694/15/14/3720

“Brown Tumour in Chronic Kidney Disease: Revisiting an Old Disease with a New Perspective”
by Djoko Santoso, Mochammad Thaha, Maulana A. Empitu, Ika Nindya Kadariswantiningsih, Satriyo Dwi Suryantoro, Mutiara Rizki Haryati, Decsa Medika Hertanto, Dana Pramudya, Siprianus Ugroseno Yudho Bintoro, Nasronudin Nasronudin et al.
Cancers 2023, 15(16), 4107; https://doi.org/10.3390/cancers15164107
Available online: https://www.mdpi.com/2072-6694/15/16/4107

“Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms”
by Canxia Shi, Sanne de Wit, Emina Učambarlić, George Markousis-Mavrogenis, Elles M. Screever, Wouter C. Meijers, Rudolf A. de Boer and Joseph Pierre Aboumsallem
Cancers 2023, 15(3), 729; https://doi.org/10.3390/cancers15030729
Available online: https://www.mdpi.com/2072-6694/15/3/729

“Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine”
by Elisa Longhitano, Paola Muscolino, Claudia Lo Re, Serena Ausilia Ferrara, Valeria Cernaro, Guido Gembillo, Dalila Tessitore, Desirèe Speranza, Francesco Figura, Mariacarmela Santarpia et al.
Cancers 2023, 15(6), 1891; https://doi.org/10.3390/cancers15061891
Available online: https://www.mdpi.com/2072-6694/15/6/1891

“Impact of Developing Dialysis-Requiring Acute Kidney Injury on Long-Term Mortality in Cancer Patients with Septic Shock”
by June-Sung Kim, Ye-Jee Kim, Youn-Jung Kim and Won Young Kim
Cancers 2023, 15(14), 3619; https://doi.org/10.3390/cancers15143619
Available online: https://www.mdpi.com/2072-6694/15/14/3619

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

26 February 2024
Cancers | National Cancer Prevention Month


February is designated as National Cancer Prevention Month, with various global activities that highlight and increase awareness of cancer prevention for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of cancer prevention, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review”
by Sergiusz Łukasiewicz, Marcin Czeczelewski, Alicja Forma, Jacek Baj, Robert Sitarz and Andrzej Stanisławek
Cancers 2021, 13(17), 4287; https://doi.org/10.3390/cancers13174287
Available online: https://www.mdpi.com/2072-6694/13/17/4287

“A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis”
by Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, Ewa Niedźwiedzka, Tomasz Arłukowicz and Katarzyna E. Przybyłowicz
Cancers 2021, 13(9), 2025; https://doi.org/10.3390/cancers13092025
Available online: https://www.mdpi.com/2072-6694/13/9/2025

“Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies”
by Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi, Der Jiun Ooi, Akbar John, Ya Chee Lim, K. M. Kaderi Kibria, A.K. M. Mohiuddin, Long Chiau Ming et al.
Cancers 2022, 14(7), 1732; https://doi.org/10.3390/cancers14071732
Available online: https://www.mdpi.com/2072-6694/14/7/1732

“Epidemiology and Prevention of Renal Cell Carcinoma”
by Tomoyuki Makino, Suguru Kadomoto, Kouji Izumi and Atsushi Mizokami
Cancers 2022, 14(16), 4059; https://doi.org/10.3390/cancers14164059
Available online: https://www.mdpi.com/2072-6694/14/16/4059

“Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention”
 by Jadwiga Maniewska and Dagmara Jeżewska
Cancers 2021, 13(4), 594; https://doi.org/10.3390/cancers13040594
Available online: https://www.mdpi.com/2072-6694/13/4/594

“Mother-to-Child Transmission of Human T-Cell Leukemia Virus Type 1: Mechanisms and Nutritional Strategies for Prevention”
by Kazuo Itabashi and Tokuo Miyazawa
Cancers 2021, 13(16), 4100; https://doi.org/10.3390/cancers13164100
Available online: https://www.mdpi.com/2072-6694/13/16/4100

“Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy”
by Yang Li, Maryam B. Lustberg and Shuiying Hu
Cancers 2021, 13(4), 766; https://doi.org/10.3390/cancers13040766
Available online: https://www.mdpi.com/2072-6694/13/4/766

“Fucoxanthin and Colorectal Cancer Prevention”
by Masaru Terasaki, Atsuhito Kubota, Hiroyuki Kojima, Hayato Maeda, Kazuo Miyashita, Chikara Kawagoe, Michihiro Mutoh and Takuji Tanaka
Cancers 2021, 13(10), 2379; https://doi.org/10.3390/cancers13102379
Available online: https://www.mdpi.com/2072-6694/13/10/2379

“Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM)”
by Elena Fasanaro, Paola Del Bianco, Elena Groff, Antonella Riva, Giovanna Petrangolini, Fabio Busato, Paola Stritoni, Giovanni Scarzello, Lucio Loreggian and Gian Luca De Salvo
Cancers 2022, 14(24), 6192; https://doi.org/10.3390/cancers14246192
Available online: https://www.mdpi.com/2072-6694/14/24/6192

“Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future”
by Karla Alfaro, Montserrat Soler, Mauricio Maza, Mauricio Flores, Leticia López, Juan C. Rauda, Andrea Chacón, Patricia Erazo, Nora Villatoro, Eveline Mumenthaler et al.
Cancers 2022, 14(11), 2776; https://doi.org/10.3390/cancers14112776
Available online: https://www.mdpi.com/2072-6694/14/11/2776

“Impact of Distribution of a Tip Sheet to Increase Early Detection and Prevention Behavior among First-Degree Relatives of Melanoma Patients: A Randomized Cluster Trial”
by Diane Marcé, Floriane Le Vilain-Abraham, Morgiane Bridou, Gaelle Quéreux, Alain Dupuy, Thierry Lesimple, Yannick Le Corre, Ewa Wierzbicka-Hainaut, Delphine Legoupil, Philippe Célérier et al.
Cancers 2022, 14(16), 3864; https://doi.org/10.3390/cancers14163864
Available online: https://www.mdpi.com/2072-6694/14/16/3864

“Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review”
by Samuel Oxley, Ran Xiong, Xia Wei, Ashwin Kalra, Michail Sideris, Rosa Legood and Ranjit Manchanda
Cancers 2022, 14(23), 5832; https://doi.org/10.3390/cancers14235832
Available online: https://www.mdpi.com/2072-6694/14/23/5832

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

26 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Metastasis


We are delighted to share some highly viewed papers on cancer metastasis that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“Multidisciplinary Approach to Spinal Metastases and Metastatic Spinal Cord Compression—A New Integrative Flowchart for Patient Management”
by Miguel Esperança-Martins, Diogo Roque, Tiago Barroso, André Abrunhosa-Branquinho, Diogo Belo, Nuno Simas and Luis Costa
Cancers 202315(6), 1796; https://doi.org/10.3390/cancers15061796
Available online: https://www.mdpi.com/2072-6694/15/6/1796

“Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling”
by Carlos Costas-Insua, Marta Seijo-Vila, Cristina Blázquez, Sandra Blasco-Benito, Francisco Javier Rodríguez-Baena, Giovanni Marsicano, Eduardo Pérez-Gómez, Cristina Sánchez, Berta Sánchez-Laorden and Manuel Guzmán
Cancers 2023, 15(9), 2439; https://doi.org/10.3390/cancers15092439
Available online: https://www.mdpi.com/2072-6694/15/9/2439

“Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients”
by Evan N. Cohen, Gitanjali Jayachandran, Hui Gao, Phillip Peabody, Heather B. McBride, Franklin D. Alvarez, Megumi Kai, Juhee Song, Yu Shen, Jie S. Willey et al.
Cancers 2023, 15(5), 1616; https://doi.org/10.3390/cancers15051616
Available online: https://www.mdpi.com/2072-6694/15/5/1616

“Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local Recurrence”
by Ruben Touati, Vincent Bourbonne, Gurvan Dissaux, Gaëlle Goasduff, Olivier Pradier, Charles Peltier, Romuald Seizeur, Ulrike Schick and François Lucia
Cancers 2023, 15(3), 996; https://doi.org/10.3390/cancers15030996
Available online: https://www.mdpi.com/2072-6694/15/3/996

“The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo”
by Lubaid Saleh, Penelope D. Ottewell, Janet E. Brown, Steve L. Wood, Nichola J. Brown, Caroline Wilson, Catherine Park, Simak Ali and Ingunn Holen
Cancers 2023, 15(8), 2211; https://doi.org/10.3390/cancers15082211
Available online: https://www.mdpi.com/2072-6694/15/8/2211

“Biomolecules Involved in Both Metastasis and Placenta Accreta Spectrum—Does the Common Pathophysiological Pathway Exist?”
by Anna K. Rekowska, Karolina Obuchowska, Magdalena Bartosik, Żaneta Kimber-Trojnar, Magdalena Słodzińska, Magdalena Wierzchowska-Opoka and Bożena Leszczyńska-Gorzelak
Cancers 2023, 15(9), 2618; https://doi.org/10.3390/cancers15092618
Available online: https://www.mdpi.com/2072-6694/15/9/2618

Special Issues:

Molecular Pathways in Metastasis of Lung Cancer
Edited by Dr. Hanibal Bohnenberger
Submission deadline: 30 September 2024

Breast Cancer Metastasis: Novel Insights into Molecular Mechanisms and Treatments
Edited by Dr. Delphine Denoyer
Submission deadline: 10 April 2024

Advances in Metastatic Non-small Cell Lung Cancer–Implications on Diagnosis and Treatment as We Head towards 2024
Edited by Dr. Nagashree Seetharamu and Dr. Morana Vojnic
Submission deadline: 31 May 2024

Bone and Spine Metastases
Edited by Dr. Kenichiro Kakutani and Dr. Yutaro Kanda
Submission deadline: 30 June 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

23 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Drug Development


We are delighted to share some highly viewed papers on cancer drug development that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition”
by Kentaro Tokumo, Takeshi Masuda, Taku Nakashima, Masashi Namba, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka et al.
Cancers 2023, 15(4), 1092; https://doi.org/10.3390/cancers15041092
Available online: https://www.mdpi.com/2072-6694/15/4/1092

“Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas”
by Luogen Peng, Yuchan Li, Sha Yao, Jochen Gaedcke, Victor M. Baart, Cornelis F. M. Sier, Albrecht Neesse, Volker Ellenrieder, Hanibal Bohnenberger, Frieder Fuchs et al.
Cancers 2023, 15(5), 1587; https://doi.org/10.3390/cancers15051587
Available online: https://www.mdpi.com/2072-6694/15/5/1587

“The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer”
by Michele Vigolo, Charlotte Urech, Sebastien Lamy, Giulia Monticone, Jovanny Zabaleta, Fokhrul Hossain, Dorota Wyczechowska, Luis Del Valle, Ruth M. O’Regan, Lucio Miele et al.
Cancers 2023, 15(15), 3957; https://doi.org/10.3390/cancers15153957
Available online: https://www.mdpi.com/2072-6694/15/15/3957

“Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride”
by Haichao Xia, Yanran Huang, Lulu Zhang, Lijuan Luo, Xiaoxuan Wang, Qiuping Lu, Jingtao Xu, Chunmei Yang, Habu Jiwa, Shiqiong Liang et al.
Cancers 2023, 15(3), 961; https://doi.org/10.3390/cancers15030961
Available online: https://www.mdpi.com/2072-6694/15/3/961

“Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms”
by Himali Gujrati, Siyoung Ha and Bi-Dar Wang
Cancers 2023, 15(12), 3140; https://doi.org/10.3390/cancers15123140
Available online: https://www.mdpi.com/2072-6694/15/12/3140

“Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues”
by Annalisa Schirizzi, Giampiero De Leonardis, Vincenza Lorusso, Rossella Donghia, Alessandro Rizzo, Simona Vallarelli, Carmela Ostuni, Laura Troiani, Ivan Roberto Lolli, Gianluigi Giannelli et al.
Cancers 2023, 15(8), 2376; https://doi.org/10.3390/cancers15082376
Available online: https://www.mdpi.com/2072-6694/15/8/2376

Special Issues:

Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies

Edited by Dr. Rajeev K. Singla and Prof. Dr. Anupam Bishayee
Submission deadline: 31 December 2024

Cancer Cell Metabolism and Drug Targets

Edited by Dr. Daniel S. Sitar and Prof. Dr. Donald Miller
Submission deadline: 30 June 2024

 

Molecular Mechanisms of Anti-cancer Drugs Action

Edited by Dr. Barbara Pucelik
Submission deadline: 30 May 2024

The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance, Volume II

Edited by Dr. Bi-Dar Wang and Prof. Dr. Luciane R Cavalli
Submission deadline: 29 February 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

22 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Infectious Agents and Cancer


We are delighted to share some highly viewed papers on infectious agents and cancer that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“Increased Prevalence of EBV Infection in Nasopharyngeal Carcinoma Patients: A Six-Year Cross-Sectional Study”
by Abdullah E. Al-Anazi, Bader S. Alanazi, Huda M. Alshanbari, Emad Masuadi, Maaweya E. Hamed, Iman Dandachi, Abdulrahman Alkathiri, Atif Hanif, Islam Nour, Hanadi Fatani et al.
Cancers 2023, 15(3), 643https://doi.org/10.3390/cancers15030643
Available online: https://www.mdpi.com/2072-6694/15/3/643

“Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses”
by Mike Dorothea, Jia Xie, Stephanie Pei Tung Yiu and Alan Kwok Shing Chiang
Cancers 2023, 15(7), 2120; https://doi.org/10.3390/cancers15072120
Available online: https://www.mdpi.com/2072-6694/15/7/2120

“Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder”
by Elshafa Hassan Ahmed, Mark Lustberg, Claire Hale, Shelby Sloan, Charlene Mao, Xiaoli Zhang, Hatice Gulcin Ozer, Sarah Schlotter, Porsha L. Smith, Frankie Jeney et al.
Cancers 2023, 15(11), 3046; https://doi.org/10.3390/cancers15113046
Available online: https://www.mdpi.com/2072-6694/15/11/3046

“Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer”
by Aastha Sobti, Christina Sakellariou, Johan S. Nilsson, David Askmyr, Lennart Greiff and Malin Lindstedt
Cancers 2023, 15(7), 2165; https://doi.org/10.3390/cancers15072165
Available online: https://www.mdpi.com/2072-6694/15/7/2165

“COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study”
by Joaquín Martínez-López, Javier De la Cruz, Rodrigo Gil-Manso, Adrián Alegre, Javier Ortiz, Pilar Llamas, Yolanda Martínez, José-Ángel Hernández-Rivas, Isabel González-Gascón, Celina Benavente et al.
Cancers 2023, 15(5), 1497; https://doi.org/10.3390/cancers15051497
Available online: https://www.mdpi.com/2072-6694/15/5/1497

“Constitutive Expression of a Cytotoxic Anticancer Protein in Tumor-Colonizing Bacteria”
by Phuong-Thu Mai, Daejin Lim, EunA So, Ha Young Kim, Taner Duysak, Thanh-Quang Tran, Miryoung Song, Jae-Ho Jeong and Hyon E. Choy
Cancers 2023, 15(5), 1486; https://doi.org/10.3390/cancers15051486
Available online: https://www.mdpi.com/2072-6694/15/5/1486

Special Issues:

Advances in HPV-Associated Cancers of Different Organs

Edited by Prof. Dr. Adhemar Longatto-Filho and Prof. Dr. Kari Syrjanen
Submission deadline: 15 September 2024

Epstein–Barr Virus (EBV) Associated Cancers

Edited by Dr. Mário Henrique Magalhães Barros and Dr. Paola A. Chabay
Submission deadline: 20 August 2024

 

Potential Therapeutic Targets and Non-invasive Procedures for Improving the Treatment and Follow-Up of HPV-Associated Malignancies

Edited by Dr. Xavier Sastre-Garau
Submission deadline: 15 June 2024

Hepatitis Viruses and Cancer

Edited by Prof. Dr. John Koskinas and Dr. Urania Georgopoulou
Submission deadline: 1 November 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

22 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Epidemiology and Prevention


We are delighted to share some highly viewed papers on cancer epidemiology and prevention that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“NPM 1 Mutations in AML—The Landscape in 2023”
by Naman Sharma and Jane L. Liesveld
Cancers 2023, 15(4), 1177; https://doi.org/10.3390/cancers15041177
Available online: https://www.mdpi.com/2072-6694/15/4/1177

“Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer”
by Ilaria Capasso, Angela Santoro, Emanuela Lucci Cordisco, Emanuele Perrone, Francesca Tronconi, Ursula Catena, Gian Franco Zannoni, Giovanni Scambia, Francesco Fanfani, Domenica Lorusso et al.
Cancers 2023, 15(5), 1400; https://doi.org/10.3390/cancers15051400
Available online: https://www.mdpi.com/2072-6694/15/5/1400

“Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy”
by Florian Poullenot and David Laharie
Cancers 2023, 15(4), 1083; https://doi.org/10.3390/cancers15041083
Available online: https://www.mdpi.com/2072-6694/15/4/1083

“Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000–2018”
by Jamil S. Samaan, Yazan Abboud, Janice Oh, Yi Jiang, Rabindra Watson, Kenneth Park, Quin Liu, Katelyn Atkins, Andrew Hendifar, Jun Gong et al.
Cancers 2023, 15(3), 870; https://doi.org/10.3390/cancers15030870
Available online: https://www.mdpi.com/2072-6694/15/3/870

“In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix and HPV-Type Impact: Pathologic Features, Treatment Options, and Follow-Up Outcomes—Cervical Adenocarcinoma Study Group (CAS-Group)”
by Luca Giannella, Giovanni Delli Carpini, Jacopo Di Giuseppe, Giorgio Bogani, Francesco Sopracordevole, Nicolò Clemente, Giorgio Giorda, Rosa Pasqualina De Vincenzo, Maria Teresa Evangelista, Barbara Gardella et al.
Cancers 2023, 15(11), 2876; https://doi.org/10.3390/cancers15112876
Available online: https://www.mdpi.com/2072-6694/15/11/2876

“Early Onset Colorectal Cancer in Arabs, Are We Dealing with a Distinct Disease?”
by Adhari Al Zaabi, Asmaa Al Shehhi, Shaymaa Sayed, Humaid Al Adawi, Faris Al Faris, Omaima Al Alyani, Maitha Al Asmi, Abdulrahman Al-Mirza, Sathiya Panchatcharam and Maha Al-Shaibi
Cancers 2023, 15(3), 889; https://doi.org/10.3390/cancers15030889
Available online: https://www.mdpi.com/2072-6694/15/3/889

Special Issues:

Cancer and Nutrients

Edited by Dr. Vikas Yadav, Dr. Hardeep Singh Tuli and Prof. Dr. Mukerrem Betul Yerer Aycan
Submission deadline: 20 May 2024

Current Epidemiologic, Diagnostic, and Therapeutic Aspects of Cholangiocarcinoma (CCA)

Edited by Dr. Sven Loosen and Prof. Dr. Christoph Roderburg
Submission deadline: 20 December 2024

 

Innovations in Diagnosis, Prognostic Evaluation, and Therapeutic Management of Gynecologic Tumors

Edited by Dr. Donatella Santini and Dr. Antonio De Leo
Submission deadline: 15 April 2024

Viruses in Cancer Etiology

Edited by Dr. Natalia Issaeva and Prof. Dr. Wendell G. Yarbrough
Submission deadline: 31 May 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

21 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Molecular Cancer Biology


We are delighted to share some highly viewed papers on molecular cancer biology that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of related papers and Special Issues that we believe will interest you:

“Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients”
by Nancy Alnassar, Malgorzata Borczyk, Georgia Tsagkogeorga, Michal Korostynski, Namshik Han and Dariusz C. Górecki
Cancers 2023, 15(5), 1378; https://doi.org/10.3390/cancers15051378  
Available online: https://www.mdpi.com/2072-6694/15/5/1378

“The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy”
by Katarzyna Starska-Kowarska
Cancers 2023, 15(6), 1642; https://doi.org/10.3390/cancers15061642
Available online: https://www.mdpi.com/2072-6694/15/6/1642

“Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges”
by Lorenzo Guidi, Gloria Pellizzari, Paolo Tarantino, Carmine Valenza and Giuseppe Curigliano
Cancers 2023, 15(4), 1130; https://doi.org/10.3390/cancers15041130
Available online: https://www.mdpi.com/2072-6694/15/4/1130

“Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management”
by Leili Rejali, Romina Seifollahi Asl, Fatemeh Sanjabi, Nayeralsadat Fatemi, Hamid Asadzadeh Aghdaei, Mahsa Saeedi Niasar, Pardis Ketabi Moghadam, Ehsan Nazemalhosseini Mojarad, Enrico Mini and Stefania Nobili
Cancers 2023, 15(10), 2746; https://doi.org/10.3390/cancers15102746
Available online: https://www.mdpi.com/2072-6694/15/10/2746

“The BAFF-APRIL System in Cancer”
by Md Ashik Ullah and Fabienne Mackay
Cancers 2023, 15(6), 1791; https://doi.org/10.3390/cancers15061791
Available online: https://www.mdpi.com/2072-6694/15/6/1791

“Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance”
by Sonia Mazumder, Paul J. Higgins and Rohan Samarakoon
Cancers 2023, 15(4), 1316; https://doi.org/10.3390/cancers15041316
Available online: https://www.mdpi.com/2072-6694/15/4/1316

Liver Cancers Molecular Biomarkers Predicting Outcome
Edited by Dr. Nima Kokabi
Submission deadline: 10 July 2024
Molecular Insights into Drug Resistance in Cancer
Edited by Dr. Yang Yuqi
Submission deadline: 30 June 2024
Exosomes in Tumor
Edited by Dr. Sandra E. Ghayad and Dr. Nader Hussein
Submission deadline: 24 June 2024
The Study of Cancer Susceptibility Genes (Volume II)
Edited by Prof. Dr. Youri I. Pavlov
Submission deadline: 25 June 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

21 February 2024
Cancers | Highly Viewed Papers on Systematic Review or Meta-Analysis in Cancer Research


We are delighted to share some highly viewed papers on systematic review or meta-analysis in cancer research that were published in Cancers (ISSN: 2072-6694) in 2023. The following is a list of articles that we believe will interest you:

“Effectiveness of Colorectal Cancer (CRC) Screening on All-Cause and CRC-Specific Mortality Reduction: A Systematic Review and Meta-Analysis”
by Senshuang Zheng, Jelle J. A. Schrijvers, Marcel J. W. Greuter, Gürsah Kats-Ugurlu, Wenli Lu and Geertruida H. de Bock
Cancers 2023, 15(7), 1948; https://doi.org/10.3390/cancers15071948
Available online: https://www.mdpi.com/2072-6694/15/7/1948

“New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review”
by Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, Kalliopi Keramida, Andri Papakonstantinou, Carlo M. Cipolla, Dorothea Tsekoura, Katerina Naka, Ketti Mazzocco, Davide Mauri et al.
Cancers 2023, 15(13), 3290; https://doi.org/10.3390/cancers15133290
Available online: https://www.mdpi.com/2072-6694/15/13/3290

“The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis”
by Robert B. Basmadjian, Kristian Chow, Dayoung Kim, Matthew Kenney, Aysha Lukmanji, Dylan E. O’Sullivan, Yuan Xu, May Lynn Quan, Winson Y. Cheung, Sasha Lupichuk et al.
Cancers 2023, 15(7), 1923; https://doi.org/10.3390/cancers15071923  
Available online: https://www.mdpi.com/2072-6694/15/7/1923

“Occupational Exposures and Risks of Non-Hodgkin Lymphoma: A Meta-Analysis”
by Luiza Flavia Veiga Francisco, Rogério Nunes da Silva, Marco Antônio Oliveira, Martins Fideles dos Santos Neto, Iara Zapparoli Gonçalves, Márcia M. C. Marques and Henrique C. S. Silveira
Cancers 2023, 15(9), 2600; https://doi.org/10.3390/cancers15092600
Available online: https://www.mdpi.com/2072-6694/15/9/2600

“Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis”
by Anna Amela Valsecchi, Rossana Dionisio, Olimpia Panepinto, Jessica Paparo, Andrea Palicelli, Francesca Vignani and Massimo Di Maio
Cancers 2023, 15(9), 2435; https://doi.org/10.3390/cancers15092435
Available online: https://www.mdpi.com/2072-6694/15/9/2435

“Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia”
by Lijuan Wu, Junchao Chen, Ruifen Cai, Xinrui Wang, Yixiao Liu, Qingshan Zheng and Lujin Li
Cancers 2023, 15(10), 2767; https://doi.org/10.3390/cancers15102767
Available online: https://www.mdpi.com/2072-6694/15/10/2767

“Impact of Imaging Biomarkers and AI on Breast Cancer Management: A Brief Review”
by Gehad A. Saleh, Nihal M. Batouty, Abdelrahman Gamal, Ahmed Elnakib, Omar Hamdy, Ahmed Sharafeldeen, Ali Mahmoud, Mohammed Ghazal, Jawad Yousaf, Marah Alhalabi et al.
Cancers 2023, 15(21), 5216; https://doi.org/10.3390/cancers15215216
Available online: https://www.mdpi.com/2072-6694/15/21/5216

“Molecular Characterization and Treatment Approaches for Pediatric H3 K27-Altered Diffuse Midline Glioma: Integrated Systematic Review of Individual Clinical Trial Participant Data”
by Sudarshawn Damodharan, Alexandra Abbott, Kaitlyn Kellar, Qianqian Zhao and Mahua Dey
Cancers 2023, 15(13), 3478; https://doi.org/10.3390/cancers15133478
Available online: https://www.mdpi.com/2072-6694/15/13/3478

“Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time”
by Khizar R. Nandoliya, Nishanth S. Sadagopan, Vineeth Thirunavu, Ethan J. Houskamp, Constantine L. Karras, Rahul K. Chaliparambil, Nikhil Sriram, Pouya Jamshidi, David R. Raleigh, Rimas V. Lukas et al.
Cancers 2023, 15(13), 3374; https://doi.org/10.3390/cancers15133374
Available online: https://www.mdpi.com/2072-6694/15/13/3374

“Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review”
by Adriana Aguilar, Jacques Planas, Enrique Trilla and Juan Morote
Cancers 2023, 15(13), 3479; https://doi.org/10.3390/cancers15133479
Available online: https://www.mdpi.com/2072-6694/15/13/3479

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office


21 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Causes, Screening and Diagnosis


We are delighted to share some highly viewed papers on cancer causes, screening and diagnosis that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review”
by Michael G. Fadel, Mosab Ahmed, Gianluca Pellino, Shahnawaz Rasheed, Paris Tekkis, David Nicol, Christos Kontovounisios and Erik Mayer
Cancers 2023, 15(2), 455; https://doi.org/10.3390/cancers15020455
Available online: https://www.mdpi.com/2072-6694/15/2/455

“Gastric Intestinal Metaplasia: Challenges and the Opportunity for Precision Prevention”
by Douglas Tjandra, Rita A. Busuttil and Alex Boussioutas
Cancers 2023, 15(15), 3913; https://doi.org/10.3390/cancers15153913
Available online: https://www.mdpi.com/2072-6694/15/15/3913

“Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review”
by Alexandra Teixeira, Luís Carreira, Sara Abalde-Cela, Belém Sampaio-Marques, Anabela C. Areias, Paula Ludovico and Lorena Diéguez
Cancers 2023, 15(5), 1362; https://doi.org/10.3390/cancers15051362
Available online: https://www.mdpi.com/2072-6694/15/5/1362

“Targeting the Molecular and Immunologic Features of Leiomyosarcoma”
by Brandon M. Cope, Raymond S. Traweek, Rossana Lazcano, Emily Z. Keung, Alexander J. Lazar, Christina L. Roland and Elise F. Nassif
Cancers 2023, 15(7), 2099; https://doi.org/10.3390/cancers15072099
Available online: https://www.mdpi.com/2072-6694/15/7/2099

“Is Pediatric Melanoma Really That Different from Adult Melanoma? A Multicenter Epidemiological, Clinical and Dermoscopic Study”
by Vincenzo De Giorgi, Elisabetta Magnaterra, Biancamaria Zuccaro, Serena Magi, Manfredi Magliulo, Matelda Medri, Laura Mazzoni, Federico Venturi, Flavia Silvestri, Gian Marco Tomassini et al.
Cancers 2023, 15(6), 1835; https://doi.org/10.3390/cancers15061835
Available online: https://www.mdpi.com/2072-6694/15/6/1835

“Is Pediatric Melanoma Really That Different from Adult Melanoma? A Multicenter Epidemiological, Clinical and Dermoscopic Study”
by Dmitri Pchejetski, Ewan Hunter, Mehrnoush Dezfouli, Matthew Salter, Ryan Powell, Jayne Green, Tarun Naithani, Christina Koutsothanasi, Heba Alshaker, Jiten Jaipuria et al.
Cancers 2023, 15(3), 821; https://doi.org/10.3390/cancers15030821
Available online: https://www.mdpi.com/2072-6694/15/3/821

Special Issues:

Innovations in Soft Tissue Sarcoma Diagnosis and Treatment
Edited by: Dr. Erlinda M. Gordon, Dr. Sant P. Chawla and Dr. Frederick L. Hall
Submission deadline: 30 May 2024
Gynecologic Cancer: From Diagnosis to Treatment
Edited by: Dr. Vito Andrea Capozzi
Submission deadline: 1 July 2024
Diagnosis of Hematologic Malignancies
Edited by: Dr. Leonor Arenillas and Dr. Xavier Calvo
Submission deadline: 25 May 2024
Differential Scanning Calorimetry and Related Thermal Analysis Techniques as Complementary Approaches for Cancer Diagnosis, Prognosis, Monitoring and Assessment of Treatment Response
Edited by: Dr. Nichola C. Garbett
Submission deadline: 1 May 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

21 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Survivorship and Quality of Life


We are delighted to share some highly viewed papers on cancer survivorship and quality of life that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Deep Learning Prediction Model for Patient Survival Outcomes in Palliative Care Using Actigraphy Data and Clinical Information”
by Yaoru Huang, Nidita Roy, Eshita Dhar, Umashankar Upadhyay, Muhammad Ashad Kabir, Mohy Uddin, Ching-Li Tseng and Shabbir Syed-Abdul
Cancers 2023, 15(8), 2232; https://doi.org/10.3390/cancers15082232
Available online: https://www.mdpi.com/2072-6694/15/8/2232  

“Results of DUET: A Web-Based Weight Loss Randomized Controlled Feasibility Trial among Cancer Survivors and Their Chosen Partners”
by Wendy Demark-Wahnefried, Robert A. Oster, Tracy E. Crane, Laura Q. Rogers, W. Walker Cole, Harleen Kaur, David Farrell, Kelsey B. Parrish, Hoda J. Badr, Kathleen Y. Wolin et al.
Cancers 2023, 15(5), 1577; https://doi.org/10.3390/cancers15051577
Available online: https://www.mdpi.com/2072-6694/15/5/1577

“A Scoping Review and a Taxonomy to Assess the Impact of Mobile Apps on Cancer Care Management”
by Eshita Dhar, Adama Ns Bah, Irene Alice Chicchi Giglioli, Silvia Quer, Luis Fernandez-Luque, Francisco J. Núñez-Benjumea, Shwetambara Malwade, Mohy Uddin, Umashankar Upadhyay and Shabbir Syed-Abdul
Cancers 2023, 15(6), 1775; https://doi.org/10.3390/cancers15061775
Available online: https://www.mdpi.com/2072-6694/15/6/1775

“Physician Perceptions on Cancer Screening for LGBTQ+ Patients”
by Nicolas G. Nelson, Joseph F. Lombardo, Ayako Shimada, Marissa L. Ruggiero, Alexandria P. Smith, Kevin Ko, Amy E. Leader, Edith P. Mitchell and Nicole L. Simone
Cancers 2023, 15(11), 3017; https://doi.org/10.3390/cancers15113017
Available online: https://www.mdpi.com/2072-6694/15/11/3017  

“Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review”
by Dania Comparcini, Valentina Simonetti, Francesco Galli, Ilaria Saltarella, Concetta Altamura, Marco Tomietto, Jean-François Desaphy and Giancarlo Cicolini
Cancers 2023, 15(3), 985; https://doi.org/10.3390/cancers15030985
Available online: https://www.mdpi.com/2072-6694/15/3/985

“Oligometastatic Prostate Cancer Treated with Metastasis-Directed Therapy Guided by Positron Emission Tomography: Does the Tracer Matter?”
by Francesco Lanfranchi, Liliana Belgioia, Michela Marcenaro, Elisa Zanardi, Giorgia Timon, Mattia Riondato, Veronica Giasotto, Jeries Paolo Zawaideh, Laura Tomasello, Guglielmo Mantica et al.
Cancers 2023, 15(1), 323; https://doi.org/10.3390/cancers15010323
Available online: https://www.mdpi.com/2072-6694/15/1/323

Special Issues:

Strategies for Cancer Pain Management
Edited by: Prof. Dr. Sebastiano Mercadante
Submission deadline: 30 April 2024
Oncologic Emergencies: The Emergency Care of Cancer Patients
Edited by: Dr. Aiham Qdaisat and Prof. Dr. Sai-Ching Jim Yeung
Submission deadline: 30 April 2024
Prevention and Quality of Life of Lung Cancer
Edited by: Prof. Dr. Servet Bölükbas
Submission deadline: 15 May 2024
Anesthesia and Cancers
Edited by: Dr. Jun Lin, Prof. Dr. James P. Dilger and Dr. Ru Li
Submission deadline: 31 May 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

21 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Therapy


We are delighted to share some highly viewed papers on cancer therapy that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches”
by Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik and Viktor Grünwald
Cancers 2023, 15(2), 461; https://doi.org/10.3390/cancers15020461
Available online: https://www.mdpi.com/2072-6694/15/2/461

“Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)”
by Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat, Isabel Rubio, Jana de Boniface, Nina Ditsch, Güldeniz Karadeniz Cakmak, Andreas Karakatsanis, Rajiv Dave, Markus Hahn et al.
Cancers 2023, 15(4), 1173; https://doi.org/10.3390/cancers15041173
Available online: https://www.mdpi.com/2072-6694/15/4/1173

“Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities”
by Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, Roberto Cairoli, Marco Montillo and Alessandra Tedeschi
Cancers 2023, 15(5), 1504; https://doi.org/10.3390/cancers15051504
Available online: https://www.mdpi.com/2072-6694/15/5/1504

“Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer”
by Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies and Rajesh Singh
Cancers 2023, 15(4), 1320; https://doi.org/10.3390/cancers15041320
Available online: https://www.mdpi.com/2072-6694/15/4/1320

“A Recent Review on Cancer Nanomedicine”
by Paras Mani Giri, Anurag Banerjee and Buddhadev Layek
Cancers 2023, 15(8), 2256; https://doi.org/10.3390/cancers15082256
Available online: https://www.mdpi.com/2072-6694/15/8/2256

“Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment”
by Robert Kleszcz
Cancers 2023, 15(17), 4247; https://doi.org/10.3390/cancers15174247
Available online: https://www.mdpi.com/2072-6694/15/17/4247

Feature Review for Cancer Therapy
Edited by: Dr. Robert Kleszcz and Dr. Jarosław Paluszczak
Submission deadline: 15 May 2024
Correlating Patient-Reported Quality of Life before, during, and after Therapy with Objective Measures and Outcomes
Edited by: Prof. Dr. Anurag K. Singh and Dr. Evan Michael Graboyes
Submission deadline: 5 July 2024
Hepatocellular Carcinoma: Advances and Challenges in Research and Treatment
Edited by: Dr. Huei-Lung Liang
Submission deadline: 30 April 2024
Contemporary Treatment of Colorectal Cancer
Edited by: Dr. Michel Adamina
Submission deadline: 10 December 2024
Advances in Ovarian Cancer Research and Treatment
Edited by: Dr. Maria Barbolina
Submission deadline: 24 October 2024
Innovative Treatment Strategies for Lung Cancer and Radiotherapy
Edited by: Prof. Dr. Fernando Mendes and Prof. Dr. Maria Filomena Botelho
Submission deadline: 15 May 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

20 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Transplant Oncology


We are delighted to share some highly viewed papers on transplant oncology that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology”
by Karen Abboud, Godsfavour Umoru, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, Humaid O. Al-Shamsi, Milind Javle, Ashish Saharia, Ashton A. Connor, Sudha Kodali et al.
Cancers 2023, 15(5), 1433; https://doi.org/10.3390/cancers15051433
Available online: https://www.mdpi.com/2072-6694/15/5/1433

“Prognostic Role of the Intrahepatic Lymphatic System in Liver Cancer”
by Katsunori Sakamoto, Kohei Ogawa, Kei Tamura, Masahiko Honjo, Naotake Funamizu and Yasutsugu Takada
Cancers 2023, 15(7), 2142; https://doi.org/10.3390/cancers15072142
Available online: https://www.mdpi.com/2072-6694/15/7/2142

“Influence of De Novo Malignancies on Long-Term Survival after Lung Transplantation”
by Eloisa Ruiz, Paula Moreno, Francisco Javier Gonzalez, Alba Maria Fernandez, Benito Cantador, Juan Luis Parraga, Angel Salvatierra and Antonio Alvarez
Cancers 2023, 15(15), 4011; https://doi.org/10.3390/cancers15154011
Available online: https://www.mdpi.com/2072-6694/15/15/4011

“Transplant Oncology: An Emerging Discipline of Cancer Treatment”
by Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, David Victor, Sudha Kodali, Yee Lee Cheah, Caroline J. Simon, Mazen Noureddin, Ashton Connor et al.
Cancers 2023, 15(22), 5337; https://doi.org/10.3390/cancers15225337
Available online: https://www.mdpi.com/2072-6694/15/22/5337

“Declined Organs for Liver Transplantation: A Right Decision or a Missed Opportunity for Patients with Hepatocellular Carcinoma?”
by Vladimir J. Lozanovski, Said Adigozalov, Elias Khajeh, Omid Ghamarnejad, Ehsan Aminizadeh, Christina Schleicher, Thilo Hackert, Beat Peter Müller-Stich, Uta Merle, Susanne Picardi et al.
Cancers 2023, 15(5), 1365; https://doi.org/10.3390/cancers15051365
Available online: https://www.mdpi.com/2072-6694/15/5/1365

“Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology”
by Saad Alghamdi and Waleed Al-Hamoudi
Cancers 2023, 15(21), 5115; https://doi.org/10.3390/cancers15215115
Available online: https://www.mdpi.com/2072-6694/15/21/5115

Immunotherapy and Transplantation in the Era of Transplant Oncology

Edited by Dr. Maen Abdelrahim, Dr. Ala Abudayyeh and Dr. Abdullah Esmail
Submission deadline: 31 August 2024

Lung Transplantation and Lung Cancer: Clinical Scenarios, Outcomes and Future Perspectives

Edited by Dr. Andrea Dell'Amore, Dr. Eleonora Faccioli and Dr. Alessio Campisi
Submission deadline: 31 July 2024

 

Liver Transplantation for Cancer: The Future of Transplant Oncology

Edited by Prof. Dr. Tomoharu Yoshizumi
Submission deadline: 30 April 2024

Stem Cell Transplantation on Multiple Myeloma

Edited by Dr. Ho-Jin Shin
Submission deadline: 25 March 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers

Cancers Editorial Office

20 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Informatics and Big Data


We are delighted to share some highly viewed papers on cancer informatics and big data that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer”
by John-Melle Bokhorst, Iris D. Nagtegaal, Inti Zlobec, Heather Dawson, Kieran Sheahan, Femke Simmer, Richard Kirsch, Michael Vieth, Alessandro Lugli, Jeroen van der Laak et al.
Cancers 2023, 15(7), 2079; https://doi.org/10.3390/cancers15072079
Available online: https://www.mdpi.com/2072-6694/15/7/2079

“The Role of AI in Breast Cancer Lymph Node Classification: A Comprehensive Review”
by Josip Vrdoljak, Ante Krešo, Marko Kumrić, Dinko Martinović, Ivan Cvitković, Marko Grahovac, Josip Vickov, Josipa Bukić and Joško Božic
Cancers 2023, 15(8), 2400; https://doi.org/10.3390/cancers15082400
Available online: https://www.mdpi.com/2072-6694/15/8/2400

“Multimodal Data Integration to Predict Severe Acute Oral Mucositis of Nasopharyngeal Carcinoma Patients Following Radiation Therapy”
by Yanjing Dong, Jiang Zhang, Saikt Lam, Xinyu Zhang, Anran Liu, Xinzhi Teng, Xinyang Han, Jin Cao, Hongxiang Li, Francis Karho Lee et al.
Cancers 2023, 15(7), 2032; https://doi.org/10.3390/cancers15072032
Available online: https://www.mdpi.com/2072-6694/15/7/2032

“NRK-ABMIL: Subtle Metastatic Deposits Detection for Predicting Lymph Node Metastasis in Breast Cancer Whole-Slide Images”
by Usama Sajjad, Mostafa Rezapour, Ziyu Su, Gary H. Tozbikian, Metin N. Gurcan and M. Khalid Khan Niazi
Cancers 2023, 15(13), 3428; https://doi.org/10.3390/cancers15133428
Available online: https://www.mdpi.com/2072-6694/15/13/3428

“Comparative Analysis of Three Predictive Models of Performance Indicators with Results-Based Management: Cancer Data Statistics in a National Institute of Health”
by Joel Martínez-Salazar and Filiberto Toledano-Toledano
Cancers 2023, 15(18), 4649; https://doi.org/10.3390/cancers15184649
Available online: https://www.mdpi.com/2072-6694/15/18/4649

“Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis”
by Zeenat Mirza, Md Shahid Ansari, Md Shahid Iqbal, Nesar Ahmad, Nofe Alganmi, Haneen Banjar, Mohammed H. Al-Qahtani and Sajjad Karim
Cancers 2023, 15(12), 3237; https://doi.org/10.3390/cancers15123237
Available online: https://www.mdpi.com/2072-6694/15/12/3237

Artificial Intelligence in Cancer Research: Knowledge Representation and Data Perspectives

Edited by Dr. Catia Pesquita and  Dr. Andreas Schlicker
Views: 8800+
Submission deadline: 15 August 2024

Advances in Cancer Data and Statistics

Edited by Prof. Dr. Vesna Zadnik
Views: 5800+
Submission deadline: 26 April 2024

 

Novel Approaches to Machine Learning and Artificial Intelligence in Cancer Research and Care

Edited by Dr. Caroline Chung and Dr. Christopher Gibbons
Views: 1400+
Submission deadline: 30 September 2024

Next Generation Sequencing for Cancer Diagnostics

Edited by Dr. Gayatry Mohapatra
Views: 900+
Submission deadline: 31 May 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers

Cancers Editorial Office

19 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Clinical Research of Cancer


We are delighted to share some highly viewed papers on clinical research of cancer that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“Current Main Topics in Multiple Myeloma”
by Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Attilio Olivieri and Massimo Offidani
Cancers 2023, 15(8), 2203; https://doi.org/10.3390/cancers15082203
Available online: https://www.mdpi.com/2072-6694/15/8/2203

“Management of Advanced Prostate Cancer in the Precision Oncology Era”
by Claire M. Gillette, Gabriel A. Yette, Scott D. Cramer and Laura S. Graham
Cancers 2023, 15(9), 2552; https://doi.org/10.3390/cancers15092552
Available online: https://www.mdpi.com/2072-6694/15/9/2552

“Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors”
by Vladimir Chernov, Anastasiya Rybina, Roman Zelchan, Anna Medvedeva, Olga Bragina, Nadejda Lushnikova, Artem Doroshenko, Evgeniy Usynin, Liubov Tashireva, Sergey Vtorushin et al.
Cancers 2023, 15(6), 1631; https://doi.org/10.3390/cancers15061631
Available online: https://www.mdpi.com/2072-6694/15/6/1631

“Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment”
by Lien Smets, Annelies Debucquoy, Eva Oldenburger, Chantal Van Audenhove, Lynn Debrun, Jeroen Dekervel, Gabriele Bislenghi, André D’Hoore, Albert Wolthuis and Karin Haustermans
Cancers 2023, 15(3), 806; https://doi.org/10.3390/cancers15030806
Available online: https://www.mdpi.com/2072-6694/15/3/806

“A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma”
by Nam Bui, Hilary Dietz, Sheima Farag, Angela C. Hirbe, Michael J. Wagner, Brian A. Van Tine, Kristen Ganjoo, Robin L. Jones, Vicki L. Keedy and Elizabeth J. Davis
Cancers 2023, 15(9), 2617; https://doi.org/10.3390/cancers15092617
Available online: https://www.mdpi.com/2072-6694/15/9/2617

“Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer”
by Rieneke T. Lugtenberg, Stefanie de Groot, Danny Houtsma, Vincent O. Dezentjé, Annelie J. E. Vulink, Maarten J. Fischer, Johanneke E. A. Portielje, Jacobus J. M. van der Hoeven, Hans Gelderblom, Hanno Pijl et al.
Cancers 2023, 15(6), 1691; https://doi.org/10.3390/cancers15061691
Available online: https://www.mdpi.com/2072-6694/15/6/1691

Bone and Soft Tissue Tumors: Molecular Mechanisms, Clinical Practice, and Emerging Therapeutics
Edited by Prof. Dr. Toshihiro Akisue, Dr. Shintaro Iwata and Dr. Toru Akiyama
Submission deadline: 31 May 2024
The Evolving Treatment and Clinical Trials of Hepatocellular Carcinoma
Edited by Dr. Zachary J. Brown and Dr. John D. Allendorf
Submission deadline: 31 May 2024
Clinical Outcomes in Urologic Cancers
Edited by Dr. Simone Morra and Prof. Dr. Pierre Karakiewicz
Submission deadline: 30 June 2024
Prognostic Factors in Urologic Cancers—Assessment and Integration into Clinical Care
Edited by Prof. Dr. Maximilian Burger and Prof. Dr. Christian Thomas
Submission deadline: 30 June 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

19 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Tumor Microenvironment


We are delighted to share some highly viewed papers on tumor microenvironment that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the ‘NSCLC’ of GI Oncology?”
by Amol Gupta, Razelle Kurzrock and Jacob J. Adashek
Cancers 2023, 15(5), 1578; https://doi.org/10.3390/cancers15051578
Available online: https://www.mdpi.com/2072-6694/15/5/1578

“Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer”
by Samradhi Singh, Poonam Sharma, Devojit Kumar Sarma, Manoj Kumawat, Rajnarayan Tiwari, Vinod Verma, Ravinder Nagpal and Manoj Kumar
Cancers 2023, 15(6), 1913; https://doi.org/10.3390/cancers15061913
Available online: https://www.mdpi.com/2072-6694/15/6/1913

“The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome”
by Kazutoshi Fujita, Makoto Matsushita, Marco A. De Velasco, Koji Hatano, Takafumi Minami, Norio Nonomura and Hirotsugu Uemura
Cancers 2023, 15(5), 1375; https://doi.org/10.3390/cancers15051375
Available online: https://www.mdpi.com/2072-6694/15/5/1375

“Brain Tumor Detection Based on Deep Learning Approaches and Magnetic Resonance Imaging”
by Akmalbek Bobomirzaevich Abdusalomov, Mukhriddin Mukhiddinov and Taeg Keun Whangbo
Cancers 2023, 15(16), 4172; https://doi.org/10.3390/cancers15164172
Available online: https://www.mdpi.com/2072-6694/15/16/4172

“Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response”
by Marylène Lejeune, Laia Reverté, Esther Sauras, Noèlia Gallardo, Ramon Bosch, Albert Roso, Anna Petit, Vicente Peg, Francisco Riu, Joan García-Fontgivell et al.
Cancers 2023, 15(3), 597; https://doi.org/10.3390/cancers15030597
Available online: https://www.mdpi.com/2072-6694/15/3/597

“The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer”
by Pariyada Tanjak, Amphun Chaiboonchoe, Tharathorn Suwatthanarak, Onchira Acharayothin, Kullanist Thanormjit, Jantappapa Chanthercrob, Thanawat Suwatthanarak, Bundit Wannasuphaphol, Kemmapon Chumchuen, Bhoom Suktitipat et al.
Cancers 2023, 15(4), 1098; https://doi.org/10.3390/cancers15041098
Available online: https://www.mdpi.com/2072-6694/15/4/1098

Targeting Signal Transduction Pathways in Cancer
Edited by Dr. Mohd W. Nasser, Prof. Dr. Shahab Uddin, Prof. Dr. Klaus Podar and Dr. Martin Sattler
Submission deadline: 31 March 2024
 “Tumor Microenvironment in Primary Liver Cancer
Edited by Dr. Stefania Mantovani and Dr. Barbara Oliviero
Submission deadline: 28 June 2024
 “Unique Perspectives in Cancer Signaling
Edited by Dr. Peiwen Fei
Submission deadline: 15 September 2024
 Tumor-Associated Microenvironments and Inflammation
Edited by Prof. Dr. Ren Xu and Prof. Dr. Bing Li
Submission deadline: 15 April 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

19 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Methods and Technologies Development


We are delighted to share some highly viewed papers on methods and technologies development that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?”
by Domenico Albano, Giorgio Treglia, Francesco Dondi, Anna Calabrò, Alessio Rizzo, Salvatore Annunziata, Luca Guerra, Silvia Morbelli, Alessandra Tucci and Francesco Bertagna
Cancers 2023, 15(9), 2494; https://doi.org/10.3390/cancers15092494
Available online: https://www.mdpi.com/2072-6694/15/9/2494

“Role of PET/CT in Oropharyngeal Cancers”
by Emily W. Avery, Kavita Joshi, Saral Mehra and Amit Mahajan
Cancers 2023, 15(9), 2651; https://doi.org/10.3390/cancers15092651
Available online: https://www.mdpi.com/2072-6694/15/9/2651

“Artificial Intelligence in CT and MR Imaging for Oncological Applications”
by Ramesh Paudyal, Akash D. Shah, Oguz Akin, Richard K. G. Do, Amaresha Shridhar Konar, Vaios Hatzoglou, Usman Mahmood, Nancy Lee, Richard J. Wong, Suchandrima Banerjee et al.
Cancers 2023, 15(9), 2573; https://doi.org/10.3390/cancers15092573
Available online: https://www.mdpi.com/2072-6694/15/9/2573

“See Lung Cancer with an AI”
by Joanna Bidzińska and Edyta Szurowska
Cancers 2023, 15(4), 1321; https://doi.org/10.3390/cancers15041321
Available online: https://www.mdpi.com/2072-6694/15/4/1321

“Multimodal Deep Learning-Based Prognostication in Glioma Patients: A Systematic Review”
by Kaitlyn Alleman, Erik Knecht, Jonathan Huang, Lu Zhang, Sandi Lam and Michael DeCuypere
Cancers 2023, 15(2), 545; https://doi.org/10.3390/cancers15020545
Available online: https://www.mdpi.com/2072-6694/15/2/545

“Long Axial Field-of-View PET/CT Could Answer Unmet Needs in Gynecological Cancers”
by Elizabeth Katherine Anna Triumbari, Vittoria Rufini, Clemens Mingels, Axel Rominger, Abass Alavi, Francesco Fanfani, Ramsey D. Badawi and Lorenzo Nardo
Cancers 2023, 15(9), 2407; https://doi.org/10.3390/cancers15092407
Available online: https://www.mdpi.com/2072-6694/15/9/2407

The Role of PET Imaging in Oncology: New Advancements in Clinical and Research Setting
Edited by Dr. Pierpaolo Alongi and Dr. Desiree Deandreis
Submission deadline: 31 March 2024
Artificial Intelligence and Machine Learning in Precision Oncology
Edited by Dr. Carmen Belli and Dr. Santosh Anand
Submission deadline: 30 April 2024
Recent Trends in PET/CT Tracer Development and Multimodal Imaging
Edited by Prof. Dr. Olaf Prante and Prof. Dr. Tobias Bäuerle
Submission deadline: 30 June 2024
Radionuclide Therapy and Hybrid Imaging in Oncology
Edited by Dr. Amir Sabet and Prof. Dr. Frank Grünwald
Submission deadline: 29 February 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

7 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Biomarkers in 2023


We are delighted to share some highly viewed papers on cancer biomarkers that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Effect of Selenium and Lycopene on Radiation Sensitivity in Prostate Cancer Patients Relative to Controls”
by Varinderpal S. Dhillon, Permal Deo and Michael Fenech
Cancers 2023, 15(3), 979; https://doi.org/10.3390/cancers15030979
Available online: https://www.mdpi.com/2072-6694/15/3/979

“Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors”
by Yasuyuki Matsumoto and Tongzhong Ju
Cancers 2023, 15(14), 3536; https://doi.org/10.3390/cancers15143536  
Available online: https://www.mdpi.com/2072-6694/15/14/3536

“Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1”
by Jessica M. Logan, Ashley M. Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R. D. Johnson, Shane M. Hickey, Ben S.-Y. Ung et al.
Cancers 2023, 15(12), 3215; https://doi.org/10.3390/cancers15123215  
Available online: https://www.mdpi.com/2072-6694/15/12/3215

“Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data”
by Katrin S. Kurz, Sabrina Kalmbach, Michaela Ott, Annette M. Staiger, German Ott and Heike Horn
Cancers 2023, 15(3), 785; https://doi.org/10.3390/cancers15030785  
Available online: https://www.mdpi.com/2072-6694/15/3/785

“Mucins as Potential Biomarkers for Early Detection of Cancer”
by Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser and Maneesh Jain
Cancers 2023, 15(6), 1640; https://doi.org/10.3390/cancers15061640  
Available online: https://www.mdpi.com/2072-6694/15/6/1640

“LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer”
by Shuaibu Nazifi Sani, Wei Zhou, Balarabe B. Ismail, Yongkui Zhang, Zhijun Chen, Binjie Zhang, Changqian Bao, Houde Zhang and Xiaozhi Wang
Cancers 2023, 15(4), 1186; https://doi.org/10.3390/cancers15041186  
Available online: https://www.mdpi.com/2072-6694/15/4/1186

Head and Neck Cancers—Novel Approaches and Future Outlook
Edited by Dr. Claudia Maletzki
Submission deadline: 31 October 2024
Feature Papers in Section "Cancer Biomarkers" in 2023–2024
Edited by Prof. Dr. Maxim V. Berezovski
Submission deadline: 31 May 2024

Advances in Soft Tissue and Bone Sarcoma
Edited by Dr. Catrin Sian Rutland
Submission deadline: 30 April 2024
 Liquid Biopsy for Lung Cancer Treatment
Edited by Dr. Maria Palmieri and Dr. Frullanti Elisa
Submission deadline: 30 July 2024

PTEN: Regulation, Signalling and Targeting in Cancer
Edited by Dr. Mark G.H. Scott, Dr. Larissa Kotelevets and Dr. Éric Chastre
Submission deadline: 31 December 2024
Genome Sequencing of Cancer: Identifying Targets and Biomarkers for Therapy
Edited by Dr. Haruhiko Takeda
Submission deadline: 25 October 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

 

6 February 2024
Cancers | Highly Viewed Papers and Hot Topic Special Issues on Cancer Immunology and Immunotherapy


We are delighted to share some highly viewed papers on cancer immunology and immunotherapy that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

“Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment”
by Dimitrios C. Ziogas, Charalampos Theocharopoulos, Panagiotis-Petros Lialios, Dimitra Foteinou, Ioannis-Alexios Koumprentziotis, Georgios Xynos and Helen Gogas
Cancers 2023, 15(10), 2718; https://doi.org/10.3390/cancers15102718
Available online: https://www.mdpi.com/2072-6694/15/10/2718

“Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events”
by Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Virginia Arrazubi, Nuria Torrego, Ana Campillo-Calatayud, Iñaki Elejalde, Grazyna Kochan et al.
Cancers 2023, 15(5), 1629; https://doi.org/10.3390/cancers15051629
Available online: https://www.mdpi.com/2072-6694/15/5/1629

“Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes”
by Mefotse Saha Cyrelle Ornella, Narayanasamy Badrinath, Kyeong-Ae Kim, Jung Hee Kim, Euna Cho, Tae-Ho Hwang and Jae-Joon Kim
Cancers 2023, 15(8), 2383; https://doi.org/10.3390/cancers15082383
Available online: https://www.mdpi.com/2072-6694/15/8/2383

“Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma”
by Tatsuya Deguchi, Naoya Maekawa, Satoru Konnai, Ryo Owaki, Kenji Hosoya, Keitaro Morishita, Motoji Nakamura, Tomohiro Okagawa, Hiroto Takeuchi, Sangho Kim et al.
Cancers 2023, 15(11), 3013; https://doi.org/10.3390/cancers15113013
Available online: https://www.mdpi.com/2072-6694/15/11/3013

“Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis”
by Melissa M. De Meza, Willeke A. M. Blokx, Johannes J. Bonenkamp, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. De Groot, John B. A. G. Haanen, Geke A. P. Hospers et al.
Cancers 2023, 15(2), 409; https://doi.org/10.3390/cancers15020409  
Available online: https://www.mdpi.com/2072-6694/15/2/409

“Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma”
by Gitanjali Sharma, Marta C. Braga, Chiara Da Pieve, Wojciech Szopa, Tatjana Starzetz, Karl H. Plate, Wojciech Kaspera and Gabriela Kramer-Marek
Cancers 2023, 15(12), 3131; https://doi.org/10.3390/cancers15123131
Available online: https://www.mdpi.com/2072-6694/15/12/3131

Anticancer Immunity with Physical Treatment Modalities”
Edited by Dr. Sander Bekeschus
Submission deadline: 1 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/GWHKI53P66
Cancer and Immunomediated Inflammatory Diseases (IMIDs)”
Edited by Prof. Dr. Sandro Ardizzone
Submission deadline: 10 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/D63VX78S95

The Tumor Microenvironment and Molecular Aberrations Convey Immune Evasion (Volume II)”
Edited by Prof. Dr. Razelle Kurzrock, Dr. Anwaar Saeed, Dr. Linlin Guo and Dr. Ludimila Cavalcante
Submission deadline: 20 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/4BPEBEU010
Immune Checkpoint Inhibitors for Urologic Cancers”
Edited by Dr. Panagiotis Vlachostergios
Submission deadline: 30 June 2024
Available online: https://www.mdpi.com/journal/cancers/special_issues/9LF513VT85

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

2 February 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Drug Development”


We are pleased to invite you to read the top 10 cited papers in 2023 from the Section “Cancer Drug Development” of Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“Seaweed-Derived Sulfated Polysaccharides; The New Age Chemopreventives: A Comprehensive Review”
by Prajna Paramita Bhuyan, Rabindra Nayak, Srimanta Patra, Hadi Sajid Abdulabbas, Mrutyunjay Jena and Biswajita Pradhan
Cancers 2023, 15(3), 715; https://doi.org/10.3390/cancers15030715
Available online: https://www.mdpi.com/2072-6694/15/3/715

“Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases”
by Christian Bailly and Xavier Thuru
Cancers 2023, 15(7), 2186; https://doi.org/10.3390/cancers15072186
Available online: https://www.mdpi.com/2072-6694/15/7/2186

“Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma”
by Basma Awad, Alaaeldin Ahmed Hamza, Amna Al-Maktoum, Suhail Al-Salam and Amr Amin
Cancers 2023, 15(16), 4063; https://doi.org/10.3390/cancers15164063
Available online: https://www.mdpi.com/2072-6694/15/16/4063

“Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives”
by A K M Helal Morshed, Supti Paul, Arafat Hossain, Tuli Basak, Md. Sanower Hossain, Md. Mehedi Hasan, Md. Al Hasibuzzaman, Tanjim Ishraq Rahaman, Md. Abdur Rashid Mia, Pollob Shing et al.
Cancers 2023, 15(7), 2128; https://doi.org/10.3390/cancers15072128
Available online: https://www.mdpi.com/2072-6694/15/7/2128

“Discovery of Novel Bioactive Tanshinones and Carnosol Analogues against Breast Cancer”
by Miguel A. González-Cardenete, Natalia González-Zapata, Lucinda Boyd and Fatima Rivas
Cancers 2023, 15(4), 1318; https://doi.org/10.3390/cancers15041318
Available online: https://www.mdpi.com/2072-6694/15/4/1318

“Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements”
by Alexandre Bertucci, François Bertucci and Anthony Gonçalves
Cancers 2023, 15(5), 1416; https://doi.org/10.3390/cancers15051416
Available online: https://www.mdpi.com/2072-6694/15/5/1416

“Precision Oncology: Evolving Clinical Trials across Tumor Types”
by I-Wen Song, Henry Hiep Vo, Ying-Shiuan Chen, Mehmet A. Baysal, Michael Kahle, Amber Johnson and Apostolia M. Tsimberidou
Cancers 2023, 15(7), 1967; https://doi.org/10.3390/cancers15071967
Available online: https://www.mdpi.com/2072-6694/15/7/1967

“Naturally Isolated Sesquiterpene Lactone and Hydroxyanthraquinone Induce Apoptosis in Oral Squamous Cell Carcinoma Cell Line”
by Afshan Shams, Ayaz Ahmed, Ajmal Khan, Shariqa Khawaja, Najeeb Ur Rehman, Asma Saleem Qazi, Adnan Khan, Sami Bawazeer, Syed Abid Ali and Ahmed Al-Harrasi
Cancers 2023, 15(2), 557; https://doi.org/10.3390/cancers15020557
Available online: https://www.mdpi.com/2072-6694/15/2/557

“Vemurafenib and Dabrafenib Downregulates RIPK4 Level”
by Ewelina Madej, Anna A. Brożyna, Agnieszka Adamczyk, Norbert Wronski, Agnieszka Harazin-Lechowska, Anna Muzyk, Krzysztof Makuch, Michal Markiewicz, Janusz Rys and Agnieszka Wolnicka-Glubisz
Cancers 2023, 15(3), 918; https://doi.org/10.3390/cancers15030918
Available online: https://www.mdpi.com/2072-6694/15/3/918

“Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas”
by Maria Caffo, Antonello Curcio, Kumar Rajiv, Gerardo Caruso, Mario Venza and Antonino Germanò
Cancers 2023, 15(9), 2575; https://doi.org/10.3390/cancers15092575
Available online: https://www.mdpi.com/2072-6694/15/9/2575

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

1 February 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Immunology and Immunotherapy”


We are pleased to invite you to read the top 10 cited papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Cancer Immunology and Immunotherapy”. We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“CAR-T: What Is Next?”
by Yi-Ju Chen, Bams Abila and Yasser Mostafa Kamel
Cancers 2023, 15(3), 663; https://doi.org/10.3390/cancers15030663
Available online: https://www.mdpi.com/2072-6694/15/3/663

“Immunotherapy in Melanoma: Recent Advances and Future Directions”
by Andrew Knight, Lilit Karapetyan and John M. Kirkwood
Cancers 2023, 15(4), 1106; https://doi.org/10.3390/cancers15041106
Available online: https://www.mdpi.com/2072-6694/15/4/1106

“Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome”
by Liying Li, Fan Zhang, Zhenyu Liu and Zhimin Fan
Cancers 2023, 15(1), 321; https://doi.org/10.3390/cancers15010321
Available online: https://www.mdpi.com/2072-6694/15/1/321

“Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment”
by Carmine Valenza, Beatrice Taurelli Salimbeni, Celeste Santoro, Dario Trapani, Gabriele Antonarelli and Giuseppe Curigliano
Cancers 2023, 15(3), 767; https://doi.org/10.3390/cancers15030767
Available online: https://www.mdpi.com/2072-6694/15/3/767

“Emerging Targeted Therapies for HER2-Positive Breast Cancer”
by María Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro and Roxana Schillaci
Cancers 2023, 15(7), 1987; https://doi.org/10.3390/cancers15071987
Available online: https://www.mdpi.com/2072-6694/15/7/1987

“Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer”
by Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal et al.
Cancers 2023, 15(2), 418; https://doi.org/10.3390/cancers15020418
Available online: https://www.mdpi.com/2072-6694/15/2/418

“Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA)”
by Nic G. Reitsam, Bruno Märkl, Sebastian Dintner, Eva Sipos, Przemyslaw Grochowski, Bianca Grosser, Florian Sommer, Stefan Eser, Pia Nerlinger, Frank Jordan et al.
Cancers 2023, 15(3), 994; https://doi.org/10.3390/cancers15030994
Available online: https://www.mdpi.com/2072-6694/15/3/994

“Complement Activation and Up-Regulated Expression of Anaphylatoxin C3a/C3aR in Glioblastoma: Deciphering the Links with TGF-β and VEGF”
by Franck Ah-Pine, Axelle Malaterre-Septembre, Yosra Bedoui, Mohamed Khettab, James W. Neal, Sébastien Freppel and Philippe Gasque
Cancers 2023, 15(9), 2647; https://doi.org/10.3390/cancers15092647
Available online: https://www.mdpi.com/2072-6694/15/9/2647

“mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth”
by Vita Golubovskaya, John Sienkiewicz, Jinying Sun, Yanwei Huang, Liang Hu, Hua Zhou, Hizkia Harto, Shirley Xu, Robert Berahovich, Walter Bodmer et al.
Cancers 2023, 15(10), 2860; https://doi.org/10.3390/cancers15102860
Available online: https://www.mdpi.com/2072-6694/15/10/2860

“PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma”
by Alexander Yakobson, Ashraf Abu Jama, Omar Abu Saleh, Regina Michlin and Walid Shalata
Cancers 2023, 15(16), 4041; https://doi.org/10.3390/cancers15164041
Available online: https://www.mdpi.com/2072-6694/15/16/4041

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

31 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Pathophysiology”


We are pleased to invite you to read the top 10 cited papers in 2023 from the Section “Cancer Pathophysiology” of Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages”
by Eri Matsubara, Hiromu Yano, Cheng Pan, Yoshihiro Komohara, Yukio Fujiwara, Shukang Zhao, Yusuke Shinchi, Daisuke Kurotaki and Makoto Suzuki
Cancers 2023, 15(8), 2250; https://doi.org/10.3390/cancers15082250
Available online: https://www.mdpi.com/2072-6694/15/8/2250

“The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans”
by Nourhan Hassan, Janes Efing, Ludwig Kiesel, Gerd Bendas and Martin Götte
Cancers 2023, 15(5), 1524; https://doi.org/10.3390/cancers15051524  
Available online: https://www.mdpi.com/2072-6694/15/5/1524

“How Warburg-Associated Lactic Acidosis Rewires Cancer Cell Energy Metabolism to Resist Glucose Deprivation”
by Zoé Daverio, Aneta Balcerczyk, Gilles J. P. Rautureau and Baptiste Panthu
Cancers 2023, 15(5), 1417; https://doi.org/10.3390/cancers15051417
Available online: https://www.mdpi.com/2072-6694/15/5/1417

“Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature”
by Lina Posada Calderon, Lennert Eismann, Stephen W. Reese, Ed Reznik and Abraham Ari Hakimi
Cancers 2023, 15(2), 354; https://doi.org/10.3390/cancers15020354
Available online: https://www.mdpi.com/2072-6694/15/2/354

“Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses”
by Nirmala Chandralega Kampan, Apriliana Ellya Ratna Kartikasari, Cyril Deceneux, Mutsa Tatenda Madondo, Orla M. McNally, Katie Louise Flanagan, Norhaslinda A. Aziz, Andrew N. Stephens, John Reynolds, Michael A. Quinn et al.
Cancers 2023, 15(3), 667; https://doi.org/10.3390/cancers15030667
Available online: https://www.mdpi.com/2072-6694/15/3/667

“Hormone Receptor Expression in Meningiomas: A Systematic Review”
by Mikaël Agopiantz, Mélanie Carnot, Constance Denis, Elena Martin and Guillaume Gauchotte
Cancers 2023, 15(3), 980; https://doi.org/10.3390/cancers15030980
Available online: https://www.mdpi.com/2072-6694/15/3/980

“Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging—Getting Closer to PET-CT”
by Mirela Gherghe, Mario-Demian Mutuleanu, Adina Elena Stanciu, Ionela Irimescu, Alexandra Maria Lazar, Radu Valeriu Toma, Oana Gabriela Trifanescu and Rodica Maricela Anghel
Cancers 2023, 15(3), 696; https://doi.org/10.3390/cancers15030696
Available online: https://www.mdpi.com/2072-6694/15/3/696

“Metastatic Breast Cancer: Review of Emerging Nanotherapeutics”
by Ranga Dissanayake, Rheal Towner and Marya Ahmed
Cancers 2023, 15(11), 2906; https://doi.org/10.3390/cancers15112906
Available online: https://www.mdpi.com/2072-6694/15/11/2906

“Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma”
b
y Juliana Maria Motta, Hebatallah Hassan and Sherif Abdelaziz Ibrahim
Cancers 2023, 15(6), 1794; https://doi.org/10.3390/cancers15061794
Available online: https://www.mdpi.com/2072-6694/15/6/1794

“Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer”
by Giovanni Tossetta, Sonia Fantone, Daniela Marzioni and Roberta Mazzucchelli
Cancers 2023, 15(11), 3037; https://doi.org/10.3390/cancers15113037
Available online: https://www.mdpi.com/2072-6694/15/11/3037

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Pediatric Oncology”


We are pleased to invite you to read the top 10 cited papers in 2023 in the Section “Pediatric Oncology” of Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma”
by Yujia Chen, Chao Zhao, Shenglun Li, Jun Wang and Hongwei Zhang
Cancers 2023, 15(3), 602; https://doi.org/10.3390/cancers15030602
Available online: https://www.mdpi.com/2072-6694/15/3/602

“Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma”
by Pierluigi Calò, Nicolas Pianton, Alexandre Basle, Alexandre Vasiljevic, Marc Barritault, Pierre Aurélien Beuriat, Cécile Faure-Conter and Pierre Leblond
Cancers 2023, 15(4), 1036; https://doi.org/10.3390/cancers15041036
Available online: https://www.mdpi.com/2072-6694/15/4/1036

“Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature”
by Louisa Taylor, Philippa K. Wade, James E. C. Johnson, Macha Aldighieri, Sonia Morlando, Gianpiero Di Leva, Ian D. Kerr and Beth Coyle
Cancers 2023, 15(4), 1086; https://doi.org/10.3390/cancers15041086
Available online: https://www.mdpi.com/2072-6694/15/4/1086

“Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience”
by Adriana Trabal, Amber Gibson, Jiasen He, David McCall, Michael Roth, Cesar Nuñez, Miriam Garcia, Meredith Buzbee, Laurie Toepfer, Aram Bidikian et al.
Cancers 2023, 15(7), 1983; https://doi.org/10.3390/cancers15071983
Available online: https://www.mdpi.com/2072-6694/15/7/1983

“Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma”
by Sheila Terwisscha van Scheltinga, Timothy Rogers, Naima Smeulders, Federica deCorti, Florent Guerin, Ross Craigie, Gabriela Guillén Burrieza, Ludi Smeele, Marinka Hol, Rick van Rijn et al.
Cancers 2023, 15(2), 449; https://doi.org/10.3390/cancers15020449
Available online: https://www.mdpi.com/2072-6694/15/2/449

“Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children’s Hepatic Tumors International Collaboration (CHIC)”
by Angela D. Trobaugh-Lotrario, Rudolf Maibach, Daniel C. Aronson, Arun Rangaswami, Beate Häberle, Allison F. O’Neill, Irene Schmid, Marc Ansari, Tomoro Hishiki, Sarangarajan Ranganathan et al.
Cancers 2023, 15(2), 467; https://doi.org/10.3390/cancers15020467
Available online: https://www.mdpi.com/2072-6694/15/3/467

“Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research”
by Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini and Katia Scotlandi
Cancers 2023, 15(3), 588; https://doi.org/10.3390/cancers15030588
Available online: https://www.mdpi.com/2072-6694/15/3/588

“Implications of an Underlying Beckwith–Wiedemann Syndrome for Wilms Tumor Treatment Strategies”
by Paola Quarello, Diana Carli, Davide Biasoni, Simona Gerocarni Nappo, Carlo Morosi, Roberta Cotti, Emanuela Garelli, Giulia Zucchetti, Manuela Spadea, Elisa Tirtei et al.
Cancers 2023, 15(4), 1292; https://doi.org/10.3390/cancers15041292
Available online: https://www.mdpi.com/2072-6694/15/4/1292

“Somatic, Genetic and Epigenetic Changes in Nephrogenic Rests and Their Role in the Transformation to Wilms Tumors, a Systematic Review”
by Tessa Bánki, Jarno Drost, Marry M. van den Heuvel-Eibrink, Annelies M. C. Mavinkurve-Groothuis and Ronald R. de Krijger
Cancers 2023, 15(5), 1363; https://doi.org/10.3390/cancers15051363
Available online: https://www.mdpi.com/2072-6694/15/5/1363

“Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology”
by Kristin E. Zorn, Ashley M. Cunningham, Alison E. Meyer, Karen Sue Carlson and Sridhar Rao
Cancers 2023, 15(5), 1443; https://doi.org/10.3390/cancers15051443
Available online: https://www.mdpi.com/2072-6694/15/5/1443

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

26 January 2024
Acknowledgment of the Reviewers of Cancers in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Cancers. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Cancers received 21,016 review reports, from 12,496 reviewers. This past year, we worked with reviewers from 88 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Cancers family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. R. M. Saifuddin Ekram Leire Pedrosa
Aadil Javed Lekshmi R. Nath
Aamir Ahmad Leny Jose
Aamir Jalil Leonard Ionut Atanase
Abbas Mardani Leonardo Di Gennaro
Abdolhassan Kazemi Leonardo Roever
Abdou Zoure Leonid Bystrykh
Abdul Razak Mariatulqabtiah Lesley Storey
Abdul Sadiq Letao Fan
Abdullah Gibriel Letizia Deantonio
Abdulqadir Nashwan Li Sun
Abhinav Joshi Li Wang
Abhishek Anant Kulkarni Liam Chen
Abhishek Jha Liang Hu
Abhishek Thavamani Li-Ang Lee
Abraham Wall-Medrano Liang Wang
Achille Aveta Liang Yi
Ada Funaro Liang Zhong
Adam Krysztofiak Licio Collavin
Adam Reich Lidia Santarpia
Adel Al Fatease Lidia Strigari
Adelaida Avino Liewei Wen
Adelina Vlad Liliana Torres-López
Adem Ozcelik Liming Hou
Adetoun Asala Lin Yang
Adi Sarig-Axelrod Linbo Zhao
Aditi Chatterjee Linchong Sun
Adity Pore Ling Yang
Aditya Sarode Linlin Guo
Adrian Costache Liqiang Xi
Adriana Alexandru Lisardo Boscá
Adriana Cifù Liting Wang
Afshan Fathima Nawas Liton Saha
Agalliu Ilir Liudmyla V. Garmanchuk
Agata Pietrzak Livia Ruffini
Agata Poniewierska-Baran Ljubica Harhaji-Trajkovic
Agata Rita Carpentieri lmansour Mansour
Agata Stanek Loic Lemonnier
Agnieszka Bojarska-Junak London Lucien Ooi
Agnieszka Genowska Loredana Albonici
Agnieszka Kosowska Loredana Brioschi
Agnieszka Mazur-Bialy Lorena Landuzzi
Agnieszka Mazurek Lorena Torroni
Agnieszka Micek Lorenza Pecciarini
Agnieszka Potęga Lorenzo Belluomini
Agnieszka Zdzislawa Robaszkiewicz Lorenzo Faggioni
Agustina Portu Lorenzo Magrassi
Ahmad Mobed Lori Rice
Ahmad Samir Alfaar Lori Young
Ahmed Abu-Zaid Louise Hiller
Ahmed Doghish Lourdes Franco
Ahmed Farag Lovorka Brajkovic
Ahmed Hassan Lu Xiao
Ahmed Mahmoud Luca Bertolaccini
Ahmed Noreldin Luca Falzone
Ahmet Cingoz Luca Filippi
Aimin Jiang Luca Giacomelli
Aissa Abderrahmane Luca Giannella
Ajay Kumar Luca Giovanni Locatello
Aki Uutela Luca Ielasi
Akira Umemura Luca Potestio
Akira Yamauchi Luca Scapoli
Akiyoshi Kinoshita Luca Tamagnone
Akiyoshi Takami Lucia Anna Muscarella
Akshata Naik Lucia De Rosa
Alaa Aljabali Lucia Stanciakova
Alain Massart Luciana Bordin
Alba Panarese Lucio Mango
Alberto Anel Lucjusz Zaprutko
Alberto Farolfi Ludmilla Thome Chinen
Alberto Garaventa Ludovico Carbone
Alberto J. Schuhmacher Ludwig Wilkens
Alberto Martino Luigi Gargiulo
Alberto Piana Luigina Vanessa Alemanni
Albrecht Piiper Luís Carlos Lopes-Júnior
Aldo Bove Luis Ibarra
Aldona Kasprzak Luis Jave-Suarez
Alejandro Botero Carvajal Luis Mariano Esteban
Alejandro Islas-Jácome Luiz Vinicius de Sousa
Aleksandr Kichigin Łukasz Lewandowski
Aleksandra Asaturova Łukasz Szeleszczuk
Aleksey A. Nikitin Lukasz Szyc
Alessandra Alì Lunda Shen
Alessandra Gentilini Luxin Sun
Alessandra Sinopoli Lyudmila Bel'skaya
Alessandro Alaimo Maarten Donswijk
Alessandro Caputo Mabel Noemí Brunotto
Alessandro Clivio Maciej Cedzyński
Alessandro Gambella Maciej Jóźwik
Alessandro Gonfiotti Maciej Lalowski
Alessandro Mazzotta Maciej Sobczak
Alessandro Pasculli Maciej Socha
Alessandro Strumia Maciej Ugorski
Alessia Pellerino Maciej Zaborowicz
Alessio Campisi Madhu Atteraya
Alessio D'Alessio Madhubanti Mullick
Alessio Morganti Madhup Rastogi
Alessio Paladini Madhuri Dey
Alex Mohseny Magdalena Emilia Grzybowska
Alexander Bunev Magdalena Machowska
Alexander Dityatev Magdalena Wujak
Alexander Lykov Maged ELghannam
Alexander Sapozhnikov Mahdi Mahdipour
Alexander Shinkov Mahdi Sheikh
Alexander Shtil Mahesh Cheryala
Alexander Yusipovich Mahmoud Elbattah
Alexandra Filippopoulou Mahmoud Khalil
Alexandra Lazar Mahmoud Singer
Alexandra Zakharenko Maike Trommer
Alexandros Laios Maitane Asensio
Alexandros Sykaras Maja Tomicic
Alexandru Florea Makoto Endo
Alexandru Mester Makoto Kawase
Alexey Lipengolts Makoto Nakamura
Alexey Mittenberg Malene Pedersen
Alexsandra Christianne Malaquias Małgorzata Brindell
Alfonso Baldi Małgorzata Klimek
Alfred Ankrah Małgorzata Przybyło
Alfredo J. Lucendo Małgorzata Sobiecka
Ali Afzal Malka Cohen-Armon
Ali Maleki Man Qu
Ali Memarian Manfred Schmidt
Ali Raza Mangesh Thorat
Ali Salehzadeh-Yazdi Manish Dhawan
Ali Zarrabi Manish Moghe
Alicia Viloria-Petit Manjit Kaur
Alin Laurentiu Tatu Manju Singh
Alin Mihai Vasilescu Manlio Tolomeo
Alina Deshpande Manoj Sharma
Alina Falborg Manolis Fousteris
Alina-Andreea Zimta Manpreet Singh
Alin-Constantin Pînzariu Mansoor Hussain
Alisa Gisina Mansoor-Ali Vaali-Mohammed
Alison Michie Manuel Díez-Alonso
Allison Martin Manuel Durán-Poveda
Alvaro Manuel Rodriguez-Rodriguez Manuel Gomez del Moral
Amalia Ceausu Manuel Muro
Amelia Barcellini Manuel Valenzuela
Amelia Maria Gaman Manuela Andrea Hoffmann
America Vanoye-carlo Mara A. Bonelli
Amin Tamadon Mara Carsote
Amin Zehtabian Marcel Adler
Amine Khaldi Marcel Gutberlet
Amir Ashoorzadeh Marcela Lizano
Amir Sasan Mozaffari Nejad Marcella Nunziato
Amirmasoud Ahmadi Marcello Di Martino
Amit L. Jain Marcelo Moura
Amit Mehndiratta Marcin Jozwik
Amit Pandey Marco Antonio Meraz-Ríos
Amiya Patra Marco Calvaruso
Ammad Ahmad Farooqi  Marco Ciotti
Amr Ahmed El-Arabey Marco Dolci
Ana Andabak Rogulj Marco Folini
Ana Aurora Diaz Gavela Marco Gallo
Ana Duarte Marco Maruzzo
Ana Guerreiro Marco Montillo
Ana I. Faustino-Rocha Marco Orecchioni
Ana Luísa De Sousa-Coelho Marco Tonello
Ana Maria Eijan Marcus Horstmann
Ana P. Santos Marcus Mareel
Ana Podolski-Renić Marcus Schmidt
Ana Ureba Marek Bolanowski
Anastasia Karlsen Marek Murias
Anastasios Serbis Marek Sarissky
Anatoli Popov Margarida Julià-Sapé
Anca Colita Margherita Eufemi
Anca Loredana Udriștoiu Margherita Mottola
Anca-Maria Cimpean Margherita Neri
Anders Lade Nielsen Margherita Puppo
Anders Örbom Maria A. Bonifacio
Anders Palmstrøm Jørgensen Maria Addolorata Mariggiò
Anders Strom Maria Angeles Rojo
András Szász Maria Begoña Criado
Andre Luis Barros Maria Botelho
Andre Luiz Costa Maria Brattsand
Andrea Antonuzzo Maria Concetta Cufaro
Andrea Carai Maria Cristina Cangussú
Andrea Cavazzoni Maria Cristina De Martino
Andrea Cimini Maria da Glória Queiroz
Andrea Dekanić Maria Dolores Vázquez-Carretero
Andrea Di Cristofori Maria Elena Padín-Iruegas
Andrea Emanuele Guerini María Esperanza Cerdán
Andrea Franson Maria Fortofoiu
Andrea Furka Maria Gabriela Raso
Andrea Galli Maria Gaczynska
Andrea Giannini Maria Gazouli
Andrea Kleindienst Maria Giulia Cangi
Andrea Mari Maria Gomes da Silva
Andrea Mastinu Maria Julia Lamberti
Andrea Re Cecconi Maria Kapritsou
Andrea Sbrana Maria Loureiro
Andrea Tinelli Maria Lucibello
Andrei Adrian Tica Maria Luisa Belli
Andrei Colita Maria Orsaria
Andrei Marian Feier Maria Papaioannou
Andreia C. De Melo Maria Patrizia Stoppelli
Andres Garcia-Montero María Paula García
Andres Tittarelli Maria Perepechaeva
Andrew A. Gumbs Maria Ristaldi
Andrew Murphy Maria Rosaria De Miglio
Andrew Redfern Maria Samara
Andrew Stoker Maria V. T. Lobo
Andrey Sgibnev Maria Wostrack
Andrey Sudarikov Mariaconsiglia Ferriero
Andrey Zamyatnin Marialuisa Lugaresi
Andy T. Y. Lau Mariana Floria
Andy Tan Mariangela De Robertis
Anelia Horvath Mariangela Mancini
Aneta Klotzka Mariano Andrés
Ángel Luis García-Otín Mariano Bizzarri
Angela Bentivegna Mariano Francesco Caratozzolo
Angela Grassi Mariarosaria Boccellino
Angeliki Katsafadou Mariarosaria Calvello
Angeliki Magklara Marica Eoli
Angelo Naselli Marie Černá
Ania Wisniak Marie Louisa Antoni
Anil Kumar Marie-Claude Geoffroy
Anil Kumar Yadav Mariia Ivanova
Anish Ray Marijana Virijevic
Anita Kloss-Brandstätter Marika Quadri
Anja Kathrin Wege Marina Gottikh
Anja Rinke Marine Gasparian
Anjali Geethadevi Marino Paroli
Ankit Shroff Marino Venerito
Ann Hopkins Mario Serradilla-Martín
Anna Aureli Mario Valenti
Anna Caterina Milanetto Mario Vega
Anna Cleta Croce Mariola Borowska
Anna Furlan Mariola Dutkiewicz
Anna Kasielska-Trojan Marios Spanakis
Anna Koumarianou Mariusz Hartman
Anna Santarsiero Mariusz Klencki
Anna Siemiątkowska Mariusz Niemczyk
Anna Sobiepanek Marjo Campmans-Kuijpers
Anna Staniszewska Mark J. Roef
Annalisa Arcari Mark ter Laan
Annalisa Chianese Mark Ward
Annamaria Aloisio Marko Barjaktarovic
Anna-Maria Barciszewska Marko Spasic
Annarita Nappi Markus Albertsmeier
Anne Blank Markus Wilhelmi
Annelies M.C. Mavinkurve-Groothuis Marlena Godlewska
Anne-Marie Kanstrup Fiehn Marshall Williams
Anne-Sophie Wozny Marta Araujo-Castro
Annette Pfahlberg Marta de Laranjeira
Anneza Yiallourou Marta Elena Losa Iglesias
Anthony William Coleman Marta F. Estrada
Antimo Di Maro Marta Grabowska
Antoine Naem Marta Jóźwiak-Bębenista
Anton Tkachenko Marta Rossi
Antonella Caivano Marta Szekalska
Antonia Busse Martha Gallegos
Antonino Foti Martin Böttcher
Antonio Álvarez-Kindelán Martin Gazvoda
Antonio Bertoletti Martin M. Mortazavi
António Ferreira Martin Meier
antonio francesco cicione Martin Stanulla
Antonio Fuentes-Fayos Martin Thomsen
Antonio Gidaro Martina Baiardo Redaelli
Antonio J. Salinas Martina Echtenbruck
Antonio Juretić Martina Kleber
Antonio Marí-Roig Martina Maggi
Antonio Nenna Martina Smolic
Antonio Oliveira Martyn A. Sharpe
António Polónia Martyna Krzykawska-Serda
Antonio Pontoriero Mary Cutler
Antonio Raffone Mary Luz Uribe
Antonio Rodríguez Almeida Maryam Farooqui
Antonio Solana-Altabella Marzia Di Donato
Antonio Sommariva Marzia Pucci
Antti Silvoniemi Masaharu Hata
Anupam Mukherjee Masaki Nagaya
Anwar Ali Masaki Shimbo
Ao Zhang Masako Harada
Apostolos Papachristos Masako Shomura
Apostolos Tsolakis Masamichi Mizuma
Apostolos Zaravinos Masanori Someya
Aravind Thavamani Masao Murakami
Archya Dasgupta Masashi Yagi
Arda Isik Masayoshi Yada
Arianna Dal Buono Masayoshi Yamaguchi
Arianna D'Angelo Massimiliano Ammirabile
Aristotelis Perrakis Massimiliano Creta
Arjun Singh Massimiliano di Pietro
Armando Orlandi Massimiliano Mancini
Armando Patrizio Massimiliano Veroux
Armin Zebisch Massimo Broggini
Arnab Ghosh Mateusz Jacek Spałek
Arong Gaowa Mathew Kozman
Arrigo Cicero Mats Remberger
Arthur Lustig Matt Spick
Artur Słomka Matteo Bauckneht
Arun Renganathan Matteo Bocci
Arunaksharan Narayanankutty Matteo Calvaresi
Arunkumar Venkatesan Matteo Riccò
Arvind Kumar Shukla Matthew Benesch
Ashish Kabra Matthew Bottomley
Ashish Pandey Matthew Painschab
Ashwani Sharma Matthew Taylor
Asmat Ullah Matthias Kapischke
Asokan Ramasamy Matthias Müller
Atanu Khatua Matthias Ocker
Atar Singh Kushwah Mattia Russel Pantalone
Atefeh Najafi Maureen Drakes
Athanasios Bikas Maurice Collins
Athanasios Pantelis Mauricio Rodríguez-Dorantes
Athanasios Papadopoulos Maurizio Iacobone
Athanasios Papakyriakou Maurizio Parola
Atheer Zgair Mauro Giacomelli
Athina Giannoudis Mauro Lombardo
Atsushi Makimoto Maximilian Deußing
Atsuto Katano Maximilian Scheer
Audrius Dulskas Mayrel Palestino Dominguez
Aurora Nedelcu Mayur Virarkar
Avik Dutta Md Sayeed Akhtar
Avinaash Maharaj Md. Shariful Islam
Axel Semjonow Meerambika Mishra
Ayaz Ahmed Mehdi Moghanibashi
Aydin Eresen Mehdi Montazer
Ayse Gunes-Bayir Mehraju Lone
Ayslan Brant Meifang Li
B.H. Jaswanth Gowda Meijun Du
Babak Nami Meir Barak
Babita Kumari Verma Melis Palamar
Bac Viet Le Mengdi Bao
Bacem Khalele Mengze Lyu
Bailin Zhao Mercedes Mitjavila Casanovas
Baiyan Li Merry Tetef
Baiye Ruan Merve Kulbay
Bal Lokeshwar Meysam Keshavarz
Balakumar Chandrasekaran Mi Ran Choi
Balazs Murnyak Michael Bauer
Bálint Tamaskovics Michael Bette
Bang Manh Tran Michael Calcutt
Bangli Hu Michael Diamantidis
Baoquan Liu Michael Eccles
Baotong Zhang Michael Goetz
Barani Kumar Rajendran Michael Grusch
Barbara Bachtiary Michael Kelly
barbara Corti Michael Lee
Barbara Ruaro Michael Liebman
Bart Neyns Michael Morgan
Bart Westendorp Michael Osseis
Bartłomiej Barczyński Michael Paulussen
Bartlomiej Krazinski Michael Petronek
Bartłomiej Potaniec Michael Pinkawa
Bartosz Małkiewicz Michael Schwake
Baryshev Mikhail Michael Weichhaus
Basveshwar Gawali Michaela Cellina
Beata Morak-Młodawska Michail Mavros
Beatrice Albanesi Michail Sarafidis
Beenu Moza Jalali Michał Gontarz
Behnoush Abedi-Ardekani Michał Kulus
Bela Ozsvari Michal Ordak
Benedetta Donati Michal Rahat
Benedikt Engels Michal Šmída
Benedikt Hofauer Michalis V. Karamouzis
Beniamin Grabarek Michele Bartoletti
Benita McVicker Michele Bernasconi
Benjamin Rolles Michele Boffano
Benjamin Teply Michele Finotti
Benoit Miotto Michele Graciotti
Berenika Szczęśniak-Sięga Michele Manganelli
Bernadett Papp Michele Pietragalla
Bernardo Cacho-Díaz Michele Samaja
Bernardo Pereira Michele Sica
Bernardo Vega Crespo Miguel A. Ortega
Bernd Kaina Miguel Alcaraz
Beth Cadugan Miguel Ángel Rodríguez-Milla
Beyza Goncu Miguel Lopez-Gonzalez
Bhaumik Pandya Miguel Mayol Del Valle
Bhoomika Patel Miguel Muñoz
Bhupesh Kumar Thakur Mihaela Ionica
Bhuvanesh Kalal Mihaela Moscalu
Bihe Cai Mihaela Niculae
Biliana Nikolova Mihaela Vlad
Bin Liu Mihai Capilna
Bin Qiu Mihai Georgescu
Bin Wang Mihai Stefan Muresan
Binbin Wang Mihalj Poŝa
Binfeng Yin Mihaly Cserepes
Bingyan Li Mikael Lindström
Binu Kandathilparambil Sasi Mikhail Inyushin
Birgitta I. Hiddinga Mikhail Vorob'ev
Biswarup Saha Milad Rasouli
Björn Nashan Milan Reiniš
Blanca Estela García-Pérez Milan Toma
Blanca Lumbreras Lacarra Milica Aćimović
Blažen Marijić Milica Markelic
Bo Liu Milica Pešić
Bobirca Florin Milica Vukotić
Bodhisattwa Banerjee Miloš Mitić
Bogdan Socea Miloš Vittori
Bogdan-Mircea Mihai Miltiadis Fiorentzis
Bogomir Milojevic Min Hwa Shin
Bojarska Joanna Min Kyu Kang
Boleslaw T. Karwowski Min Soon Cho
Boris Minaev Min Wook Joo
Boryana Nikolova-Mladenova Minehiko Inomata
Bouke P. Hazenberg Mineko Terao
Boyan K. Garvalov Ming Xu
Brandon Huffman Mingjian Shi
Bratko Filipic Ming-Ju Hsieh
Brian D. Adams Mingli Li
Brian Wadugu Mingliang Li
Brigid Betz-Stablein Ming-Shiou Jan
Brigitte Bauvois Minhyeok Lee
Brigitte Hantusch Minjia Wang
Brigitte Kerfelec Miquéias Lopes-Pacheco
Brigitte Trétarre Miquel Armengot-Carbó
Bruno Bueno-Silva Mirabela Alecsa
Bruno Eto Mircea-Catalin Fortofoiu
Bruno Fionda Mirco Masi
Bruno Fonseca Miriam Bopp
Buckley McCall Miriam Saiz-Rodríguez
Burong Hu Mirjana Platiša
Cai Roberts Mirko H.H. Schmidt
Caleb Seavey Miryam Chiara Malacarne
Calvin Ng Mitsuaki Okodo
Cameron Tebbi Mohamed Abou El-Ghar
Camil Mirestean Mohamed Ahmed Tammam
Candan Hizel Mohamed Ali
Candido Fernando Alcazar Lopez Mohamed Kamal
Carla Loreto Mohamed Khalifa
Carla Lucia Esposito Mohamed Orabi
Carla Pisani Mohamed Rahouma
Carlo Aprile Mohammad Alwahsh
Carlo Catapano Mohammad Basha
Carlo Finelli Mohammad Mobashir
Carlo Lucchesi Mohammad Mohammadianpanah
Carlo Morasso Mohammad Soroosh
Carlos Cerdán Santacruz Mohammad Zamani
Carlos Delgado-Miguel Mohammed A. M. Abdullah
Carlos Martinez-Boubeta Mohammed El-Magd
Carlos Miguel Marto Mohammed Hawash
Carlos Perez-Torres Mohammed Ramadan
Carlos Torres-Torres Mohammed Salman Shazeeb
Carlos Viegas Mohammed Shahait
Carmelina Zirafa Mohd Hanafi Mat Som
Carmelo Caldarella Mohd Imran
Carmen Cadilla Mohit K. Midha
Carmen Ramírez Mohit Sharma
Carmine Izzo Mohith Manjunath
Carolina Nylen Mohsen Marjani
Carolyn Nessim Mohsen Soltanifar
Carsten Carlberg Mona El-Bahrawy
Catalin Bulai Monia Di Prete
Catalina Mihai Mónica Alexandra Teotónio Fernandes
Caterina Mancarella Monica Fedele
Catharina Ihre Lundgren Monica Rodolfo
Catherine Alex Monika Kopeć
Cathy Lazarus Monika Łopuszańska-Dawid
Cecilia Arici Monika Papież
Cecilia Garofalo Monika Pizon
Cecilia Taverna Monika Prendecka-Wróbel
Célia Ventura Monika Ulamec
Céline Tiffon Monique Petrousjka Van Den Tol
César López-Camarillo Monsurat Lawal
Cesare Danesino Monu Shukla
Céu Costa Moon Fai Chan
Chad Yixian Han Moon Nyeo Park
Chai Hong Yeong Morgan Broggi
Chaido Sirinian Morgan Michalet
Chana Glasser Morten Ladekarl
Chanbora Chea Morteza Motallebnezhad
Chandan Ganesh Bangalore Yogananda Mostafa Y.A. Mostafa
Chandra Mishra Mostefa Fodil
Chandra Mukhopadhyay Mrinal Kanti Bhowmik
Chandra Singh Mubarak Mustapha
Chandrani Chattopadhyay Mudassar Iqbal Arain
Chang Ming Muhamad Noor Alfarizal Kamarudin
Changtong Yang Muhammad Abdel Ghafar
Chan-Yen Kuo Muhammad Iqhrammullah
Chao Qi Muhammad Kibriya
Chao Sun Muhammad Rafiullah
Chao Wang Mukesh Yadav
Charulata Jindal Murat Akand
Chawon Yun Myron Szewczuk
Che Hsueh Yang Myunghwan Jung
Cheng Wang Nadège Kindt
Chenguang Wang Nader Tanideh
Chengwei Huang Nadia Jacobo-Herrera
Cheryl Beseler Nadine Darwiche
Chethan Sampath Nadine Wiesmann-Imilowski
Chetna Jadala Nagavendra Kommineni
Chetta Massimiliano Nagio Takigawa
Chiagoziem Ukwuoma Nahum Rosenberg
Chiang-Hung Chou Naiyun Sun
Chiara Carlomagno Nalu Navarro-Alvarez
Chiara Grana Nam Tran
Christian A. Gutschow Naoki Furuya
Christian Bäumer Naoya Kondo
Christian Borgo Naoyuki Sakamoto
Christian Klein Naresh Poondla
Christian Lehmann Narongchai Autsavapromporn
Christian Mayer Naseer Ahmed
Christina Kostara Naser Alsharairi
Christina Mertens Natália Araújo
Christine Le Roy Natalia Baran
Christine Marosi Natalia Belkova
Christine Rousset-Jablonski Natalia Díaz-Valdivia
Christof Albert Bertram Natalia Motas
Christof Vulsteke Natalia Piekuś-Słomka
Christophe Ampe Natalia Stepanova
Christopher Kobierzycki Natalie Grover
Christopher Plaisier Natalie Matthews
Christos Kontos Nataliya Babyshkina
Christos Kontovounisios Natércia Conceição
Christos Mikropoulos Nathaniel Szewczyk
Chuanguo Shi Nayden Naydenov
Chuanjin Wu Nazario Foschi
Chul Min Park Nebojsa Pavlovic
Chunsong Yang Neeladrisingha Das
Cinzia Rapino Neeraj Kumar Chauhan
Cipriana Stefanescu Neha Garg
Claire Acquaviva Nejc Umek
Claire Jean-Quartier Nelly Olova
Clara Benedetta Conti Nemat Ali
Claudia Kowolik Nessr Abu Rached
Claudia M. Hattinger Nethaji Muniraj
Claudia Ollauri-Ibáñez Neveen Said
Claudia Paret Newton Verbisck
Claudia Tregnago Nicholas Peake
Claudio Pignata Nicholas Rowell
Claudiu Morgovan Nicholas Zorko
Clement Chung Nicola Manfrini
Colin Quinn Nicola Personeni
Concepción Jimenez-Lopez Nicola Sgherza
Concetta Santonocito Nicola Tinari
Constantin Munteanu Nicolae Gica
Constantinos Giaginis Nicolas Dumaz
Conxita Mestres Nicolas Foray
Corina Ioanăș Nicole Wittwer
Corina Vasile Nicoletta Coccaro
Corinna Bruckmann Nicolò Bizzarri
Cornelia Dewald Nicolò Brandi
Cosimo Sperti Nicolò Clemente
Costa Bachas Nicolò Fabbri
Costanza Maria Cristiani Nidia Leon-Sicairos
Cristian Orasanu Nihal Ahmad
Cristian Persu Nijiro Nohata
Cristian Prieto-Garcia Nikee Awasthee
Cristian Scheau Nikesh Kunder
Cristiana Soldani Nikita Nikita
Cristina Alina Silaghi Nikita Yabbarov
Cristina Capatina Niko Radović
Cristina Casalou Nikola Skoro
Cristina Gluhovschi Nikolaos Labrou
Cristina Joao Nilay Shah
Cristina Magi-Galluzzi Nin-Chieh Hsu
Cristina Mambet Nirmalya Dasgupta
Cristina Marinela Oprean Nithyananthan Subramaniyam
Cristina Nastasă Nityanand Srivastava
Curtise Kin Cheung Ng Nobuhiro Kanemura
Cyrille Blondet Nonso Nnamoko
Daitoku Sakamuro Nora Hosny
Dalia Medhat Noriko Hosoya
Dalil Hannani Norma-Aurea Rangel-Vázquez
Damiano Patrono Normand García-Hernández
Damu Tang Norrie Pearce
Dan Granberg Noura Dosoky
Dana Lucia Stanculeanu Nuno Saraiva
Dana Niculae Nuray Acar Aydemir
Danai Fimereli Nurbubu Moldogazieva
Daniel Böger Nuwan Dharmawardana
Daniel C. Christoph Octavian Andronic
Daniel Costache Octavian Neagoe
Daniel Eiger Odd Terje Brustugun
Daniel J. Murphy Olaf Geerse
Daniel Jeong Olav Yri
Daniel Landero Huerta Oleg Shuvalov
Daniel Leucuta Oleksandr Narykov
Daniel Meier Olga Anatskaya
Daniel Menendez Olga Burenina
Daniel Novakovic Olga Cherkasova
Daniel Ortuño-Sahagún Olga Gordeeva
Daniel Paramythiotis Olga Lilia Garibay-Cerdenares
Daniel Pedregal-Mallo Olga Matveeva
Daniel Pink Olga Zakharova
Daniel Rayson Olgica Mihaljevic
Daniel Sitar Olgica Nedic
Daniel Skubleny Oliver Haase
Daniel Vallera Omar Hamdy
Daniel Zamora-Valdés Omneya Attallah
Daniela Elena Serban Omprakash Shriwas
Daniela Gasparotto Ondrej Kalita
Daniela Hanganu Oner Sanli
Daniela Lens Oreste Gallo
Daniela M. Godinho Orion Itzhak
Daniele Ugo Tari Orlando Guntinas-Lichius
Daniele Vergara Orsolya Biró
Danijela Budimir Mršić Osama Ahmed
Danijela Cvetković Oscar Briz Sanchez
Danijela Petrovic Óscar Rapado-González
Danillo Lucas Alves Esposito Osman Akdemir
Danilo Fiore Osman Öcal
Danling Wang Othman Al Musaimi
Danny Misiak Oxana Dobrovinskaya
Dante Amelio Pablo Elías Morande
Danuta Januszkiewicz-Lewandowska Pallabita Chowdhury
Danyang Wang Pamela Skrabek
Daria Chudakova Pan Huang
Dario Mizrachi Pan Zhang
Dario Rodrigues Panagiotis Mourmouris
Darren Haywood Pandurang Kolekar
Daryoush Shahbazi-Gahrouei Pankaj Gaur
David A. Hormuth Pankita H. Pandya
David Aebisher Paochu Chen
David Gewirtz Paola Dell'Albani
David Hoogewijs Paola Maroni
David Meer Paola Patrignani
David Olmeda Paola Savoia
David Parada Paola Spessotto
David Peereboom Paolo Aluffi Valletti
David Potter Paolo Arosio
Davide Giovanni Bosetti Paolo Orsaria
Davide Tosi Paolo Spinnato
Dawei Song Paolo Trucillo
Debabrata Chowdhury Paranita Ferronika
Debasish Dey Pascal Pineau
Débora Meira Patrice X. Petit
Deborah Rund Patrícia Pires
Deepak Vangala Patricia Talamás-Rohana
Deepshikha Mishra Patricio Meneses
Dejun Ma Patrick Worth
Delavar Shahbazzadeh Patrizia Ferroni
Delia Ciobanu Patsie Polly
Demetrios Arvanitis Paul Viscuse
Demin Cai Paula Paulo
Dengchao Cao Paula Pinto
Denis Dupoiron Paula Wróblewska-Łuczka
Denis Panizza Paulina Adamska
Dennis Holmes Paulina Cegla
Desmond Tobin Paulina Mertowska
Dhananjay Yadav paulo De Sepulveda
Dharambir Kashyap Paulo Linhares
Diana Feier Paulo Reis-Pina
Diana Hanna Pavan Kripashankar Patel
Diana Richter Pavan Kumar
Dianbao Zhang Pavana Suresh
Diego Colombo Pavel Bláha
Diego Tonesi Pawan Raut
Dieter Haemmerich Paweł Derlatka
Dignesh Khunt Pawel Domagala
Dik C. van Gent Payal Ganguly
Dimitra Mitsiou Payam Behzadi
Dimitri Kakabadse Pedro Marques
Dimitrios Makrakis Peng Gao
Dimitrios Papageorgiou Per Ljungman
Dimitrios Sgouros Per Olof Lundgren
Dimitrios Stravopodis Petar Brlek
Dimitrios Tzachanis Petar Ozretić
Dimitrios-Efthymios Vlachos Peter Ellis
Dimitris Emfietzoglou Peter Strang
Dimitris Tatsis Petra Korac
Dimosthenis Lykouras Petros Sountoulides
Dinesh Thekkinkattil Pezhman Shiri
Dinesh Upadhya Philip Bonomi
Dionysios Tafiadis Philip Chilibeck
Dipak Kumar Sahoo Philip Hublitz
Dirk Forner Philippe Lefrançois
Dirk Hempel Philippe Pourquier
Dirk R. Bulian Piergiuseppe Colombo
Divanshu Shukla Pierluigi Scalia
Divya Dheer Pierpaolo Alongi
Dmitrijs Bliznuks Pierre Tennstedt
Dmitry Gruzdev Pietro Geri
Dmitry Zhdanov Pietro Giorgio Calò
Doaa Zineldeen Pietro Orlando
Domagoj Vidosavljevic Pietro Scicchitano
Domenica Cavone Pietro Valerio Foti
Domenico Diacono Pinakin Pandya
Domenico Iacopetta Ping Wang
Domenico Pomarico Pingfan Hu
Domenico Tripodi Piotr Gabryel
Dominik Dłuski Piotr Korczynski
Dominik Radzki Piotr Mamczur
Dominique Heymann Piyush Baindara
Dominique Modrowski Placido Bruzzaniti
Dominique S. Michaud Plinio Cirillo
Donald Cameron Prafull Ghatage
Donald E. Spratt Prajish Iyer
Donatella Delle Cave Pranav Prabhakar
Donatella Ponti Pranjal Biswas
Dongdong Wu Prapaporn Suprasert
Dora Visnjic Prasad Dandawate
Dorival Mendes Rodrigues Junior Praveen Koganti
Dorota Formanowicz Pravin Sehgal
Douglas Adamoski Preeti Dabas
Douglas Tremblay Prem Kushwaha
Dragana Kopanja Priscilla Guglielmo
Dragana Nikolic Priya Werahera
Dragos Eugen Georgescu Priyanka Prakash Desai
Dragos Mircea Median Priyanka Sahu
Dragos Predescu Priyanka Sharma
Dragos Serban Priyojit Das
Du-Bois Asante Przemysław Borys
Duilio Divisi Purushoth Ethiraj
Dusan Dimic Pushpa Verma
Dušan Klos Qi Shao
Dzhuliia Dzhalilova Qi Xiang
Eastern Virginia School Qi Yong Hemis Ai
Eda Acikgoz Qian Zhang
Edel Noriega Álvarez Qihui Chen
Edmund Kwok Qin Xiang Ng
Edoardo Maria Muttillo Qingming Fang
Edoardo Mercadante Qingyang Xiao
Edoardo Peroni Qiuwang Zhang
Edouard Nice Qiuxu Teng
Eduardo Arellano-Rodrigo Qiuyun Xu
Eduardo López-Urrutia Rachel Taylor
Eduardo Rego Radmila Jankovic
Edward J. Pavlik Radoslaw Pach
Edyta Urbanska Radoslaw Starosta
Eiichi Kumamoto Radu Albulescu
Eiso Hiyama Radu Chicea
Elaine Harkness Radu Pirlog
Elaine Yee Lin Chung Radu Tamaian
Eleftherios Chatzellis Rafael Coveñas Rodríguez
Eleftherios Pappas Rafael de la Camara
Elena Andreeva Rafael Fernandez Castillo
Elena Bernad Rafael Gongora
Elena Bonora Rafael Ríos-Tamayo
Elena Diaz-Rodriguez Rafael Roesler
Elena Kovalenko Rafaela Vasiliadou
Elena Maria Elli Rafał Czepczyński
Elena Nemtsova Rafal Moszynski
Elena Panizza Rafał Świechowski
Elena Porumb-Andrese Rafał Watrowski
Elena Sacco Raffaele Frazzi
Elena Tarca Raffaele Palmieri
Elena Tchetina Raffaele Palmirotta
Elena Tenedini Raffaele Serra
Eleni Mavrogonatou Raghuvaran Shanmugam
Eleni Timotheadou Raghuveera Goel
Eleni-Myrto Trifylli Rahul Debnath
Elenko Popov Rahul Mandal
Eleonora Lai Rais Ansari
Elia Ranzato Raj Kumar
Elias Dritsas Raja Singh Paulraj
Elies Fuster-Garcia Rajeev K. Singla
Elisa Camela Rajesh Kumar Gandhirajan
Elisa Zavattaro Rajmohan Dharmaraj
Elisabete Borges Raju Senthil Kumar
Elisabeth Bloemena Raksha Bhat
Elise Nassif Rakshit Shah
Elizabeth Coyle Ram Kumar Selvaraju
Elizeu Carvalho Rama Kadamb
Elke Kaemmerer Rama Rao Tata
Ella Kim Ramendra Pandey
Ellas Spyratou Rameswari Chilamakuri
Elodie Pérès Rami Elshazli
Elon Donald Gullberg Ramin Raul Ossami Saidy
Elpis Mantadakis Ramkumar Kunka Mohanram
Elrashdy Redwan Ramon Garcia-Escudero
Elvira Crescenzi Ramona Danac
Elvira Grigorieva Ramya Ravindranathan
Elżbieta Cipora Randal N. Johnston
Eman Toraih Ranjeet Kumar
Emanuele Crocetti Raphael Catane
Emmanouil Karampinis Raquel Alves
Emmanouil Panagiotou Rashi Kalra
Emmanouil-Georgios Tzanakakis Rashmi Madda
Emmanuel Drouet Rashmin Savani
Emmanuel E. Zervos Rasoul Pourebrahim
Emre Küçükköse Ratha Mahendran
Endrit Shahini Ravesanker Ezhilarasan
Ene Cosmin-Victor Ravi Pratap Barnwal
Engy Elekhnawy Ravi Ramjeesingh
Enrico Capobianco Ravi Sharma
Enrico Checcucci Ravindra Kumar
Enrique Berjano Ravindra Thakkar
Enwu Liu Ravindran Caspa Gokulan
Enzo Lalli Rayaz Malik
Erden Atilla Ray-Chang Wu
Eric Blair Raymond Mattingly
Eric Durot Razmik Mirzayans
Eric Fabbrizio Rǎzvan Cosmin Petca
Eric Huet Razvan Rahota
Eric Ramirez Rebecca Brown
Eric Santoni-Rugiu Reda F.M. Elshaarawy
Erika Orban Reinhold Fuegger
Eros Di Giorgio Renata Novak Kujundžić
Ersin Günay Rene Buchet
Esther Oomen-de Hoop Renqiang Yu
Eugene S. Kandel Reuben Antony
Eugenia Yazlovitskaya Revathy Nadhan
Eurydiki Michalis Reyad Dada
Eva Dombi Reza Assaran Darban
Eva Lieto Reza Heidari
Eva Musulen Reza Mortazavi
Eva Rodriguez-Aznar Reza Shirazi
Eva Trevisson Rhitajit Sarkar
Evangelia Koutelou Ricardo Cartes
Evangelia Sarantopoulou Ricardo F. Strefezzi
Evangelos Lolis Ricardo Marques
Evangelos Terpos Ricardo Ruiz-Villaverde
Evgen Multia Riccardo Pascuzzo
Evgenia Efthymiou Richard Bennett
Evgeniya Kaigorodova Richard Gallon
Evgeniya Oshchepkova Richard Kast
Evgeniya Ostroumova Richard Riedel
Eylem Kulkoyluoglu Cotul Richard T. Waldron
F. M. Javed Mehedi Shamrat Rie Sugimoto
Fabian Bartsch Rigers Bakiu
Fabian Weykamp Rita De Sanctis
Fabiana Pani Rita Fragoso
Fabienne Lamballe Rob Hoeben
Fabio Carbone Rob McCorkle
Fabio di Mola Robert Boyd
Fabio Gasparri Robert Cheng
Fabio Guolo Robert Doczi
Fabio Melandro Robert Eibl
Fábio Seiva Robert Flisiak
Fabrizio Damiano Robert Kleszcz
Fada Guan Robert Liefke
Faisal Alzahrani Robert Newman
Falko Lange Robert Suslo
Fan Xuan Roberta Cazzola
Fan Zhang Roberta Zuntini
Fangjian Guo Roberto Cannataro
Farhad Vahid Roberto Carando
Farid Ahmed Roberto Colasanti
Farrukh Jamal Roberto Contieri
Farshad Moradi Roberto de la Plaza Llamas
Farzad Taghizadeh-Hesary Roberto Delgado Bolton
Farzaneh Tafvizi Roberto Fabiani
Fatemeh Khatami Roberto Gasparri
Fatemeh Mirzayeh Fashami Roberto Montalti
Fatih Hatipoglu Roberto Piergentili
Fausto Fiori Roberto Piva
Fausto Maffini Robin Kumar
Federica Campolo Rodis Paparodis
Federica Scarfì Rodrigo Araldi
Federico Greco Rodrigo C. Fernández-Valdivia
Federico Marchesi Rodrigo Madurga
Federico Pio Fabrizio Roger Chammas
Federico Pozzo Rogerio Buchaim
Federico Quaini Rohan Rej
Fedor Moiseenko Roland Merten
Fedora Grande Romil Parikh
Fedro Alessandro Peccatori Ronald Sroka
Felicia Grasso Rony Seger
Felipe Furtado Rosa Peracaula
Felipe Vaca-Paniagua Rosa Ventrella
Feng Ma Rosalino Vázquez-López
Feng Tian Rosario Sarabia
Fenglei Li Roseline Ogundokun
Fenglin Zhang Rosella Cataldo
Ferdinand Seith Rossella Cacciola
Ferdinando Agresta Rossella Di Stasi
Ferenc Sipos Roxana Liana Lucaciu
Fernanda Lopes Rozângela Pedrosa
Fernanda Visioli Ruby Gupta
Fernando Ferreira Rueinian Li
Fernando Leiva-Cepas Rui Han
Fernando Ramos Rui M. Gil da Costa
Fernando Sanchez Lasheras Rui Pereira
Ferran Fece de la Cruz Rui Vitorino
Filipa Fontes Rui Xi
Filippo Banchini Rukang Zhang
Filippo Carannante Rumana Hussain
Filippo Marchi Ruochen Dong
Filippo Torrisi Rupesh Kumar Chikara
Fiona Cramp Ruslan Alikhanov
Flavia Cerrato Russell Frood
Flora N. Balieva Russell Palm
Florent Morfoisse Rute Santos
Florentina Furtunescu Ruth Cronkite
Florian Ebner Ruth Schwalbe
Florin Tripon Ruth Stuckey
Florin-Andrei Taran Ruxandra Diana Sinescu
Fong-Yu Cheng Ryan Henry
Foteinos-Ioannis Dimitrakopoulos Ryo Saga
Francesc Sole Ryoji Takazawa
Francesca Agriesti Sabhiya Majid
Francesca Gaino Sabina Berezowska
Francesca Iommelli Sabina Sevcikova
Francesca Rappa Sabine Groesch
Francesca Sanguedolce Sabira Mohammed Jazir
Francesco Antonio Salzano Sabrina Battista
Francesco Boccalatte Sabrina Bossio
Francesco Claps Sabrina Lisi
Francesco Cuccia Sabyasachi Moulik
Francesco Doglietto Sadhna Aggarwal
Francesco Faita Saeed Mohammadi
Francesco Maria Pacifico Saeid Ghavami
Francesco Masedu Sahiti Chukkapalli
Francesco Tamiro Sajad Najafi
Francesco Tarantini Sajal Sen
Francesco Tovoli Sakthivel Muniyan
Francesk Mulita Salvador Gonzalez Rodríguez
Francis Lévi Salvatore Gallo
Francisco Amado Salvatore Saccone
Francisco Ayala de la Peña Salvatore Vaccaro
Francisco García‐Cozar Sameer Antani
Francisco Giner Sami Abd Elwahab
Francisco Gomez Veiga Sami-Alexander Safi
Francisco Guerra Liberal Samrita Dogra
Francisco Javier Silvestre Samuel Bobholz
Francisco Lázaro-Diéguez Samuel Campos
Francisco Maria Calisto Samuel Peña-Llopis
Francisco Miguel Martínez-Arnau Samuele Vaccari
Franco Alchiede Simonato Sandeep K. Singhal
Franco Laccone Sandeep Kumar Mishra
François Jamar Sandra Brosda
Frank Pfeffer Sandra Casimiro
Frantz Poulsen Sanith Cheriyamundath
Franz Zehentmayr Sanjay Gupta
Franziska Herbst Sanjay Patel
Frédéric Chibon Sanjiv Prashar
Frederic Panthier Sankha Bhattacharya
Frederic Triponez Santa Cirmi
Frederik Damm Santanu Maji
Fredrik Schjesvold Santhosh Kumar Pasupuleti
Frezghi Habte Santiago Cepeda
Fritz Parl Sara Frias
Fuat Demirkíran Sara Gutiérrez-Enríquez
Fulvio Adorni Sara Sergio
Fumitaka Koga Sarabjeet Sudan
Furong Tian Sarah Taylor
Gabi Drochioiu Sarah Tettamanti
Gábor Méhes Sarika Gupta
Gabriel Kacso Sarita Prabhakaran
Gabriela Iancu Sarmad Al-Marsoummi
Gabriele Reinartz Sashi Debnath
Gabriele Sorce Sathish Thirunavukkarasu
Gabriele Tuderti Satish Sagar
Gaetana Costanza Satoru Demura
Gaetano Aurilio Satoru Munakata
Gaetano Marverti Satoshi Muto
Gaetano Santulli Saul Gomez-Manzo
Gagandeep Gahlay Saulius Svagzdys
Gaia Barisione Saunjoo Yoon
Gajendra Jogdand Saurabh Sharma
Gatha Thacker Saveg Yadav
Gelena V. Kakurina Saveria Capria
Gemma Di Pompo Savvas Georgiades
Gemma Ferrer-Mayorga Savvas Lampridis
Gennadi Saiko Sayali Onkar
Georg Bollig Sayed Goda
Georg Flügen Sazan Rasul
Georg Johnen Scott Fisher
George Kontogeorgos Scott McComb
George Kulik Scott Ness
George Mihai Nitulescu Sead Crnalic
George Sharbeen Sebastia Sabater
George Simos Sebastian Knitter
Georgia Levidou Sebastian Stintzing
Georgiana Bianca Constantin Sebastian Theurich
Georgios Evangelou Sebastian Valverde-Martinez
Georgios Germanidis Sebastian Yu
Georgios Makris Seema Chugh
Georgios Pampalakis Seicean Radu
Geou-Yarh Liou Selena Y. Lin
Geraci Joseph Semer Maksoud
Gerardo Cazzato Semir Vranic
Gerardo Ferrara Senija Eminović
Gerardo Perrotta Seon-Yong Jeong
Gergana Zahmanova Serena Pellegatta
Gergely Keszler Serge Roche
German Ott Sergei Boichuk
Ghada Atteia Allah Sergei Titov
Gheorghiu Monica Sergey G. Afanasyev
Ghulam Jilany Khan Sergey Gavrilov
Giacomo Maria Pirola Sergey Kolomeichuk
Giacomo Sica Sergey Netesov
Giampietro Viola Sergey Vatsadze
Giancarlo Micheletto Serghei Covantsev
Gianluca Franceschini Sergi Rodríguez-Calado
Gianluca Nazzaro Sergio Bydlowski
Gianluca Scalia Sergio Comincini
Gianni Lazzarin Sergio Curto
Gil Fraqueza Sergio Facchini
Gilbert Lim Sergio Haimovich
Giorgia Zanetti Seth Frietze
Giorgio Malpeli Seung Kyu Lee
Giorgio Rispoli Severine Sigoillot
Giorgio Treglia Seyed Isaac Hashemy
Giovanna Mantini Seyed Peyman Shariatpanahi
Giovanni Butturini Shabana Bibi
Giovanni Colonna Shabnam Bakhshalizadeh
Giovanni Dell`Aversana Orabona Shailendra Maurya
Giovanni Guglielmo Laracca Shakir Khan
Giovanni Maria Garbarino Shanfeng Zhang
Giovanni Rosti Shanmuga S. Mahalingam
Giovanni Scarzello Shantanu Gupta
Girdhari Rijal Shaofeng Duan
Gitana Aceto Shaohua Wang
Giulia Ferrarazzo Shaolin Ma
Giulia Pellecchia Shaoquan Zheng
Giulia Ricci Sharad Purohit
Giulia Santo Sharia Hernandez
Giuseppe Broggi Sharon Anderson
Giuseppe Cirillo Shasha Yin
Giuseppe Colella Shatadal Ghosh
Giuseppe Emmanuele Umana Sheng Zhang
Giuseppe Gagliardi Sherien Eldaly
Giuseppe Lanzarone Sherif Fahmy
Giuseppe Migliaretti Sherif T.S. Hassan
Giuseppe Milone Shibo Yu
Giuseppe Perna Shigao Huang
Giuseppe Schepisi Shigemi Nakajima
Giuseppe Zimmitti Shigeo Takebayashi
Giuseppina Laganà Shiho Ohnishi
Giusi Irma Forte Shilin Liu
Glauco Chisci Shin Nishio
Gleiston Dias Shingen Nakamura
Glenn P. Dorsam Shingo Tsujinaka
Gongwei Long Shinichi Fukushige
Gonzalo Varela Shinichi Kinami
Gopinath M. Sundaram Shinichi Okazumi
Goran Augustin Shining Loo
Goran Gajski Shinji Kawabata
Gordana Pavliša Shinji Takamatsu
Gordon Watt Shipra Agarwal
Grażyna Nowicka Shirley D’Sa
Gregory Anstead Shixiang Sun
Grégory Verdeil Shoichi Hazama
Grzegorz Bartosz Shreya Nagar
Grzegorz Grześk Shruti Singh Kakan
Guanglin Zhang Shuchun Li
Guangyan Wu Shuhei Yoshida
Guanjun Yang Shuhua Xi
Guanying Xu Shunbin Ning
Guendalina Lucarini Shuo-Chen Chien
Guendalina Zuccari Shuta Ohara
Guglielmo Niccolò Piozzi Shweta Jadhav
Guillaume E. Courtoy Shweta Tripathi
Guillermina Ferro-Flores Shyam Kumar Gudey
Guillermo Til-Perez Sibylle Madlener
Guiyang Hao Silva Bortolussi
Gulcin Tezcan Silvano Dragonieri
Gunnar Wichmann Silvia Del Ry
Guodong Fu Silvia Di Agostino
Gurdeep Singh Silvia Galardi
Gustavo Fernandes Silvia Gonella
Gwang Ha Kim Silvia Marracci
Györgyi Műzes Silvia Marsoni
Hadel Abo El Enin Silvia Riondino
Haidi Ramadan Silvio Naviglio
Haifa Kathrin Al-Ali Simin Sharifi
Haifeng Shen Simona Ascanelli
Haijun Liu Simona Bernardi
Hailong Hu Simona Coniac
Haina Huang Simona D'Aguanno
Haiquan Lu Simona Ferraro
Haitao Luan Simona Martinotti
Haiyu Ji Simona Turco
Halilibrahim Ciftci Simone Cesaro
Halim İşsever Simone Cilio
Hamid Osman Simone de Brot
Hamid Tebyaniyan Simone Maurea
Hanfei Ding Simone Patergnani
Hanna Hübner Sirajudheen Anwar
Hannah Beird Siva Merugu
Hans J. Biersack Siyong Kim
Hans Peter Lang Slavica Kvolik
Hans R. Hendriks Sneha Pillai
Hans-Christian Kolberg Snehalata Pawar
Hans-Jonas Meyer So Hee Kwon
Hans-Ulrich Bender Sofia Kossida
Hany H. Arab Sofie Deschoemaeker
Hao Tian Sohail Mumtaz
Hao Wu Soheil Abbaspour-Ravasjani
Hao Zhang Sohyun Hwang
Harikanth Venkannagari Solomon Viswas Raja
Harikumar Rajaguru Somayeh Ghazalbash
Haris Charalambous Somnath Pandey
Harshit Shah Sonain Jamil
Harshraj Leuva Sonali Barwe
Haruhiko Sugimura Song Chen
Harunori Yoshikawa Song Wang
Haruto Nishida Songli Zhu
Harvey Pollard Søren Christensen
Hasan Özdoğan Sotiris Kyriakou
Hashem Alsaab Soumen Bera
Hassan Mubarak Ishqi Sounak Sahu
Hassan Rasouli Sousana Papadopoulou
Hathal Haddad Soyar Sari
Haya Lorberboum-Galski Sreeparna Chakraborty
Hayrani Eren Bostancı Srikanth Prabhu
He Xu Srinivasa Rao
Heather Danysh Srinivasa Reddy Bonam
Heather Hayenga Stavros Papadakos
Heba Sahyon Stefan Hohaus
Hee-Geun Jo Stefan Krause
Heerak Chugh Stefan Linsler
Heesun Cheong Stefan Pusch
Hege F. Berg Stefano Fais
Heidie Cabanos Stefano Ferretti
Heiner Schaal Stefano Granieri
Heinz Sill Stefano Mariotti
Helen Sheldrake Stefano Panareo
Heloisa Sobreiro Selistre de Araujo Stefano Restaino
Hemant Prajapati Stefano Vendrame
Hengsheng Chao Steffen Junker
Henrique Silveira Stelios Zimeras
Henry Hang Fai Kwok Stella Tsai
Herbert Kimura Stephanie Yaung
Herbert Yu Stephen Fung
Hervé Técher Stephen Hyter
Hesham Haffez Stephen J. Williams
Hiam Alquran Stephen Strum
Hidehiko Takigawa Stephen T. Sonis
Hideki Ujiie Stephen Walker
Hideo Wada Stephen Wong
Himanshu Soni Stergios Boussios
Himashu Singh Stergios Doumas
Hirohisa Kato Steven Esworthy
Hirohito Yano Steven F. Gameiro
Hiroki Ide Stuart Rundle
Hiromichi Yumoto Stylianos Korasidis
Hiroshi Yaegashi Su Jung Oh-Hohenhorst
Hirotaka Matsui Su Woong Yoo
Hirotaka Suto Subhadeep Das
Hiroto Ohguchi Subhadip Das
Hiroyuki Nojima Subhajit Chatterjee
Hitesh Singhavi Subhajit Giri
Ho Lin Subramanyam Dasari
Hong Wan Suchitra Mohanty
Hongbing Liu Sudhir Morla
Hongping Deng Sueli Carneiro
Hongwei Cheng Sufyan Ibrahim
Hongyang Ma Suisui Hao
Hongyi Lin Sujata Jana
Hongyu Zhang Sujeenthar Tharmalingam
Hooman Yarmohammadi Sukanya Saha
Houchuan Lai Sulev Kõks
Houman Sotoudeh Suman Mukhopadhyay
Howard Boudreau Suman Samantray
Hrishikesh Pandit Sumedha Agashe
Hsiang-Hsuan Michael Yu Sumedha Prabhu
Hsiang-Ning Luk Sumeet Nayak
Hsin-Hua Lee Sumeet Patiyal
Hua Wang Sung Hoon Sim
Huacheng Zhang Sung-Lang Chen
Huaifu Deng Sung-Min Kang
Huaitian Liu Sung-Soo Kim
Hua-Sheng Chiu Sunilgowda Sunnagatta Nagaraja
Hugo Arias-Pulido Supandeep Hallan
Hui Li Supriya Chakraborty
Hui Yin Lim Supriya Gupta
Hui Zhao Surajit Basak
Huina Zhang Surbhi Chouhan
Huining Kang Suresh Kalathil
Hülya Özsahin Susan Burchill
Hung-Chi Cheng Susan Heatley
Hung-Pin Tu Susana Belén Bravo López
Hung-Vu Tran Susana Lechuga
Husam Qanash Susanne Füssel
Hussein Almasri Sushil Middha
Huu Phuc Nguyen Suzanne Orchard
Hyuck Jin Lee Sveinung Sorbye
Hyun Jin Kwun Sven Niklander
Hyungseok Cho Sven Stadlbauer
Hyunwoo Hwangbo Svetlana Batasheva
Iakowos Karakesisoglou Svjetlana Raus
Ian M. Collins Swarbhanu Sarkar
Ibrahim Bello Swarnalatha Manickavinayaham
Ibrahim Sayed Swarup Roy
Ichwaku Rastogi Swati Dahariya
Idan Goren Sweta Ghosh
Ignacija Vlašić Sweta Patel
Ignacio Perez De Castro Syed Furqan Qadri
Ignazio Gaspare Vetrano Syed Mohd Faisal
Ignazio Marino Sylvain Bourgoin
Igor Sivaev Sylwia Dziegielewska-Gesiak
Igor Zubrycki Szidónia Lefkovits
Iichiroh Onishi Tadateru Maehata
I-Ju Yeh Tae-Eun Kwon
Ik-Hwan Han Tae-Hong Kang
Ilaria D'Agostino Tagliaferri Pierosandro
Ilaria Floris Taha Koray Sahin
Ilaria Girolami Tajana Pavic
Ilaria Saltarella Takaaki Hirotsu
Ildiko Szanto Takahiro Homma
Ileana Rubio Takamichi Ito
Iliana Medina-Ramirez Takashi Yazawa
Ilias Mylonis Takatsune Shimizu
Ilias Tsochantaridis Takemichi Fukasawa
I-Lun Hsin Takeo Nakada
Ilze Strumfa Takeshi Okamoto
iman van den Bout Taketo Yamada
Imran Mohamed Takuji Tanaka
Ina Sevic Takuma Hayashi
Indrajeet Kumar Takuro Nishikawa
Ingrid Boere Takuya Koie
Ingrid Ehrenfeld Talha Bin Emran
Ingrid Lilienthal Talha Burak Alakus
Ingrid Tonning Olsson Tamara Čačev
Ingrida Balnyte Tamer Sakr
In-Jae Oh Tanel Punga
Inmaculada Lérida Tanushree Dangi
Innokenty Mokhosoev Tao Li
Ioannis Dedes Tao Wu
Ioannis Iakovou Tara M. Strutt
Ioannis Ilias Tarek M.A. Abdel-Fatah
Ioannis Katsaros Tarek Mohamed
Ioannis Kotsianidis Tarkan Jäger
Ioannis Kyriakidis Tateaki Naito
Ioannis Maroulis Tatsuhiro Sato
Ioannis Ntanasis-Stathopoulos Tatsuji Mizukami
Ioannis Vamvakaris Tatsuo Kanda
Ion Cosmin Puia Tatsuo Kido
Ionel Alexandru Checherita Teh-Ia Huo
Irena Glažar Tejeshwar Rao
Irena Ilic Teng Zhou
Irene Scalera Teodora Alexa-Stratulat
Irène Tatischeff Terenzio Cosio
Irina Balalaeva Teresa Lettini
Irina Pronina Teresa Paíno
Iris Uras Jodl Teresa Perra
Irma Gabriela Anaya Saavedra Teresa Rubio-Tomás
Isabel Soto-Cruz Teresa Tellez Santana
Isabell Lang Terrance Johns
Isabelle Fitton Terrence Hui
Isain Zapata Terry Lichtor
Isao Otsuka Terry Yip
Isidoro Feliciello Teruya Kawamoto
Islam Khalil Teruya Komatsu
Ismael Fuente Tetsuyuki Takahashi
Ismaheel Lawal Tetyana Chumachenko
Ismail Toygar Thanaset Senawong
Ismini Lasithiotaki Thanigaivelan Kanagasabai
Issa Al-Amri Theo Kantidakis
István Kertész Theodora Papamitsou
Ita Hadžisejdić Theodoros Karalis
Iulia-Ioana Stanescu-Spinu Theodoros Tokas
Iurii Krak Thiebaud Picart
Ivan Henriquez Thierry Magnaldo
Ivan Sabol Thomas Botton
Ivan Savic Thomas G. Hofmann
Ivana Guševac Stojanović Thomas Greither
Ivana Lazarevic Thomas Lindner
Ivana Mrklić Thomas Mürdter
Ivanildo Sousa Tianjie Pu
Ivonne Nel Tie Zhou
Iwona Kwiecień Tijana Išić Denčić
Iwona Maria Zarnowska Tijl Vermassen
Iwona Wertel Tilahun Debele
Izabela Zakrocka Tim Hohmann
Jabar H. Yousif Timo F.W. Soeterik
Jacek Wilczyński Timothy Secomb
Jackline Ayres-Silva Tina Batista Napotnik
Jacobo Trebol Tingfeng Wu
Jacqueline M. Bentel Tingming Liang
Jacques Barbet Ting-Wen Lo
Jacques Zimmer Tingyou Wang
Jae Kyu Ryu Tivadar Bara Jr.
Jae Myoung Noh Tolga Olmez
Jaehong Kim Tomas Knedlik
Jaesik Park Tomas Ruzgas
Jafar Rezaie Tomasz Kubrak
Jagannadha Sastry Tomasz Płoszaj
Jaime Feliu Tomasz Szczepański
Jaime Tome-Amat Tomasz Zieliński
Jakub Kucharz Tomaz Velnar
Jakub Rok Tommaso Fabrizio
James Chow Tommaso Lombardi
James Chung-Wai Cheung Tomohiro Chiba
James Coffman Tongtong Lu
James Leigh Torben Redmer
James Solomon Toru Hiraga
Jamie S. Myers Toshiaki Ohara
Jan Hrbacek Toshio Ohashi
Jan Klozar Toyonori Tsuzuki
Jan Lowery Tracy Daniels-Wells
Jan Žatecký Travis Johnson
Jana Fox Tsung-I Hsu
Jana Gevertz Tsung-Jung Liang
Jane Wang Tuba Çiğdem Oğuzoğlu
Janet Douglass Tudor Lucian Pop
Janet M. Gray Tulasigeri M. Totiger
Janet Mertz Tuomo Mantere
Janitschke Daniel Tuula Kallunki
Janusz Madaj Udaya Sree Dakarapu
Jan-Willem Beenakker Ugo Grossi
Jared Ahrendsen Uhi Toh
Jared Fischer Ulrich Ronellenfitsch
Jarek Baran Umang Swami
Jarosław Czyż Umberto Laforenza
Jasminka Stepan Giljević Umberto Vitolo
Jason Tasoulas Univeristy Antwerp
Jaume Grau Urmila Sehrawat
Javad Hassannataj Joloudari Uros Bumbasirevic
Javed Ali Khan Usein M. Dzhemilev
Javier Arredondo Montero Üsküdar University
Javier Marco-Hernández Utibe-Abasi Udoh
Javier Martinez-Useros Vadim Elagin
Javier Ros Vahid Haghpanah
Jean-Francois Fonteneau Vaishali Inamdar
Jean-Michel Escoffre Vaitsa Giannouli
Jeannine Diesch Valentin Barthet
Jean-Pierre Gagner Valentin Ritschl
Jeffrey Velotta Valentin Zaharia
Jeiha Lee Valentina Dini
Jelena Korać Prlić Valentina Giannini
Jen-Chih Tseng Valentina Giudice
Jeni Prosperi Valentina Sancisi
Jennifer Haynes Valentina Silvestri
Jennifer Pursley Valentina Tuninetti
Jeon Lee Valeria D'Argenio
Jeong Heo Valeria Dionisi
Jeongmin Lee Valeria Merz
Jérémie Rouger-Gaudichon Valeria Visconte
Jeremie Vitte Valerio Leoni
Jerry Malayer Valerio Vercesi
Jessica Da Gama Duarte Van-An Duong
Jessica Ranieri Vanessa Desantis
Jesús Adrián López Vanessa Ramírez-Mayorga
Jesus Lacal Vânia Gonçalves
Jesús M. Paramio Varun Monga
Jesus Vioque Vasanthan Ravichandran
Jesús Zepeda-Cervantes Vasile Musteata
Jia Li Vasile Valeriu Lupu
Jian Yan Vasileios Kontogeorgakos 
Jianan Zhang Vasily Yakovlev
Jiangjiang Gu Veli Ozalp
Jianguo Zhou Vellone Gaetano
Jianjiu Chen Vera Damuzzo
Jianli Tao Vera Panzarella
Jianmin Zhang Vera Wenter
Jianxun Song Verena Boschert
Jianyuan Chai Verónica Burzio
Jiaquan Yu Veronica Filetti
Jiawei Huo Veronica Rivi
Jiawei Wang Veronika Benson
Jiaxi Yao Veronique Serre-Beinier
Jie Zhuang Vibhav Gautam
Jiekai Yin Vicki Butenschoen
Jimin Han Victor Seledtsov
Jimma Lenjisa Victoria L. Green
Jin Wang Victoria Sanchez-Martin
Jinbiao Chen Vijaya Anand Arumugam
Jinda Fan Vijeta Sharma
Jindong Xie Vikas Jhawat
Jinfeng Li Vikas Kuma Somani
Jingan Li Vikas Kundra
Jinyan Zhang Vikas Yadav
Jiri Vachtenheim Vikash Singh
Jit Kong Cheong Ville Pimenoff
Jiyuan Li Vilma Yuzbasiyan-Gurkan
Joanna Boncela Vinay Vakharia
Joanna Domagala-Kulawik Vincent Van der Velden
Joanna Moes-Sosnowska Vincenzo Savarino
Joanna Stefanowicz Vinicius Osterne
Joanna Zawitkowska Vinod Nadella
João Alfredo Moraes Vipin Shankar Chelakkot
João Casanova Vipul D. Prajapati
João Henrique G. Lago Virginia Valentini
Joaquim C.G. Esteves Da Silva Virović Jukić
Joaquim Carreras Vitor Parola
Joaquim Soares do Brito Vittoria Disciglio
Jochen Maurer Vittorio Aprile
Joe Mymryk Vivek Anand
Joel L. Schwartz Vlad Porumb
Joelle Coumans Vladimir Babenko
Joëlle Wiels Vladimir Bilim
Johann Wendler Vladimir Jurisic
Johanne Poudrier Vladimir K. Lyadov
John Amson Capitman Vladimir Rogalewicz
John Ayeelyan Vladimir Strelnikov
John Cunha Vladimir Tsurkov
John Greenman Vlad-Olimpiu Butiurca
John Inge Johnsen Volodymyr Ponomaryov
John Lalith Charles Richard Wacław Hołówko
John Lamar Wai Kin Chan
John Lucas Waldemar Wagner
John M. Perry Walter H. Pavicic
Jon Salmanton-García Wanda Maria Gerding
Jong-Young Kwak Wang Wang
Jordi Ribera Wanhe Wang
Jörg Weimer Wansu Park
Jorge A. Morales Waseem Jerjes
Jorge Feito Wassim Abou-Kheir
Jorge Ferreira Wei Feng
José A. Carrión Wei Ni
José A. García-Sanz Wei Shi
José Azevedo Wei Zhou
José Fontanari Wei-Chun Chin
José Lopes Weichung Shia
Jose Luis Perez Gracia Wei-Fan Hsu
José Luis Subiza Wei-Hsiung Yang
Jose Manuel Almeida Weihua Huang
José Manuel Ramia Weiren Luo
José Miguel Amenábar Céspedes Weizhi Xu
José Pedraza-Chaverri Wen Li
José Sanches Wenchao Xu
Jose-Antonio Mirón-Canelo Wenlin Yang
Joseph Diverdi Wentao Hu
Joseph Hornak Wilhelm Mistiaen
Joseph Kwong Wing Wong
Joshua Jue Winkins Santosh
Josip A. Borovac Władysław Węglarz
Josko Bozic Wojciech G. Polak
Jovana Jasnic Wojciech Szlasa
Jozsef Dudas Wolfgang Brückl
József Furák Wolfgang Jungraithmayr
József Virga Wolfram Samlowski
Juan A. Galán-Llopis Wyanne A. Noortman
Juan Carlos Illera Xavier Sastre-Garau
Juan Carlos Rodríguez-Manzaneque Xiang Ma
Juan Garcia Xiangyu Liu
Juan Manuel Velázquez-Enríquez Xianxiu Chen
Juan Pablo Cerapio Xiao Ding
Juan Pablo Rigalli Xiao Shen
Juan Pablo Rodrigo Tapia Xiaobo Wu
Juan R. De Los Toyos Xiaochun Peng
Juan-Carlos Galvez-Ruiz Xiaodong Wang
Jubina Balan Venghateri Xiaohui Lin
Judith Raber-Durlacher Xiaojie Sun
Jue Ling Xiaolin Nan
Jui-Hung Yen Xiaoming Lyu
Jules Tianyu Zhang-Yin Xiaonan Zhang
Julian Künzel Xiaosheng Tan
Julian Rozenberg Xiaowei Tang
Juliana Schwaab Ximena Mimica
Julie Cwikel Xin Lai
Julie Deleemans Xin Wang
Julie Townsend Xing Wei
Julien Edeline Xingchun Gao
Julio Plaza-Díaz Xingfeng Li
Julita Kulbacka Xinghua Pan
Julius Höhne Xinghua Sui
Julius Moratin Xingyi Yang
Jun Huang Xinpei Deng
Jun Suh Lee Xinxiang Yang
Junji Zhu Xinyuan Lei
Junquan Liu Xu Zhang
Junting Ren Xuanrong Chen
Junya Kuroda Xue Dong
Junzi Wu Xuefei Tan
Juozas Lazutka Xueming Zhang
Jürgen Dittmer Xufeng Chen
Jürgen Geisler Xuyi Yue
Jürgen Schlegel Yan Zubavichus
K. Sreedhara Pai Yanal Murad
Kah Hui Wong Yang Chen
Kah Teik Chew Yanming Xu
Kaida Atsushi Yanqiang Li
Kaimeng Huang Yanyan Cui
Kalliopi Keramida Yanying Huo
Kamalakannan Radhakrishnan Yao Jiang
Kamil Barański Yaoxiang Li
Kamil Gareev Yasemin Ceyhan
Kamil Nelke Yaser Gamallat
Kamil Reza Khondakar Yasin Tülüce
kanakaraju manupati Yasmina Abd-Elhakim
Kanan T. Desai Yasser Majeed
Kandarp Joshi Yasser Mostafa Kamel
Kapil Sirohi Yasuhiko Ebina
Karel Kostev Yasumasa Okazaki
Karen Kopciuk Yasuo Imai
Karen Liby Yasushi Adachi
Karim Dorgham Yasushi Arano
Karim Farhat Yawei Li
Karin Welén Yaya Chu
Karina Barbosa Yeong-Min Yoo
Karl Aigner Yhiya Amen
Karla Willows Yi Huang
Karolina Czarnecka-Chrebelska Yi Wang
Karolina Markiet Yi-Lin Chiu
Karoly Szuhai Yilu Zhou
Katarina Nikolic Yiming Huang
Katarzyna Malarz Yin Sun
Katarzyna Pawińska-Wąsikowska Ying Qing
Katarzyna Pogoda Ying-Cheng Chiang
Katarzyna Winter Yinghuai Zhu
Katerina Kambouri Yingqian Chen
Katerina Kotzampassi Yiqun Zhang
Katherina Psarra Yiwen Zhao
Katie Devine Yiyang Chen
Katsuhiko Kato Ymera Pignochino
Katsuhiro Ito Yogesh Vashist
Kausik Bishayee Yohei Inaba
Kawsar Ahmed Yoichi Watanabe
Kay-Dietrich Wagner Yona Keisari
Kazi Abdul Mannan Yonehiro Kanemura
Kazuhiko Ikeda Yong Weon Yi
Kazuhito Funai Yonggang Pei
Kazunari K. Yokoyama Yongmin Yan
Ke Cheng Yong-Moon Lee
Ke Cong Yongxin Liu
Keisuke Ishizawa Yoonsun Chung
Keita Kai Yoshiaki Yura
Keith W.H. Chiu Yoshiharu Motoo
Kelvin Ng Yoshikane Yamauchi
Kenichi Suda Yoshimitsu Akiyama
Kenji Hayashida Yoshinobu Kariya
Kenji Hirata Yoshinori Okamoto
Kenji Nakano Youness Limami
Kenji Yamagata Young Hye Song
Kenneth Chat Pan Cheung Young Zoon Kim
Keren Dopelt Youngbeom Seo
Kerou Zhang Youri Pavlov
Kevin M. Zbuk Yousef Mohammad Jaber Al-Saraireh
Kezhou Zhu Yu Gu
Khalid Rehman Hakeem Yu Zhang
Kin Yin Cheung Yuan Tang
Kiran Kumar Mangalaparthi Yuanzhang Zheng
Kirsten Marie Jochumsen Yue Liu
Kishor Pant Yue Wang
Kishu Ranjan Yufeng Zhou
Kishwor Poudel Yuhong Fan
Kit-Leong Cheong Yuh-Seog Jung
Klaus Fortschegger Yuh-Yih Lin
Klaus Holzmann Yu-ichiro Koma
Klazien Matter-Walstra Yuliang Zhang
Knut Jørgen Labori Yuliya Klymenko
Koji Yamatsu Yulong Fu
Koki Nakanishi Yunfeng Zhao
Konrad Nesteruk Yunjie Zhao
Konstantin Panov Yuqi Yang
Konstantinos Arvanitakis Yuqing Zhang
Konstantinos Chatzipapas Yurong Song
Konstantinos Dimopoulos Yury Rubtsov
Konstantinos Perivoliotis Yusuke Kawamura
Konstantinos Seretis Yutaka Endo
Konstantinos Tosios Yutaka Tagaya
Koraljka Gall Troselj Yutian Ma
Koroknai Viktória Yutian Zou
Kouji Izumi Yuyang Jiang
Koustav Sarkar Yves Borbély
Kresimir Dolic Zaid Taha
Krishan Thakur Zakariya Algamal
Kristanna Fredenburg Zangbéwendé Ouedraogo
Kristijan Skok Zbigniew Adamiak
Krzysztof Dąbkowski Zekiye Altun
Krzysztof Dowgierd Zeliha Selamoglu
Krzysztof Roszkowski Željko Antić
Kubilay Gürünlüoğlu Zenichi Morise
Kui Zhang Zenon Pogorelić
Kulandaisamy Arulsamy Zhanchao Li
Kunihiro Tsuchida Zhanying Hu
Kurubaran Ganasegeran Zhao Cheng
Kyle Swanson Zhaofeng Liang
Kyung-hee Kim Zhaoqing Cong
Lajos Gergely Zhe Li
Lalu Muhammad Irham Zheng Chen
Lan Lin Zhengtao Xiao
Larisa Litovchick Zhengwei Huang
Larisa Ryskalin Zhi Zeng
Larry Anderson Zhijie Qi
László Szilák Zhila Semnani-Azad
Laura Casalino Zhipeng Li
Laura Conti Zhiping Liu
Laura Eadie Zhiyong He
Laura Grunewald Zhiyuan Xu
Laura Kasman Zhong Wu
Laura Lafon-Hughes Zhonglei Wang
Laura Marinela Ailioaie zhongshan cheng
Laura Mazilu Zhou Tao
Laura Răducu Zhuhuang Zhou
Laura Ridolfi Zibo Chen
Laura Vicente Zihua Zeng
Lauren Gollahon Zijun Y. Xu-Monette
Laurent Villeneuve Ziqing Chen
Laurentiu M. Pop Zisis Kozlakidis
Laurentiu Simion Zizhu Zhang
Leandro Kasuki Zizy Elbialy
Lei Duan Zoárd Krasznai
Lei Huang Zoltan Herold
Lei Wang Zoltán Wiener
Lei Zhang Zoran Gluvic
Leifeng Chen Zoran Todorovic
Leila Allahqoli Zorana Dobrijević
Lein‐Ray Mo Zygmunt Warzecha

25 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Therapy”


We are pleased to invite you to read the top 10 cited papers in 2023 from the Section “Cancer Therapy” in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited”
by Kevin Dzobo, Dimakatso A. Senthebane and Collet Dandara
Cancers 2023, 15(2), 376; https://doi.org/10.3390/cancers15020376
Available online: https://www.mdpi.com/2072-6694/15/2/376

“Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches”
by Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik and Viktor Grünwald
Cancers 2023, 15(2), 461; https://doi.org/10.3390/cancers15020461
Available online: https://www.mdpi.com/2072-6694/15/2/461

“Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer”
by Houssein Chhouri, David Alexandre and Luca Grumolato
Cancers 2023, 15(2), 504; https://doi.org/10.3390/cancers15020504
Available online: https://www.mdpi.com/2072-6694/15/2/504

“Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer”
by Vivek P. Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K. Singla, Avinash Khadela, Lalitkumar Vora and Vladimir N. Uversky
Cancers 2023, 15(4), 1023; https://doi.org/10.3390/cancers15041023
Available online: https://www.mdpi.com/2072-6694/15/4/1023

“Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)”
by Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat, Isabel Rubio, Jana de Boniface, Nina Ditsch, Güldeniz Karadeniz Cakmak, Andreas Karakatsanis, Rajiv Dave, Markus Hahn et al.
Cancers 2023, 15(4), 1173; https://doi.org/10.3390/cancers15041173
Available online: https://www.mdpi.com/2072-6694/15/4/1173

“Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities”
by Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, Roberto Cairoli, Marco Montillo and Alessandra Tedeschi
Cancers 2023, 15(5), 1504; https://doi.org/10.3390/cancers15051504
Available online: https://www.mdpi.com/2072-6694/15/5/1504

“Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma”
by Chia-Chi Yeh, Huang-Kai Kao, Yenlin Huang, Tsung-You Tsai, Chi-Kuang Young, Shao-Yu Hung, Chuieng-Yi Lu and Kai-Ping Chang
Cancers 2023, 15(1), 322; https://doi.org/10.3390/cancers15010322
Available online: https://www.mdpi.com/2072-6694/15/1/322

“Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input”
by Valentine Wang, Mélanie Gauthier, Véronique Decot, Loïc Reppel and Danièle Bensoussan
Cancers 2023, 15(4), 1003; https://doi.org/10.3390/cancers15041003
Available online: https://www.mdpi.com/2072-6694/15/4/1003

“From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy”
by Peter Vaupel, Helmut Piazena, Markus Notter, Andreas R. Thomsen, Anca-L. Grosu, Felix Scholkmann, Alan Graham Pockley and Gabriele Multhoff
Cancers 2023, 15(5), 1394; https://doi.org/10.3390/cancers15051394
Available online: https://www.mdpi.com/2072-6694/15/5/1394

“Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer”
by Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies and Rajesh Singh
Cancers 2023, 15(4), 1320; https://doi.org/10.3390/cancers15041320
Available online: https://www.mdpi.com/2072-6694/15/4/1320

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office

25 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Epidemiology and Prevention”


We are pleased to invite you to read the top 10 cited papers in 2023 from the Section “Cancer Epidemiology and Prevention” of Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience”
by Daniel Aliseda, Pablo Martí-Cruchaga, Gabriel Zozaya, Macarena Rodríguez-Fraile, José I. Bilbao, Alberto Benito-Boillos, Antonio Martínez De La Cuesta, Luis Lopez-Olaondo, Francisco Hidalgo, Mariano Ponz-Sarvisé et al.
Cancers 2023, 15(3), 733; https://doi.org/10.3390/cancers15030733
Available online: https://www.mdpi.com/2072-6694/15/3/733

“Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century”
by Filip Tichanek, Asta Försti, Vaclav Liska, Akseli Hemminki and Kari Hemminki
Cancers 2023, 15(3), 991; https://doi.org/10.3390/cancers15030991
Available online: https://www.mdpi.com/2072-6694/15/3/991

“Metabolic Health, Mitochondrial Fitness, Physical Activity, and Cancer”
by Vicente Javier Clemente-Suárez, Alexandra Martín-Rodríguez, Laura Redondo-Flórez, Pablo Ruisoto, Eduardo Navarro-Jiménez, Domingo Jesús Ramos-Campo and José Francisco Tornero-Aguilera
Cancers 2023, 15(3), 814; https://doi.org/10.3390/cancers15030814
Available online: https://www.mdpi.com/2072-6694/15/3/814

“DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities”
by María Ovejero-Sánchez, Rogelio González-Sarmiento and Ana Belén Herrero
Cancers 2023, 15(2), 448; https://doi.org/10.3390/cancers15020448
Available online: https://www.mdpi.com/2072-6694/15/2/448

“Breast Cancer Prediction Using Fine Needle Aspiration Features and Upsampling with Supervised Machine Learning”
by Rahman Shafique, Furqan Rustam, Gyu Sang Choi, Isabel de la Torre Díez, Arif Mahmood, Vivian Lipari, Carmen Lili Rodríguez Velasco and Imran Ashraf
Cancers 2023, 15(3), 681; https://doi.org/10.3390/cancers15030681
Available online: https://www.mdpi.com/2072-6694/15/3/681

“Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial”
by Sumedha Chhatre, Joseph J. Gallo, Thomas Guzzo, Knashawn H. Morales, Diane K. Newman, Neha Vapiwala, Keith Van Arsdalen, Alan J. Wein, Stanley Bruce Malkowicz and Ravishankar Jayadevappa
Cancers 2023, 15(7), 2124; https://doi.org/10.3390/cancers15072124
Available online: https://www.mdpi.com/2072-6694/15/7/2124

“Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy”
by Olga Maria Nardone, Irene Zammarchi, Giovanni Santacroce, Subrata Ghosh and Marietta Iacucci
Cancers 2023, 15(8), 2389; https://doi.org/10.3390/cancers15082389
Available online: https://www.mdpi.com/2072-6694/15/8/2389

“A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma”
by Tommaso Stroffolini and Giacomo Stroffolini
Cancers 2023, 15(8), 2388; https://doi.org/10.3390/cancers15082388
Available online: https://www.mdpi.com/2072-6694/15/8/2388

“Changing Patterns in Cancer Mortality from 1987 to 2020 in China”
by Binbin Su, Panliang Zhong, Yundong Xuan, Junqing Xie, Yu Wu, Chen Chen, Yihao Zhao, Xinran Shen and Xiaoying Zheng
Cancers 2023, 15(2), 476; https://doi.org/10.3390/cancers15020476
Available online: https://www.mdpi.com/2072-6694/15/2/476

“Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry”
by Claudia Sargas, Rosa Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda et al.
Cancers 2023, 15(2), 438; https://doi.org/10.3390/cancers15020438
Available online: https://www.mdpi.com/2072-6694/15/2/438

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

25 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Metastasis”


We are pleased to invite you to read the top 10 cited papers in 2023 from the Section “Cancer Metastasis” of Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells”
by Gregory T. Gallanis, Ghada M. Sharif, Marcel O. Schmidt, Benjamin N. Friedland, Rohith Battina, Raneen Rahhal, John E. Davis, Jr., Irfan S. Khan, Anton Wellstein and Anna T. Riegel
Cancers 202315(6), 1908; https://doi.org/10.3390/cancers15061908
Available online: https://www.mdpi.com/2072-6694/15/6/1908

“Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice”
by Valentina Fanotto, Francesca Salani, Caterina Vivaldi, Mario Scartozzi, Dario Ribero, Marco Puzzoni, Francesco Montagnani, Francesco Leone, Enrico Vasile, Maria Bencivenga et al.
Cancers 202315(3), 900; https://doi.org/10.3390/cancers15030900
Available online: https://www.mdpi.com/2072-6694/15/3/900

“A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC”
by Xuan-Mei Piao, Young Joon Byun, Chuang-Ming Zheng, Sun Jin Song, Ho Won Kang, Won Tae Kim and Seok Joong Yun
Cancers 2023, 15(3), 935; https://doi.org/10.3390/cancers15030935
Available online: https://www.mdpi.com/2072-6694/15/3/935

“Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications”
by Cinzia Baldessari, Stefania Pipitone, Eleonora Molinaro, Krisida Cerma, Martina Fanelli, Cecilia Nasso, Marco Oltrecolli, Marta Pirola, Elisa D’Agostino, Giuseppe Pugliese et al.
Cancers 2023, 15(5), 1518; https://doi.org/10.3390/cancers15051518
Available online: https://www.mdpi.com/2072-6694/15/5/1518

“Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis”
by Jerry Xiao, Utsav Sharma, Abolfazl Arab, Sohit Miglani, Sonakshi Bhalla, Shravanthy Suguru, Robert Suter, Reetu Mukherji, Marc E. Lippman, Paula R. Pohlmann et al.
Cancers 2023, 15(6), 1831; https://doi.org/10.3390/cancers15061831
Available online: https://www.mdpi.com/2072-6694/15/6/1831

“Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy”
by Baohong Song, Wei Wang, Xuemei Tang, Robby Miguel Wen-Jing Goh, Win Lwin Thuya, Paul Chi Lui Ho, Lu Chen and Lingzhi Wang
Cancers 2023, 15(10), 2758; https://doi.org/10.3390/cancers15102758
Available online: https://www.mdpi.com/2072-6694/15/10/2758

“LncRNA LINC01094 Promotes Cells Proliferation and Metastasis through the PTEN/AKT Pathway by Targeting AZGP1 in Gastric Cancer”
by Zhe Gong, Yanqiu Zhang, Yue Yang, Yanan Yang, Jieyun Zhang, Yixuan Wang, Liqin Zhao, Nuoya Yu, Zhenhua Wu and Weijian Guo
Cancers 2023, 15(4), 1261; https://doi.org/10.3390/cancers15041261
Available online: https://www.mdpi.com/2072-6694/15/4/1261

“Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies”
by Valeria Internò, Maria Chiara Sergi, Maria Elvira Metta, Michele Guida, Paolo Trerotoli, Sabino Strippoli, Salvatore Circelli, Camillo Porta and Marco Tucci
Cancers 2023, 15(5), 1542; https://doi.org/10.3390/cancers15051542
Available online: https://www.mdpi.com/2072-6694/15/5/1542

“Current Understanding of Microbiomes in Cancer Metastasis”
by Jiaqi Liu, Feiyang Luo, Liyan Wen, Zhanyi Zhao and Haitao Sun
Cancers 2023, 15(6), 1893; https://doi.org/10.3390/cancers15061893
Available online: https://www.mdpi.com/2072-6694/15/6/1893

“The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review”
by Luca Urso, Elena Bonatto, Alberto Nieri, Angelo Castello, Anna Margherita Maffione, Maria Cristina Marzola, Corrado Cittanti, Mirco Bartolomei, Stefano Panareo, Luigi Mansi et al.
Cancers 2023, 15(7), 2184; https://doi.org/10.3390/cancers15072184
Available online: https://www.mdpi.com/2072-6694/15/7/2184

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

24 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Molecular Cancer Biology”


We are pleased to invite you to read the top 10 cited papers in 2023 from the Section “Molecular Cancer Biology” in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“CircZBTB46 Protects Acute Myeloid Leukemia Cells from Ferroptotic Cell Death by Upregulating SCD”
by Fei Long, Zhi Lin, Qinpeng Long, Zhixing Lu, Kaiyu Zhu, Mingyi Zhao and Minghua Yang
Cancers 2023, 15(2), 459; https://doi.org/10.3390/cancers15020459
Available online: https://www.mdpi.com/2072-6694/15/2/459

“MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data”
by Louis Schubert, Mohamed Lamine Mariko, Jérôme Clerc, Olivier Huillard and Lionel Groussin
Cancers 2023, 15(3), 710; https://doi.org/10.3390/cancers15030710
Available online: https://www.mdpi.com/2072-6694/15/3/710

“DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets”
by Ahmad Ozair, Vivek Bhat, Reid S. Alisch, Atulya A. Khosla, Rupesh R. Kotecha, Yazmin Odia, Michael W. McDermott and Manmeet S. Ahluwalia
Cancers 2023, 15(4), 1342; https://doi.org/10.3390/cancers15041342
Available online: https://www.mdpi.com/2072-6694/15/4/1342

“The Mucin Family of Proteins: Candidates as Potential Biomarkers for Colon Cancer”
by Kristin E. Cox, Shanglei Liu, Thinzar M. Lwin, Robert M. Hoffman, Surinder K. Batra and Michael Bouvet
Cancers 2023, 15(5), 1491; https://doi.org/10.3390/cancers15051491  
Available online: https://www.mdpi.com/2072-6694/15/5/1491

“Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies”
by Samhita De, Sourav Paul, Anirban Manna, Chirantan Majumder, Koustav Pal, Nicolette Casarcia, Arijit Mondal, Sabyasachi Banerjee, Vinod Kumar Nelson, Suvranil Ghosh et al.
Cancers 2023, 15(3), 993; https://doi.org/10.3390/cancers15030993  
Available online: https://www.mdpi.com/2072-6694/15/3/993

“The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy”
by Iason Psilopatis, Nikolaos Garmpis, Anna Garmpi, Kleio Vrettou, Panagiotis Sarantis, Evangelos Koustas, Efstathios A. Antoniou, Dimitrios Dimitroulis, Gregory Kouraklis, Michail V. Karamouzis et al.
Cancers 2023, 15(8), 2222; https://doi.org/10.3390/cancers15082222  
Available online: https://www.mdpi.com/2072-6694/15/8/2222

“RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases”
by Salvatore Audia, Carolina Brescia, Vincenzo Dattilo, Lucia D’Antona, Pierluigi Calvano, Rodolfo Iuliano, Francesco Trapasso, Nicola Perrotti and Rosario Amato
Cancers 2023, 15(2), 486; https://doi.org/10.3390/cancers15020486
Available online: https://www.mdpi.com/2072-6694/15/2/486

“Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy”
by Raefa Abou Khouzam, Jean-Marie Lehn, Hemma Mayr, Pierre-Alain Clavien, Michael Bradley Wallace, Michel Ducreux, Perparim Limani and Salem Chouaib
Cancers 2023, 15(4), 1235; https://doi.org/10.3390/cancers15041235
Available online: https://www.mdpi.com/2072-6694/15/4/1235

“PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology”
by Vincenzo Quagliariello, Irma Bisceglia, Massimiliano Berretta, Martina Iovine, Maria Laura Canale, Carlo Maurea, Vienna Giordano, Andrea Paccone, Alessandro Inno and Nicola Maurea
Cancers 2023, 15(5), 1397; https://doi.org/10.3390/cancers15051397
Available online: https://www.mdpi.com/2072-6694/15/5/1397

“HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma”
by Ji Yoon Kim, Hayoung Cho, Jung Yoo, Go Woon Kim, Yu Hyun Jeon, Sang Wu Lee and So Hee Kwon
Cancers 2023, 15(4), 1123; https://doi.org/10.3390/cancers15041123
Available online: https://www.mdpi.com/2072-6694/15/4/1123

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office

24 January 2024
Cancers | Cervical Cancer Awareness Month


January is designated as “Cervical Cancer Awareness Month”, with various global activities that highlight and increase awareness of cervical cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of cervical cancers, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide the useful information for this field.

The list of relevant papers can be seen below: 

“HPV-Based Self-Sampling in Cervical Cancer Screening: An Updated Review of the Current Evidence in the Literature”
by Nikoletta Daponte, George Valasoulis, Georgios Michail, Ioulia Magaliou, Athina-Ioanna Daponte, Antonios Garas, Ioanna Grivea, Dimitrios P. Bogdanos and Alexandros Daponte
Cancers 2023, 15(6), 1669; https://doi.org/10.3390/cancers15061669
Available online: https://www.mdpi.com/2072-6694/15/6/1669

“The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy”    
by Iason Psilopatis, Nikolaos Garmpis, Anna Garmpi, Kleio Vrettou, Panagiotis Sarantis, Evangelos Koustas, Efstathios A. Antoniou, Dimitrios Dimitroulis, Gregory Kouraklis, Michail V. Karamouzis et al.
Cancers 2023, 15(8), 2222; https://doi.org/10.3390/cancers15082222
Available online: https://www.mdpi.com/2072-6694/15/8/2222

“DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway”
by Mengying Jiang, Yizuo Song, Hejing Liu, Yanshan Jin, Ruyi Li and Xueqiong Zhu
Cancers 2023, 15(2), 546; https://doi.org/10.3390/cancers15020546
Available online: https://www.mdpi.com/2072-6694/15/2/546

“Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors”
by Angela Santoro, Frediano Inzani, Giuseppe Angelico, Damiano Arciuolo, Emma Bragantini, Antonio Travaglino, Michele Valente, Nicoletta D’Alessandris, Giulia Scaglione, Stefania Sfregola et al.
Cancers 2023, 15(4), 1137; https://doi.org/10.3390/cancers15041137
Available online: https://www.mdpi.com/2072-6694/15/4/1137

“Cancer-Associated Fibroblasts Exposed to High-Dose Ionizing Radiation Promote M2 Polarization of Macrophages, Which Induce Radiosensitivity in Cervical Cancer”
by Yuhan Sheng, Baofang Zhang, Biyuan Xing, Zhao Liu, Yu Chang, Gang Wu and Yingchao Zhao
Cancers 2023, 15(5), 1620; https://doi.org/10.3390/cancers15051620
Available online: https://www.mdpi.com/2072-6694/15/5/1620

“Synergistic Combination of Luteolin and Asiatic Acid on Cervical Cancer In Vitro and In Vivo”
by Ya-Hui Chen, Jyun-Xue Wu, Shun-Fa Yang and Yi-Hsuan Hsiao
Cancers 2023, 15(2), 548; https://doi.org/10.3390/cancers15020548
Available online: https://www.mdpi.com/2072-6694/15/2/548

“Association between Tumor Mutational Burden, Stromal CD8+ Tumor-Infiltrating Lymphocytes, and Clinical Factors in Cervical Cancers Treated with Radiotherapy”
by Hanguang Ruan, Takahiro Oike, Hiro Sato, Ken Ando and Tatsuya Ohno
Cancers 2023, 15(4), 1210; https://doi.org/10.3390/cancers15041210
Available online: https://www.mdpi.com/2072-6694/15/4/1210

“Candidate Genes and Pathways in Cervical Cancer: A Systematic Review and Integrated Bioinformatic Analysis”
by Marjanu Hikmah Elias, Srijit Das and Nazefah Abdul Hamid
Cancers 2023, 15(3), 853; https://doi.org/10.3390/cancers15030853
Available online: https://www.mdpi.com/2072-6694/15/3/853

“The Impact of Psychological Distress on Cervical Cancer”
by Chen-Ta Wu and Lu-Ting Chiu
Cancers 2023, 15(4), 1100; https://doi.org/10.3390/cancers15041100
Available online: https://www.mdpi.com/2072-6694/15/4/1100

“A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities”
by Jonathan Peña Avila, Bruno Melo Carvalho and Eliane Campos Coimbra
Cancers 2023, 15(4), 1333; https://doi.org/10.3390/cancers15041333
Available online: https://www.mdpi.com/2072-6694/15/4/1333

“Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne’s Thread in Early Cervical Cancer Treatment?”   
by Benjamin Serouart, Abel Cordoba, Carlos Martinez-Gomez, Emilie Bogart, Marie Cecile Le Deley, Éric Leblanc, Delphine Hudry, Alexandre Escande, Florence Le Tinier, Camille Pasquesoone et al.
Cancers 2023, 15(5), 1570; https://doi.org/10.3390/cancers15051570
Available online: https://www.mdpi.com/2072-6694/15/5/1570

“Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications”
by Daniel G. Sausen, Oren Shechter, Elisa S. Gallo, Harel Dahari and Ronen Borenstein
Cancers 2023, 15(14), 3692; https://doi.org/10.3390/cancers15143692
Available online: https://www.mdpi.com/2072-6694/15/14/3692

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office

24 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Infectious Agents and Cancer”


We are pleased to invite you to read the top 10 cited papers published in Cancers (ISSN: 2072-6694) in 2023, in the Section “Infectious Agents and Cancer”. We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“EBV and Lymphomagenesis”
by Daniel G. Sausen, Ayeman Basith and Syed Muqeemuddin
Cancers 2023, 15(7), 2133; https://doi.org/10.3390/cancers15072133
Available online: https://www.mdpi.com/2072-6694/15/7/2133

“Gut Microbiota and Breast Cancer: The Dual Role of Microbes”
by Ana Isabel Álvarez-Mercado, Ana del Valle Cano, Mariana F. Fernández and Luis Fontana
Cancers 2023, 15(2), 443; https://doi.org/10.3390/cancers15020443
Available online: https://www.mdpi.com/2072-6694/15/2/443

“Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma”
by Roland Houben, Büke Celikdemir, Thibault Kervarrec and David Schrama
Cancers 2023, 15(2), 444; https://doi.org/10.3390/cancers15020444
Available online: https://www.mdpi.com/2072-6694/15/2/444

“Relationship of Post-Transplant Lymphoproliferative Disorders (PTLD) Subtypes and Clinical Outcome in Pediatric Heart Transplant Recipients: A Retrospective Single Institutional Analysis/Experience of 558 Patients”
by Yan Liu, Billy C. Wang, Craig W. Zuppan, Peter Chau, James Fitts, Richard Chinnock and Jun Wang
Cancers 2023, 15(3), 976; https://doi.org/10.3390/cancers15030976
Available online: https://www.mdpi.com/2072-6694/15/3/976

“Genotoxins: The Mechanistic Links between Escherichia coli and Colorectal Cancer”
by Ya Wang and Kai Fu
Cancers 2023, 15(4), 1152; https://doi.org/10.3390/cancers15041152
Available online: https://www.mdpi.com/2072-6694/15/4/1152

“Impact of Preventive Strategies on HPV-Related Diseases: Ten-Year Data from the Italian Hospital Admission Registry”
by Vincenzo Restivo, Giuseppa Minutolo, Marianna Maranto, Antonio Maiorana, Francesco Vitale, Alessandra Casuccio and Emanuele Amodio
Cancers 2023, 15(5), 1452; https://doi.org/10.3390/cancers15051452
Available online: https://www.mdpi.com/2072-6694/15/5/1452

“SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines”
by Olga A. Smirnova, Olga N. Ivanova, Irina T. Fedyakina, Gaukhar M. Yusubalieva, Vladimir P. Baklaushev, Dmitry V. Yanvarev, Olga I. Kechko, Vladimir A. Mitkevich, Pavel O. Vorobyev, Vyacheslav S. Fedorov et al.
Cancers 2023, 15(3), 632; https://doi.org/10.3390/cancers15030632
Available online: https://www.mdpi.com/2072-6694/15/3/632

“The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions”
by Despoina E. Kiousi, Antonia Z. Kouroutzidou, Konstantinos Neanidis, Emmanuel Karavanis, Dimitrios Matthaios, Aglaia Pappa and Alex Galanis
Cancers 2023, 15(7), 2101; https://doi.org/10.3390/cancers15072101
Available online: https://www.mdpi.com/2072-6694/15/7/2101

“Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis”
by Efstathia Liatsou, Ioannis Ntanasis-Stathopoulos, Stavros Lykos, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, Theodoros N. Sergentanis and Evangelos Terpos
Cancers 2023, 15(8), 2266; https://doi.org/10.3390/cancers15082266
Available online: https://www.mdpi.com/2072-6694/15/8/2266

“Breast Cancer Survivors and Healthy Women: Could Gut Microbiota Make a Difference?—“BiotaCancerSurvivors”: A Case-Control Study”
by Telma Caleça, Pedro Ribeiro, Marina Vitorino, Maria Menezes, Mafalda Sampaio-Alves, Ana Duarte Mendes, Rodrigo Vicente, Ida Negreiros, Ana Faria and Diogo Alpuim Costa
Cancers 2023, 15(3), 594; https://doi.org/10.3390/cancers15030594
Available online: https://www.mdpi.com/2072-6694/15/3/594

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

23 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Survivorship and Quality of Life”


We are pleased to invite you to read the top 10 cited papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Cancer Survivorship and Quality of Life”. We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis”
by Rolf A. H. Snijders, Linda Brom, Maurice Theunissen and Marieke H. J. van den Beuken-van Everdingen
Cancers 2023, 15(3), 591; https://doi.org/10.3390/cancers15030591
Available online: https://doi.org/10.3390/cancers15030591

“Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?”
by Vincent Bourbonne, Ulrike Schick, Olivier Pradier, Dimitris Visvikis, Jean-Philippe Metges and Bogdan Badic
Cancers 2023, 15(2), 432; https://doi.org/10.3390/cancers15020432
Available online: https://www.mdpi.com/2072-6694/15/2/432

“Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancer in the United States”
by Kekoa Taparra, Brandon I. Ing, Agnes Ewongwo, Jacqueline B. Vo, Jaimie Z. Shing, Megan Y. Gimmen, Kiana M. K. Keli‘i, Jason Uilelea, Erqi Pollom and Elizabeth Kidd
Cancers 2023, 15(9), 2571; https://doi.org/10.3390/cancers15092571
Available online: https://www.mdpi.com/2072-6694/15/9/2571

“A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors”
by Charlotte Kerstens, Hans P. M. W. Wildiers, Gwen Schroyen, Mercedes Almela, Ruth E. Mark, Maarten Lambrecht, Sabine Deprez and Charlotte Sleurs
Cancers 2023, 15(4),1215; https://doi.org/10.3390/cancers15041215
Available online: https://www.mdpi.com/2072-6694/15/4/1215

“Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging”
by Luigia Vetrone, Riccardo Mei, Lorenzo Bianchi, Francesca Giunchi, Andrea Farolfi, Paolo Castellucci, Matteo Droghetti, Massimiliano Presutti, Alessio Degiovanni, Riccardo Schiavina and et al.
Cancers 2023, 15(6), 1716; https://doi.org/10.3390/cancers15061716
Available online: https://www.mdpi.com/2072-6694/15/6/1716

“Impact of Hormone Replacement Therapy on the Overall Survival and Progression Free Survival of Ovarian Cancer Patients: A Systematic Review and Meta-Analysis”
by Patriciu Andrei Achimaș-Cadariu, Diana Loreta Păun and Andrei Pașca
Cancers 2023, 15(2), 356; https://doi.org/10.3390/cancers15020356
Available online: https://www.mdpi.com/2072-6694/15/2/356

“Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation”
by Dionysios Vythoulkas, Panagiotis Tsirigotis, Marianna Griniezaki, Ioannis Konstantellos and Ioanna Lazana
Cancers 2023, 15(3), 680; https://doi.org/10.3390/cancers15030680
Available online: https://www.mdpi.com/2072-6694/15/3/680

“Fear of Cancer Recurrence in Patients with Sarcoma in the United Kingdom”
by Anika Petrella, Lesley Storey, Nicholas J. Hulbert-Williams, Lorna A. Fern, Maria Lawal, Craig Gerrand, Rachael Windsor, Julie Woodford, Jennie Bradley, Hatty O’Sullivan et al.
Cancers 2023, 15(3), 956; https://doi.org/10.3390/cancers15030956
Available online: https://www.mdpi.com/2072-6694/15/3/956

“Cancer Disparities among Pacific Islanders: A Review of Sociocultural Determinants of Health in the Micronesian Region”
by Eric Pineda, Ryan Benavente, Megan Y. Gimmen, Nicole V. DeVille and Kekoa Taparra
Cancers 2023, 15(5),1392; https://doi.org/10.3390/cancers15051392
Available online: https://www.mdpi.com/2072-6694/15/5/1392

“Applications of Machine Learning in Palliative Care: A Systematic Review”
by Erwin Vu, Nina Steinmann, Christina Schröder, Robert Förster, Daniel M. Aebersold, Steffen Eychmüller, Nikola Cihoric, Caroline Hertler, Paul Windisch and Daniel R. Zwahlen
Cancers 2023, 15(5), 1596; https://doi.org/10.3390/cancers15051596
Available online: https://www.mdpi.com/2072-6694/15/5/1596

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

22 January 2024
Cancers | Highly Cited Papers in 2023 in the Section “Clinical Research of Cancer”


We are pleased to invite you to read the highly cited papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Clinical Research of Cancer”. We hope this announcement will provide useful information for this field.

The papers list is as follows:

“The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer”
by Jerome Canady, Saravana R. K. Murthy, Taisen Zhuang, Steven Gitelis, Aviram Nissan, Lawan Ly, Olivia Z. Jones, Xiaoqian Cheng, Mohammad Adileh, Alan T. Blank et al.
Cancers 2023, 15(14), 3688; https://doi.org/10.3390/cancers15143688
Available online: https://www.mdpi.com/2072-6694/15/14/3688

“Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation”
by Fanny Lundmark, Ayman Abouzayed, Sara S. Rinne, Vasiliy Timofeev, Nadezhda Sipkina, Maria Naan, Anastasia Kirichenko, Maria Vasyutina, Daria Ryzhkova, Vladimir Tolmachev et al.
Cancers 2023, 15(2), 442; https://doi.org/10.3390/cancers15020442
Available online: https://www.mdpi.com/2072-6694/15/2/442

“Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer”
by Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Manon Reda, Juliette Albuisson, Laurent Arnould et al.
Cancers 2023, 15(4), 1299; https://doi.org/10.3390/cancers15041299
Available online: https://www.mdpi.com/2072-6694/15/4/1299

“A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)”
by Joshua D. Rosenblat, Froukje E. deVries, Zoe Doyle, Roger S. McIntyre, Gary Rodin, Camilla Zimmermann, Ernie Mak, Breffni Hannon, Christian Schulz-Quach, Aida Al Kindy et al.
Cancers 2023, 15(2), 400; https://doi.org/10.3390/cancers15020400
Available online: https://www.mdpi.com/2072-6694/15/2/400

“A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma”
by Chijioke Nze, Pavlos Msaouel, Mohamed H. Derbala, Bettzy Stephen, Abdulrahman Abonofal, Funda Meric-Bernstam, Nizar M. Tannir and Aung Naing
Cancers 2023, 15(15), 3806; https://doi.org/10.3390/cancers15153806
Available online: https://www.mdpi.com/2072-6694/15/15/3806

“Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer”
by Yeong Gyu Jeong, Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Sa Deok Hong, Seong Min Park, Seul-Gi Kim, Tae Hoen Kim and Yong Wha Moon
Cancers 2023, 15(19), 4887; https://doi.org/10.3390/cancers15194887
Available online: https://www.mdpi.com/2072-6694/15/19/4887

“Prevalence of Homologous Recombination Deficiency in First-Line PARP Inhibitor Maintenance Clinical Trials and Further Implication of Personalized Treatment in Ovarian Cancer”
by E Sun Paik, Ha Kyun Chang and Sanghoon Lee
Cancers 2023, 15(12), 3095; https://doi.org/10.3390/cancers15123095
Available online: https://www.mdpi.com/2072-6694/15/12/3095

“Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?”
by Michael Tachezy, Florian Gebauer, Emre Yekebas and Jakob Robert Izbicki
Cancers 2023, 15(17), 4262; https://doi.org/10.3390/cancers15174262
Available online: https://www.mdpi.com/2072-6694/15/17/4262

“Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas”
by Angela Buonadonna, Simona Scalone, Davide Lombardi, Arianna Fumagalli, Alessandra Guglielmi, Chiara Lestuzzi, Jerry Polesel, Vincenzo Canzonieri, Stefano Lamon, Petros Giovanis et al.
Cancers 2023, 15(20), 5036; https://doi.org/10.3390/cancers15205036
Available online: https://www.mdpi.com/2072-6694/15/20/5036

“A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia”
by Neil Palmisiano, Grace Jeschke, Lindsay Wilde, Onder Alpdogan, Matthew Carabasi, Joanne Filicko-O’Hara, Dolores Grosso, Thomas Klumpp, Ubaldo Martinez, John Wagner et al.
Cancers 2023, 15(21), 5129; https://doi.org/10.3390/cancers15215129
Available online: https://www.mdpi.com/2072-6694/15/21/5129

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

22 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Systematic Review or Meta-Analysis in Cancer Research”


We are pleased to invite you to read the top 10 cited papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Systematic Review or Meta-Analysis in Cancer Research”. We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review”
by Alessio Rizzo, Manuela Racca, Sara Dall’Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata and Giorgio Treglia
Cancers 2023, 15(2), 355; https://doi.org/10.3390/cancers15020355
Available online: https://www.mdpi.com/2072-6694/15/2/355

“Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis”
by Ainsley Ryan Yan Bin Lee, Chun En Yau, Chen Ee Low, Jiaqi Li, Sara Moiz Tyebally, Weiqin Lin, Li-Ling Tan, Chia-Te Liao, Wei-Ting Chang, Matilda Xinwei Lee et al.
Cancers 2023, 15(2), 512; https://doi.org/10.3390/cancers15020512
Available online: https://www.mdpi.com/2072-6694/15/2/512

“A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma”
by Gabriela Villanueva, Martin Guscott, Paula Schaiquevich, Claudia Sampor, Ryan Combs, Nicolás Tentoni, Miriam Hwang, Jennifer Lowe and Scott Howard
Cancers 2023, 15(5), 1459, https://doi.org/10.3390/cancers15051459
Available online: https://www.mdpi.com/2072-6694/15/5/1459

“Rate of Malignant Transformation Differs Based on Diagnostic Criteria for Oral Lichenoid Conditions: A Systematic Review and Meta-Analysis of 24,277 Patients”
by Jing-Wen Li, Kar Yan Li, Bik Wan Amy Chan, Colman Patrick McGrath and Li-Wu Zheng
Cancers 2023, 15(9), 2537, https://doi.org/10.3390/cancers15092537
Available online: https://www.mdpi.com/2072-6694/15/9/2537

“Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes—Systematic Review and Meta-Analysis”
by Rafał Osiecki, Mieszko Kozikowski, Beata Sarecka-Hujar, Michał Pyzlak and Jakub Dobruch
Cancers 2023, 15(5), 1372; https://doi.org/10.3390/cancers15051372
Available online: https://www.mdpi.com/2072-6694/15/5/1372

“Role of Adjuvant Chemotherapy in Stage I Pure Ovarian Immature Teratoma: A Systematic Review and Meta-Analysis”
by Sijian Li, Yuelin Wang, Xinyue Zhang, Tianyu Zhang, Min Yin and Jiaxin Yang
Cancers 2023, 15(6), 1741; https://doi.org/10.3390/cancers15061741
Available online: https://www.mdpi.com/2072-6694/15/6/1741

“Systematic Review of Tumor Segmentation Strategies for Bone Metastases”
by Iromi R. Paranavithana, David Stirling, Montserrat Ros and Matthew Field
Cancers 2023, 15(6), 1750; https://doi.org/10.3390/cancers15061750
Available online: https://www.mdpi.com/2072-6694/15/6/1750

“The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis”
by Jonathan Abdelmalak, Natassia Tan, Danny Con, Guy Eslick, Ammar Majeed, William Kemp and Stuart K. Roberts
Cancers 2023, 15(13), 3518; https://doi.org/10.3390/cancers15133518
Available online: https://www.mdpi.com/2072-6694/15/13/3518

“Mixed-Method Systematic Review and Meta-Analysis of Shared Decision-Making Tools for Cancer Screening”
by Deborah Jael Herrera, Wessel van de Veerdonk, Neamin M. Berhe, Sarah Talboom, Marlon van Loo, Andrea Ruiz Alejos, Allegra Ferrari and Guido Van Hal
Cancers 2023, 15(15), 3867; https://doi.org/10.3390/cancers15153867
Available online: https://www.mdpi.com/2072-6694/15/15/3867

“Deep Learning for Lung Cancer Diagnosis, Prognosis and Prediction Using Histological and Cytological Images: A Systematic Review”
by Athena Davri, Effrosyni Birbas, Theofilos Kanavos, Georgios Ntritsos, Nikolaos Giannakeas, Alexandros T. Tzallas and Anna Batistatou
Cancers 2023, 15(15), 3981, https://doi.org/10.3390/cancers15153981
Available online: https://www.mdpi.com/2072-6694/15/15/3981

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

22 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Causes, Screening and Diagnosis”


We are pleased to invite you to read the top 10 cited papers published in the Section “Cancer Causes, Screening and Diagnosis” of Cancers (ISSN: 2072-6694) in 2023. We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“DSCC_Net: Multi-Classification Deep Learning Models for Diagnosing of Skin Cancer Using Dermoscopic Images”
by Maryam Tahir, Ahmad Naeem, Hassaan Malik, Jawad Tanveer, Rizwan Ali Naqvi and Seung-Won Lee
Cancers 2023, 15(7), 2179; https://doi.org/10.3390/cancers15072179
Available online: https://www.mdpi.com/2072-6694/15/7/2179

“Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review”
by Federica Di Spirito, Giuseppe Pantaleo, Maria Pia Di Palo, Alessandra Amato, Annunziata Raimondo and Massimo Amato
Cancers 2023, 15(4), 1096; https://doi.org/10.3390/cancers15041096
Available online: https://www.mdpi.com/2072-6694/15/4/1096

“Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study”
by Barbara Bailly-Caillé, Diane Kottler, Rémy Morello, Marie Lecornu, William Kao, Emmanuel Meyer, Anne Dompmartin and L’Orphelin Jean-Matthieu
Cancers 2023, 15(2), 495; https://doi.org/10.3390/cancers15020495
Available online: https://www.mdpi.com/2072-6694/15/2/495

“The Use of Artificial Intelligence in the Diagnosis and Classification of Thyroid Nodules: An Update”
by Maksymilian Ludwig, Bartłomiej Ludwig, Agnieszka Mikuła, Szymon Biernat, Jerzy Rudnicki and Krzysztof Kaliszewski
Cancers 2023, 15(3), 708; https://doi.org/10.3390/cancers15030708
Available online: https://www.mdpi.com/2072-6694/15/3/708

“Outcomes of Robot-Assisted Surgery in Rectal Cancer Compared with Open and Laparoscopic Surgery”
by Elias Khajeh, Ehsan Aminizadeh, Arash Dooghaie Moghadam, Rajan Nikbakhsh, Gil Goncalves, Carlos Carvalho, Amjad Parvaiz, Yakup Kulu and Arianeb Mehrabi
Cancers 2023, 15(3), 839; https://doi.org/10.3390/cancers15030839
Available online: https://www.mdpi.com/2072-6694/15/3/839

“Intraoperative Evaluation of Soft Tissue Sarcoma Surgical Margins with Indocyanine Green Fluorescence Imaging”
by Matthew F. Gong, William T. Li, Sumail Bhogal, Brittany Royes, Tanya Heim, Maria Silvaggio, Marcus Malek, Rajeev Dhupar, Stella J. Lee, Richard L. McGough et al.
Cancers 2023, 15(3), 582; https://doi.org/10.3390/cancers15030582
Available online: https://www.mdpi.com/2072-6694/15/3/582

“Endocrine Tumor Classification via Machine-Learning-Based Elastography: A Systematic Scoping Review”
by Ye-Jiao Mao, Li-Wen Zha, Andy Yiu-Chau Tam, Hyo-Jung Lim, Alyssa Ka-Yan Cheung, Ying-Qi Zhang, Ming Ni, James Chung-Wai Cheung and Duo Wai-Chi Wong
Cancers 2023, 15(3), 837; https://doi.org/10.3390/cancers15030837
Available online: https://www.mdpi.com/2072-6694/15/3/837

“Improving Automatic Melanoma Diagnosis Using Deep Learning-Based Segmentation of Irregular Networks”
by Anand K. Nambisan, Akanksha Maurya, Norsang Lama, Thanh Phan, Gehana Patel, Keith Miller, Binita Lama, Jason Hagerty, Ronald Stanley and William V. Stoecker
Cancers 2023, 15(4), 1259; https://doi.org/10.3390/cancers15041259
Available online: https://www.mdpi.com/2072-6694/15/4/1259

“The Risk of Endometrial Cancer and Uterine Sarcoma Following Endometriosis or Pelvic Inflammatory Disease”
by Jing-Yang Huang, Kevin Sheng-Kai Ma, Li-Tzu Wang, Cho-Han Chiang, Shun-Fa Yang, Chun-Hao Wang and Po-Hui Wang
Cancers 2023, 15(3), 833; https://doi.org/10.3390/cancers15030833
Available online: https://www.mdpi.com/2072-6694/15/3/833

“Endoscopic Ultrasound Advanced Techniques for Diagnosis of Gastrointestinal Stromal Tumours”
by Socrate Pallio, Stefano Francesco Crinò, Marcello Maida, Emanuele Sinagra, Vincenzo Francesco Tripodi, Antonio Facciorusso, Andrew Ofosu, Maria Cristina Conti Bellocchi, Endrit Shahini and Giuseppinella Melita
Cancers 2023, 15(4),1285; https://doi.org/10.3390/cancers15041285
Available online: https://www.mdpi.com/2072-6694/15/4/1285

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office

19 January 2024
Cancers | Top 10 Cited Papers in 2023 in the Section “Methods and Technologies Development”


We are pleased to invite you to read the Top 10 Cited Cancers Papers of 2023 (ISSN: 2072-6694) in Section “Methods and Technologies Development”. We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“Multiphysics Modeling of Low-Intensity Pulsed Ultrasound Induced Chemotherapeutic Drug Release from the Surface of Gold Nanoparticles”
by Tyler K. Hornsby, Farshad Moradi Kashkooli, Anshuman Jakhmola, Michael C. Kolios and Jahangir (Jahan) Tavakkoli
Cancers 2023, 15(2), 523; https://doi.org/10.3390/cancers15020523
Available online: https://www.mdpi.com/2072-6694/15/2/523

“New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy”
by Sara C. Freitas, Daniel Sanderson, Sofia Caspani, Ricardo Magalhães, Belén Cortés-Llanos, Andreia Granja, Salette Reis, João Horta Belo, José Azevedo, Maria Victoria Gómez-Gaviro et al.
Cancers 2023, 15(2), 383; https://doi.org/10.3390/cancers15020383
Available online: https://www.mdpi.com/2072-6694/15/2/383

“Hybrid Quantum Neural Network for Drug Response Prediction”
by Asel Sagingalieva, Mohammad Kordzanganeh, Nurbolat Kenbayev, Daria Kosichkina, Tatiana Tomashuk and Alexey Melnikov
Cancers 2023, 15(10), 2705; https://doi.org/10.3390/cancers15102705
Available online: https://www.mdpi.com/2072-6694/15/10/2705

“Thin-Slice Prostate MRI Enabled by Deep Learning Image Reconstruction”
by Sebastian Gassenmaier, Verena Warm, Dominik Nickel, Elisabeth Weiland, Judith Herrmann, Haidara Almansour, Daniel Wessling and Saif Afat
Cancers 2023, 15(3), 578; https://doi.org/10.3390/cancers15030578
Available online: https://www.mdpi.com/2072-6694/15/3/578

“Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety”
by Dawn Swan, Philip Murphy, Siobhan Glavey and John Quinn
Cancers 2023, 15(6), 1819; https://doi.org/10.3390/cancers15061819
Available online: https://www.mdpi.com/2072-6694/15/6/1819

“PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment”
by Lorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, Francesco Costa, Matteo Droghetti, Pietro Piazza, Alessandro Pissavini, Massimiliano Presutti, Andrea Farolfi, Riccardo Mei et al.
Cancers 2023, 15(7), 2027; https://doi.org/10.3390/cancers15072027
Available online: https://www.mdpi.com/2072-6694/15/7/2027

“Within-Modality Synthesis and Novel Radiomic Evaluation of Brain MRI Scans”
by Seyed Masoud Rezaeijo, Nahid Chegeni, Fariborz Baghaei Naeini, Dimitrios Makris and Spyridon Bakas
Cancers 2023, 15(14), 3565; https://doi.org/10.3390/cancers15143565
Available online: https://www.mdpi.com/2072-6694/15/14/3565

“State of the Art MR Imaging for Lung Cancer TNM Stage Evaluation”
by Yoshiharu Ohno, Yoshiyuki Ozawa, Hisanobu Koyama, Takeshi Yoshikawa, Daisuke Takenaka, Hiroyuki Nagata, Takahiro Ueda, Hirotaka Ikeda and Hiroshi Toyama
Cancers 2023, 15(3), 950; https://doi.org/10.3390/cancers15030950
Available online: https://www.mdpi.com/2072-6694/15/3/950

“Modulating T Cell Responses by Targeting CD3”
by Ashwathi Puravankara Menon, Beatriz Moreno, Daniel Meraviglia-Crivelli, Francesca Nonatelli, Helena Villanueva, Martin Barainka, Angelina Zheleva, Hisse M. van Santen and Fernando Pastor
Cancers 2023, 15(4), 1189; https://doi.org/10.3390/cancers15041189
Available online: https://www.mdpi.com/2072-6694/15/4/1189

“Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience”
by Caroline Burgard, Manuela A. Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J. Marlowe, Mathias Schreckenberger, Samer Ezziddin and Florian Rosar
Cancers 2023, 15(5), 1376; https://doi.org/10.3390/cancers15051376
Available online: https://www.mdpi.com/2072-6694/15/5/1376

You are invited to view and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

18 January 2024
Cancers | Highly Cited Papers in 2023 in the Section “Cancer Informatics and Big Data”


We are pleased to invite you to read the highly cited papers published in Cancers in 2023 (ISSN: 2072-6694) in the Section “Cancer Informatics and Big Data”. We hope this announcement will provide useful information for this field.

The papers list is as follows:

“Leveraging Marine Predators Algorithm with Deep Learning for Lung and Colon Cancer Diagnosis”
by Hanan Abdullah Mengash, Mohammad Alamgeer, Mashael Maashi, Mahmoud Othman, Manar Ahmed Hamza, Sara Saadeldeen Ibrahim, Abu Sarwar Zamani and Ishfaq Yaseen
Cancers 2023, 15(5), 1591; https://doi.org/10.3390/cancers15051591
Available online: https://www.mdpi.com/2072-6694/15/5/1591

“Application of Machine Learning for Differentiating Bone Malignancy on Imaging: A Systematic Review”
by Wilson Ong, Lei Zhu, Yi Liang Tan, Ee Chin Teo, Jiong Hao Tan, Naresh Kumar, Balamurugan A. Vellayappan, Beng Chin Ooi, Swee Tian Quek, Andrew Makmur et al.
Cancers 2023, 15(6), 1837; https://doi.org/10.3390/cancers15061837
Available online: https://www.mdpi.com/2072-6694/15/6/1837

“Population-Based Clinical Cancer Registration in Germany”
by Alexander Katalinic, Marco Halber, Martin Meyer, Maren Pflüger, Andrea Eberle, Alice Nennecke, Soo-Zin Kim-Wanner, Tobias Hartz, Kerstin Weitmann, Andreas Stang et al.
Cancers 2023, 15(15), 3934; https://doi.org/10.3390/cancers15153934
Available online: https://www.mdpi.com/2072-6694/15/15/3934

“Association of Multi-Phasic MR-Based Radiomic and Dosimetric Features with Treatment Response in Unresectable Hepatocellular Carcinoma Patients following Novel Sequential TACE-SBRT-Immunotherapy”
by Lok-Man Ho, Sai-Kit Lam, Jiang Zhang, Chi-Leung Chiang, Albert Chi-Yan Chan and Jing Cai
Cancers 2023, 15(4), 1105; https://doi.org/10.3390/cancers15041105
Available online: https://www.mdpi.com/2072-6694/15/4/1105

“Prediction of Deep Myometrial Infiltration, Clinical Risk Category, Histological Type, and Lymphovascular Space Invasion in Women with Endometrial Cancer Based on Clinical and T2-Weighted MRI Radiomic Features”
by Xingfeng Li, Michele Dessi, Diana Marcus, James Russell, Eric O. Aboagye, Laura Burney Ellis, Alexander Sheeka, Won-Ho Edward Park, Nishat Bharwani, Sadaf Ghaem-Maghami et al.
Cancers 2023, 15(8), 2209; https://doi.org/10.3390/cancers15082209
Available online: https://www.mdpi.com/2072-6694/15/8/2209

“Involvement of Epithelial–Mesenchymal Transition Genes in Small Cell Lung Cancer Phenotypic Plasticity”
by Sarah M. Groves, Nicholas Panchy, Darren R. Tyson, Leonard A. Harris, Vito Quaranta and Tian Hong
Cancers 2023, 15(5), 1477; https://doi.org/10.3390/cancers15051477
Available online: https://www.mdpi.com/2072-6694/15/5/1477

“Exact Probability Distribution for the ROC Area under Curve”
by Joakim Ekström, Jim Åkerrén Ögren and Tobias Sjöblom
Cancers 2023, 15(6), 1788; https://doi.org/10.3390/cancers15061788
Available online: https://www.mdpi.com/2072-6694/15/6/1788

“Unlocking the Power of Benchmarking: Real-World-Time Data Analysis for Enhanced Sarcoma Patient Outcomes”
by Bruno Fuchs, Georg Schelling, Maria Elyes, Gabriela Studer, Beata Bode-Lesniewska, Mario F. Scaglioni, Pietro Giovanoli, Philip Heesen and on behalf of the Swiss Sarcoma Network
Cancers 2023, 15(17), 4395; https://doi.org/10.3390/cancers15174395
Available online: https://www.mdpi.com/2072-6694/15/17/4395

“Impact of Stain Normalization on Pathologist Assessment of Prostate Cancer: A Comparative Study”
by Massimo Salvi, Alessandro Caputo, Davide Balmativola, Manuela Scotto, Orazio Pennisi, Nicola Michielli, Alessandro Mogetta, Filippo Molinari and Filippo Fraggetta
Cancers 2023, 15(5), 1503; https://doi.org/10.3390/cancers15051503
Available online: https://www.mdpi.com/2072-6694/15/5/1503

“Prospects of POLD1 in Human Cancers: A Review”
by Michał Gola, Przemysław Stefaniak, Janusz Godlewski, Barbara Alicja Jereczek-Fossa and Anna Starzyńska
Cancers 2023, 15(6), 1905; https://doi.org/10.3390/cancers15061905
Available online: https://www.mdpi.com/2072-6694/15/6/1905

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

17 January 2024
Cancers | Highly Cited Papers in 2023 in the Section “Tumor Microenvironment”


We are pleased to invite you to read the highly cited papers published in Cancers in 2023 (ISSN: 2072-6694) in the Section “Tumor Microenvironment”. We hope this announcement will provide useful information for this field.

The papers list is as follows:

“Optical Genome Mapping for Cytogenetic Diagnostics in AML”
by Verena Nilius-Eliliwi, Wanda M. Gerding, Roland Schroers, Huu Phuc Nguyen and Deepak B. Vangala
Cancers 2023, 15(6), 1684; https://doi.org/10.3390/cancers15061684
Available online: https://www.mdpi.com/2072-6694/15/6/1684

“Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers”
by Kellen Wright, Thuc Ly, Matthew Kriet, Andras Czirok and Sufi Mary Thomas
Cancers 2023, 15(6), 1899; https://doi.org/10.3390/cancers15061899
Available online: https://www.mdpi.com/2072-6694/15/6/1899

“Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer”
by Manuel Sánchez-de-la-Torre, Carolina Cubillos, Olivia J. Veatch, Francisco Garcia-Rio, David Gozal and Miguel Angel Martinez-Garcia
Cancers 2023, 15(4), 1061; https://doi.org/10.3390/cancers15041061
Available online: https://www.mdpi.com/2072-6694/15/4/1061

“Relationship between Tumor Budding and Partial Epithelial–Mesenchymal Transition in Head and Neck Cancer”
by Kohei Okuyama, Keiji Suzuki and Souichi Yanamoto
Cancers 2023, 15(4), 1111; https://doi.org/10.3390/cancers15041111
Available online: https://www.mdpi.com/2072-6694/15/4/1111

“PARP Inhibitors in Breast and Ovarian Cancer”
by Samuel S. Y. Wang, Yeo Ee Jie, Sim Wey Cheng, Goh Liuh Ling and Heong Valerie Yue Ming
Cancers 2023, 15(8), 2357; https://doi.org/10.3390/cancers15082357
Available online: https://www.mdpi.com/2072-6694/15/8/2357

“Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma”
by Yun-Yun Tao, Yue Shi, Xue-Qin Gong, Li Li, Zu-Mao Li, Lin Yang and Xiao-Ming Zhang
Cancers 2023, 15(2), 365; https://doi.org/10.3390/cancers15020365
Available online: https://www.mdpi.com/2072-6694/15/2/365

“Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma”
by Yu Kitamura, Yu-ichiro Koma, Kohei Tanigawa, Shuichi Tsukamoto, Yuki Azumi, Shoji Miyako, Satoshi Urakami, Takayuki Kodama, Mari Nishio, Manabu Shigeoka et al.
Cancers 2023, 15(2), 394; https://doi.org/10.3390/cancers15020394
Available online: https://www.mdpi.com/2072-6694/15/2/394

“Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics”
by Marcel Martin, Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal, Yentl Van Rymenant, Joni De Loose, Emile Verhulst, Ingrid De Meester, Pieter Van Der Veken and Frank Roesch
Cancers 2023, 15(6), 1889; https://doi.org/10.3390/cancers15061889
Available online: https://www.mdpi.com/2072-6694/15/6/1889

“Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin”
by Margherita Cortini, Francesca Macchi, Francesca Reggiani, Emanuele Vitale, Maria Veronica Lipreri, Francesca Perut, Alessia Ciarrocchi, Nicola Baldini and Sofia Avnet
Cancers 2023, 15(4), 1221; https://doi.org/10.3390/cancers15041221
Available online: https://www.mdpi.com/2072-6694/15/4/1221

“Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma”
by Yu Gu, Hao Huang, Qi Tong, Meng Cao, Wenlong Ming, Rongxin Zhang, Wenyong Zhu, Yuqi Wang and Xiao Sun
Cancers 2023, 15(8), 2338; https://doi.org/10.3390/cancers15082338
Available online: https://www.mdpi.com/2072-6694/15/8/2338

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

17 January 2024
Cancers | Highly Cited Papers in 2023 in the Section “Cancer Biomarkers”


We are pleased to invite you to read the Highly Cited papers in 2023 in Cancers (ISSN: 2072-6694) in Section “Cancer Biomarkers”. We hope this announcement will provide useful information for this field.

The papers list is as follows:

“Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors”
by Barnabas Irmer, Suganja Chandrabalan, Lukas Maas, Annalen Bleckmann and Kerstin Menck
Cancers 2023, 15(4), 1307; https://doi.org/10.3390/cancers15041307
Available online: https://www.mdpi.com/2072-6694/15/4/1307

“Liquid Biopsies, Novel Approaches and Future Directions”
by Athanasios Armakolas, Maria Kotsari and John Koskinas
Cancers 2023, 15(5), 1579; https://doi.org/10.3390/cancers15051579
Available online: https://www.mdpi.com/2072-6694/15/5/1579

“Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients”
by Othman R. Alzahrani, Rashid Mir, Hanan E. Alatwi, Yousef M. Hawsawi, Amnah A. Alharbi, Abdulrahman H. Alessa, Elham Saleh Albalawi, Imadeldin Elfaki, Yousef Alalawi, Laila Moharam et al.
Cancers 2023, 15(4), 1281; https://doi.org/10.3390/cancers15041281
Available online: https://www.mdpi.com/2072-6694/15/4/1281

“Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings”
by Jun-Ho Kim and Seul Ki Lee
Cancers 2023, 15(6), 1703; https://doi.org/10.3390/cancers15061703
Available online: https://www.mdpi.com/2072-6694/15/6/1703

“Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis and Immune Microenvironment of Osteosarcoma”
by Liangkun Huang, Fei Sun, Zilin Liu, Wenyi Jin, Yubiao Zhang, Junwen Chen, Changheng Zhong, Wanting Liang and Hao Peng
Cancers 2023, 15(8), 2405; https://doi.org/10.3390/cancers15082405
Available online: https://www.mdpi.com/2072-6694/15/8/2405

“Exosomes as a Source of Biomarkers for Gastrointestinal Cancers”
by Jingjing Yu, Arsha Ostowari, Amber Gonda, Kiarash Mashayekhi, Farshid Dayyani, Christopher C. W. Hughes and Maheswari Senthil
Cancers 2023, 15(4), 1263; https://doi.org/10.3390/cancers15041263
Available online: https://www.mdpi.com/2072-6694/15/4/1263

“Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC”
by Kathryn J. Brayer, Huining Kang, Adel K. El-Naggar, Simon Andreasen, Preben Homøe, Katalin Kiss, Lauge Mikkelsen, Steffen Heegaard, Daniel Pelaez, Acadia Moeyersoms et al.
Cancers 2023, 15(5), 1390; https://doi.org/10.3390/cancers15051390
Available online: https://www.mdpi.com/2072-6694/15/5/1390

“Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization”
by Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou and Teh-Ia Huo
Cancers 2023, 15(7), 1925; https://doi.org/10.3390/cancers15071925
Available online: https://www.mdpi.com/2072-6694/15/7/1925

“Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1”
by Fabian Krutzek, Cornelius K. Donat, Martin Ullrich, Kristof Zarschler, Marie-Charlotte Ludik, Anja Feldmann, Liliana R. Loureiro, Klaus Kopka and Sven Stadlbauer
Cancers 2023, 15(9), 2638; https://doi.org/10.3390/cancers15092638
Available online: https://www.mdpi.com/2072-6694/15/9/2638

“STARD3: A New Biomarker in HER2-Positive Breast Cancer”
by Massimo Lodi, Laetitia Voilquin, Fabien Alpy, Sébastien Molière, Nathalie Reix, Carole Mathelin, Marie-Pierrette Chenard and Catherine-Laure Tomasetto
Cancers 2023, 15(2), 362; https://doi.org/10.3390/cancers15020362
Available online: https://www.mdpi.com/2072-6694/15/2/362

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

9 January 2024
Meet Us at the 7th Symposium on Primary Breast Cancer in Older Women, 1 March 2024, Nottingham, UK


MDPI will attend the 7th Symposium on Primary Breast Cancer in Older Women as an exhibitor. This conference will be held in Nottingham, UK, on 1 March 2024.

The 7th Symposium on Primary Breast Cancer in Older Women aims to develop an in-depth understanding around the biology and treatment options, explore the specific physical and psychosocial needs and consideration including the patient perspective, and gain insight into the development of a holistic and multidisciplinary management approach and the importance of supporting research in the field of breast cancer.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.nottingham.ac.uk/conference/fac-mhs/medicine/symposia-on-primary-breast-cancer-in-older-women/index.aspx

2 January 2024
MDPI Insights: The CEO’s Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

5 December 2023
Cancers 2023 Young Investigator Award—Winner Announced


We are delighted to announce the winner of the Cancers 2023 Young Investigator Award—Dr. Nicolas Jacquelot, from the University of Calgary, Arnie Charbonneau Cancer Institute, Canada.

We would like to thank the award committee for their excellent work in the hard task of selecting the winner from such excellent candidates, as well as everyone who participated in this award and helped make it a huge success!

The winner will receive CHF 2000, a certificate, and a chance to publish a paper free of charge after peer review in Cancers (ISSN: 2072-6694) before the end of 2024.

30 November 2023
MDPI Insights: The CEO’s Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

29 November 2023
Cancers | Highly Cited Special Issues on Pediatric Oncology in 2022


We are pleased to invite you to read the highly cited Special Issues on pediatric oncology in 2022. The Special Issues list is as follows:

Pediatric Cancers

Edited by: Dr. Saurabh Agarwal and Dr. Jianhua Yang
Views: 59400+

Targeted Therapies for Pediatric Solid Tumors

Edited by: Dr. Michele Bernasconi
Views: 51100+

Recent Advances in Pediatric, Adolescent and Young Adult (AYA) Psycho-Oncology

Edited by: Dr. Ursula Sansom-Daly, Dr. Jordana McLoone, Dr. Christina Signorelli and Dr. Lauren Winkler
Views: 35300+

Childhood and Adolescent Cancer

Edited by: Dr. Henrike Karim-Kos and Dr. Rob Pieters
Views: 32300+

Young-Onset GI Cancer

Edited by: Dr. Irit Ben Aharon and Dr. Savio George Barreto
Views: 18100+

Frailty in Pediatric and Young Adult Cancer Survivors: From Bench to Bedside

Edited by: Prof. Francesca Rossi
Views: 13700+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers.

Cancers Editorial Office

28 November 2023
Editorial Board Members from Cancers Featured in the 2023 Highly Cited Researchers List Published by Clarivate

Recently, ClarivateTM revealed its 2023 list of Highly Cited ResearchersTM—individuals at universities, research institutes, and commercial organizations.

The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals, representing just 1 in 1,000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.

According to our statistics, 30 members of the editorial board of Cancers (ISSN: 2072-6694) were selected for the list of Highly Cited Researchers by ClarivateTM in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. The Cancers Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.

Researcher Category Affiliation
Kepp, Oliver Immunology Gustave Roussy, France
Madabhushi, Anant Cross-Field Case Western Reserve University, United States
Garbe, Claus Clinical Medicine Eberhard Karls University of Tubingen, Germany
Sternberg, Cora N. Clinical Medicine Azienda Ospedaliera San Camillo-Forlanini, Italy
Curigliano, Giuseppe Clinical Medicine University of Milano (UniMi), Italy
Melero, Ignacio Clinical Medicine Clinica Universidad de Navarra, Spain
Melenhorst, Jan Joseph Cross-Field University of Pennsylvania, United States
Cortes, Javier Clinical Medicine International Breast Cancer Center, Spain
Delord, Jean-Pierre Cross-Field UNICANCER, France
Blay, Jean-Yves Clinical Medicine Universite Claude Bernard Lyon 1, France
Barnholtz-Sloan, Jill S. Neuroscience and Behavior NIH National Cancer Institute (NCI), United States
Byrd, John C. Clinical Medicine Ohio State University, United States
Kirkwood, John M. Cross-Field University of Pittsburgh, United States
Cortes, Jorge Clinical Medicine UTMD Anderson Cancer Center, United States
Lu, Lu Cross-Field Fudan University, China Mainland
Demaria, Marco Molecular Biology and Genetics University of Groningen, Netherlands
Mandala, Mario Clinical Medicine ASST Papa Giovanni XXIII, Italy
Dimopoulos, Meletios-Athanasios Clinical Medicine National & Kapodistrian University of Athens, Greece
Mahmoudi, Morteza Cross-Field Michigan State University, United States
Ahn, Myung-Ju Clinical Medicine Sungkyunkwan University (SKKU), South Korea
Richardson, Paul G. Clinical Medicine Dana-Farber Cancer Institute, United States
Kurzrock, Razelle Clinical Medicine University of California San Diego, United States
Dummer, Reinhard Clinical Medicine University of Zurich, Switzerland
Soffietti, Riccardo Cross-Field A.O.U. Citta della Salute e della Scienza di Torino, Italy
Scolyer, Richard A. Clinical Medicine University of Sydney, Australia
Oudard, Stephane Cross-Field Université Paris Cité, France
Chan, Timothy A. Molecular Biology and Genetics Cleveland Clinic Foundation, United States
Gutzmer, Ralf Clinical Medicine Ruhr University Bochum, Germany
Kudo, Masatoshi Clinical Medicine Kindai University (Kinki University), Japan
Saad, Fred Clinical Medicine University of Montreal, Canada

23 November 2023
Cancers | Highly Cited Special Issues on Cancer Pathophysiology in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on Cancer Pathophysiology. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Signaling Pathway in Gastrointestinal Cancer
Edited by Prof. Dr. Tianhui Hu
Views: 33800+ | Cited by 60+

Advances in Oral Cancer: From Pathology to Treatment
Edited by Prof. Dr. Andrea Santarelli
Views: 41100+ | Cited by 100+

Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice
Edited by Dr. Paolo Graziano and Dr. Giulio Rossi
Views: 30500+ | Cited by 100+

Image Analysis and Computational Pathology in Cancer Diagnosis
Edited by Prof. Dr. Emiel A. M. Janssen
Views: 20000+ | Cited by 30+

Pathophysiology and Treatment of Gallbladder Cancer
Edited by Dr. Philip De Reuver and Dr. Chella van der Post
Views: 16500+ | Cited by 40+

Predictive and Prognostic Markers in Brain Tumors: From Physiopathology to Clinical Applications
Edited by Dr. Guillaume Gauchotte
Views: 11700+ | Cited by 10+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office at  cancers@mdpi.com.

Cancers Editorial Office

22 November 2023
Cancers | Lung Cancer Awareness Month


November is designated as “Lung Cancer Awareness Month”, with various global activities that highlight and increase awareness of lung cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of lung cancers, which published in Cancers (ISSN: 2072-6694). We hope this announcement will provide the useful information for this field.

“Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression”
by James Drury, Piotr G. Rychahou, Courtney O. Kelson, Mariah E. Geisen, Yuanyuan Wu, Daheng He, Chi Wang, Eun Y. Lee, B. Mark Evers and Yekaterina Y. Zaytseva
Cancers 2022, 14(1), 252; https://doi.org/10.3390/cancers14010252
Available online: https://www.mdpi.com/2072-6694/14/1/252

“Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers”
by Guillaume Anthony Odri, Joëlle Tchicaya-Bouanga, Diane Ji Yun Yoon and Dominique Modrowski
Cancers 2022, 14(2), 360; https://doi.org/10.3390/cancers14020360
Available online: https://www.mdpi.com/2072-6694/14/2/360

“Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges”
by Bocheng Wu, Quaovi H. Sodji and Adegboyega K. Oyelere
Cancers 2022, 14(3), 552; https://doi.org/10.3390/cancers14030552
Available online: https://www.mdpi.com/2072-6694/14/3/552

“Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment”
by Ming-Tsung Hsu, Yu-Ke Wang and Yufeng Jane Tseng
Cancers 2022, 14(3), 732; https://doi.org/10.3390/cancers14030732
Available online: https://www.mdpi.com/2072-6694/14/3/732

“Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done”
by Austin J. Bartl, Mary Mahoney, Mark W. Hennon, Sai Yendamuri, Gregory M. M. Videtic, Kevin L. Stephans, Shankar Siva, Mark K. Farrugia, Sung Jun Ma and Anurag K. Singh
Cancers 2022, 14(3), 790; https://doi.org/10.3390/cancers14030790
Available online: https://www.mdpi.com/2072-6694/14/3/790

“Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2”
by Swati Misri, Kirti Kaul, Sanjay Mishra, Manish Charan, Ajeet Kumar Verma, Martin P. Barr, Dinesh K. Ahirwar and Ramesh K. Ganju
Cancers 2022, 14(5), 1181; https://doi.org/10.3390/cancers14051181
Available online: https://www.mdpi.com/2072-6694/14/5/1181

“Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance”
by Damien Reita, Lucile Pabst, Erwan Pencreach, Eric Guérin, Laurent Dano, Valérie Rimelen, Anne-Claire Voegeli, Laurent Vallat, Céline Mascaux and Michèle Beau-Faller
Cancers 2022, 14(5), 1321; https://doi.org/10.3390/cancers14051321
Available online: https://www.mdpi.com/2072-6694/14/5/1321

“Application of Artificial Intelligence in Lung Cancer”
by Hwa-Yen Chiu, Heng-Sheng Chao and Yuh-Min Chen
Cancers 2022, 14(6), 1370; https://doi.org/10.3390/cancers14061370
Available online: https://www.mdpi.com/2072-6694/14/6/1370

“Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis”
by Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso and Gennaro Palmiotti
Cancers 2022, 14(6), 1404; https://doi.org/10.3390/cancers14061404
Available online: https://www.mdpi.com/2072-6694/14/6/1404

“Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine”
by Laetitia Seguin, Manon Durandy and Chloe C. Feral
Cancers 2022, 14(7), 1759; https://doi.org/10.3390/cancers14071759
Available online: https://www.mdpi.com/2072-6694/14/7/1759

Prevention and Quality of Life of Lung Cancer

Edited by: Prof. Dr. Servet Bölükbas
Submission deadline: 15 May 2024

Mechanisms of Therapy Resistance in Lung Cancer

Edited by: Dr. Andrea De Giglio
Submission deadline: 15 March 2024

 

Novel Biomarkers in Non-small Cell Lung Cancer (NSCLC)

Edited by: Dr. Alfredo Tartarone
Submission deadline: 1 March 2024

Genetic, Epigenetic, and Epitranscriptomic Changes in Lung Cancer

Edited by: Dr. Giovanni Nigita, Dr. Mario Acunzo and Dr. Patrick Nana-Sinkam
Submission deadline: 29 February 2024

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

21 November 2023
Cancers | Top 10 Cited Papers in 2021 in the Section “Cancer Drug Development”


We are pleased to invite you to read the top 10 cited papers in 2021 in Cancers (ISSN: 2072-6694) in the Section “Cancer Drug Development”. The paper list is as follows:

1. “Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma”
by Hamid Maadi, Mohammad Hasan Soheilifar, Won-Shik Choi, Abdolvahab Moshtaghian and Zhixiang Wang
Cancers 2021, 13(14), 3540; https://doi.org/10.3390/cancers13143540
Available online: https://www.mdpi.com/2072-6694/13/14/3540

2. “Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer”
by Ryan W. Holloway and Paola A. Marignani
Cancers 2021, 13(12), 2922; https://doi.org/10.3390/cancers13122922
Available online: https://www.mdpi.com/2072-6694/13/12/2922

3. “CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development”
by Kenji Hashimoto
Cancers 2021, 13(10), 2288; https://doi.org/10.3390/cancers13102288
Available online: https://www.mdpi.com/2072-6694/13/10/2288

4. “HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia”
by Yan Liao, Yue Yang, Di Pan, Youxiang Ding, Heng Zhang, Yuting Ye, Jia Li and Li Zhao
Cancers 2021, 13(2), 243; https://doi.org/10.3390/cancers13020243
Available online: https://www.mdpi.com/2072-6694/13/2/243

5. “Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Progression”
by Yiqiao Luo, Bin Yan, Li Liu, Libo Yin, Huihui Ji, Xuefeng An, Jury Gladkich, Zhimin Qi, Carolina De La Torre and Ingrid Herr
Cancers 2021, 13(4), 827; https://doi.org/10.3390/cancers13040827
Available online: https://www.mdpi.com/2072-6694/13/4/827

6. “Biological Significance and Targeting of the FGFR Axis in Cancer”
by Athina-Myrto Chioni and Richard P. Grose
Cancers 2021, 13(22), 5681; https://doi.org/10.3390/cancers13225681
Available online: https://www.mdpi.com/2072-6694/13/22/5681

7. “Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities”
by Chenyin Wang, Alexandra Hamacher, Patrick Petzsch, Karl Köhrer, Günter Niegisch, Michèle J. Hoffmann, Wolfgang A. Schulz and Matthias U. Kassack
Cancers 2021, 13(8), 1781; https://doi.org/10.3390/cancers13081781
Available online: https://www.mdpi.com/2072-6694/13/8/1781

8. “Autophagy Inhibition in BRAF-Driven Cancers”
by Mona Foth and Martin McMahon
Cancers 2021, 13(14), 3498; https://doi.org/10.3390/cancers13143498
Available online: https://www.mdpi.com/2072-6694/13/14/3498

9. “IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma”
by Hima Patel, Rosalin Mishra, Nour Yacoub, Samar Alanazi, Mary Kate Kilroy and Joan T. Garrett
Cancers 2021, 13(22), 5863; https://doi.org/10.3390/cancers13225863
Available online: https://www.mdpi.com/2072-6694/13/22/5863

10. “FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers”
by Katia A. Mesquita, Reem Ali, Rachel Doherty, Michael S. Toss, Islam Miligy, Adel Alblihy, Dorjbal Dorjsuren, Anton Simeonov, Ajit Jadhav, David M. Wilson III et al.
Cancers 2021, 13(8), 1866; https://doi.org/10.3390/cancers13081866
Available online: https://www.mdpi.com/2072-6694/13/8/1866

17 November 2023
Cancers | Highly Cited Special Issues on Cancer Epidemiology and Prevention in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer epidemiology and prevention. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Molecular Mechanisms Underlying Cancer Prevention and Intervention with Bioactive Food Components
by Prof. Dr. Anupam Bishayee
Viewed by 43000+ | Cited by 150+

The Mechanisms of Physical Activity, Diet, and Body Composition in Cancer Prevention and Control
by Dr. Justin C. Brown
Viewed by 42000+ | Cited by 110+

Breast Cancer: Risk Factors, Prevention and Early Detection
by Prof. Antonis Valachis
Viewed by 24000+ | Cited by 40+

Role of Diet in Cancer Prevention and Treatment
by Prof. Giovanna Caderni and Dr. Giovanna Masala
Viewed by 22000+ | Cited by 60+

Neurobiological Impacts of Cancer and Cancer Treatments: Mechanisms, Risk Factors, Biomarkers, and Prevention/Recovery
by Dr. Helene Castel
Viewed by 19000+ | Cited by 40+

Molecular Links between Cancer and Metabolic Diseases: New Perspectives and Therapeutic Strategies for Cancer Prevention and Treatment by Targeting Nutritional Patterns and Metabolic Alterations
by Prof. Dr. Hamid Morjani and Prof. Dr. Mohamed Zaiou
Viewed by 20000+ | Cited by 50+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. You can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office

16 November 2023
Cancers | Highly Cited Special Issues on Tumor Microenvironment in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on tumor microenvironment. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Molecular Aspects of Tumor Microenvironment of Colorectal Cancers
Edited by Prof. Dr. Maria Cristina Curia
Viewed by 17900+ | Cited by 70+
Engineering the Tumor Immune Microenvironment
Edited by Dr. Scott S. Verbridge
Viewed by 35900+ | Cited by 60+
Primary Bone Tumors: Microenvironment, Signaling and Therapeutic Targeting
Edited by Dr. Françoise Rédini and Dr. Franck Verrecchia
Viewed by 14900+ | Cited by 30+
Inflammation and the Immunosuppressive Pancreatic Cancer Microenvironment
Edited by Dr. Brian A. Boone and Dr. Tim D. Eubank
Viewed by 19500+ | Cited by 90+
Multicellular Effects of STAT3 in the Tumour Microenvironment
Edited by Dr. Ashwini L. Chand
Viewed by 19200+ | Cited by 70+
Cancer Microenvironment–Hypoxia
Edited by Dr. María Dolores Chiara Romero
Viewed by 15900+ | Cited by 40+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

16 November 2023
Cancers | Highly Cited Special Issues on Infectious Agents and Cancer in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on the topic of infectious agents and cancer.

The Special Issues list is as follows:

 Molecular Pathogenesis of Epstein-Barr Virus-Associated Malignancy
Edited by Prof. Dr. Hironori Yoshiyama, Prof. Dr. Asuka Nanbo and Prof. Dr. Tomoharu Yasuda
Views: 12600+ | Cited by 11+

Therapeutic Monitoring of Anti-cancer Agents
Edited by Dr. Neeltje Steeghs
Views: 17100+ | Cited by 39+

Advances in Gynecological Oncology: From Pathogenesis to Therapy
Edited by Dr. Andrea Ciavattin
Views: 29700+ | Cited by 35+

Pathogenesis and Experimental Therapeutics of Testicular Germ Cell Tumors
Edited by Prof. Dr. Michael J. Spinella, Dr. Sarah J. Freemantle, Dr. Zeeshan Fazal and Dr. Ratnakar Singh
Views: 25000+ | Cited by 73+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

16 November 2023
Cancers | Highly Cited Special Issues on Cancer Therapy in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer therapy. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Advances in Lung Cancer Therapy
Edited by Dr. Domenico Galetta
Views: 41000+

Application of Proton Beam Therapy in Cancer Treatment
Edited by Dr. Erik W. Korevaar and Dr. Arjen van der Schaaf
Views: 53900+

Drug Repurposing for Cancer Therapy
Edited by Dr. Carlos M. Telleria
Views: 45100+

Novel Targets and Approaches in Cancer Therapy
Edited by Dr. Jason Roszik
Views: 34000+

New Strategies in Diagnosis and Treatments for Brain Tumors
Edited by Prof. Dr. Sven Rainer Kantelhardt
Views: 26000+

Radiation Therapy in Thoracic Tumors: Recent Trends and Current Issues
Edited by Dr. Laura Cella, Dr. Giuseppe Palma and Dr. Andrew Hope
Views: 26700+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

16 November 2023
Cancers | Highly Cited Special Issues on Cancer Metastasis in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer metastasis. We hope this announcement will provide useful information for this field. 

The Special Issues list is as follows:

From Progression to Metastasis of Solid Cancer
Edited by Prof. Dr. Eldad Zacksenhaus and Prof. Sean Egan
Views: 44000+

Brain Metastasis in Breast Cancer
Edited by Dr. Leticia Oliveira-Ferrer, Prof. Dr. Volkmar Müller and Prof. Dr. Isabell Witzel
Views: 23700+

Understanding Molecular Regulation of Cancer Progression and Metastasis
Edited by Dr. Levi J. Beverly
Views: 32000+

Colorectal Cancer Heterogeneity and the Impact on Metastasis Formation and Therapy Efficacy
Edited by Prof. Jan Paul Medema
Views: 13900+

Metastasis and Tumor Cell Migration of Solid Tumors
Edited by Prof. Dr. Jens Hoeppner and Dr. Peter Bronsert
Views: 10700+

Genomic Landscape of Breast Cancer: From Primary to Metastasis
Edited by Dr. Athina Giannoudis and Dr. Damir Vareslija
Views: 16500+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office

15 November 2023
Cancers | Highly Cited Special Issues on Methods and Technologies Development in 2022

 

We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on the topic of methods and technologies development.

The Special Issues list is as follows:

 

Novel Techniques and Technology for Treatment of Brain Tumors
Edited by Prof. Dr. David S. Baskin
Viewed by 12600+ | Cited by 20+

Biophotonics and Imaging for Cancer Screening, Diagnosis and Treatment Monitoring
Edited by Prof. Dr. Fiona Lyng
Viewed by 107000+ | Cited by 230+

 

Recent Advances in Nanotechnologies for Cancer Detection and Treatment
Edited by Dr. Guilhem Bousquet
Viewed by 30400 + | Cited by 170+

Non-Invasive Imaging and Spectroscopic Methods in Cancer
Edited by Dr. Rheal A. Towner
Viewed by 32600 + | Cited by 30+

 

Application of Emerging Technologies in Zebrafish and Mammalian Cancer Models for Disease Characterization and Therapeutic Target Discovery
Edited by Dr. Eleanor Y. Chen and Dr. Myron Ignatius
Viewed by 19300 + | Cited by 20+

Current Advances in Chimeric Antigen Receptor Technology
Edited by Dr. Seung-Hwan Lee and Dr. Scott McComb
Viewed by 31300 + | Cited by 110+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

15 November 2023
Cancers | Highly Cited Special Issues on Molecular Cancer Biology in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on molecular cancer biology. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Updates on Molecular Targeted Therapies for CNS Tumors
Edited by Dr. Edward Pan
Viewed by 45830+ | Cited by 110+

Molecular Genetics and Treatment of Chronic Myeloid Leukemia
Edited by Dr. Masahiro Kizaki
Viewed by 31880+ | Cited by 70+

Molecular Mechanisms Underlying Tumor Onset and Progression in Liver Cancers
Edited by Dr. Cédric Coulouarn
Viewed by 25850+ | Cited by 70+

Molecular Pathogenesis and Management of Anaplastic Large Cell Lymphoma
Edited by Dr. Vasiliki Leventaki
Viewed by 26810+ | Cited by 40+

Molecular Mechanisms of Lung Cancer and Mesothelioma
Edited by Prof. Rajkumar Savai and Prof. Dr. Michael Thomas
Viewed by 24470+ | Cited by 40+

Molecular Pathogenesis of Cervical Cancer
Edited by Dr. Thilo Dörk
Viewed by 38480+ | Cited by 90+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers.

Cancers Editorial Office

15 November 2023
Cancers | Highly Cited Special Issues on Cancer Immunology and Immunotherapy in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer immunology and immunotherapy. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Tumor Immunology and Immunotherapy Resistance
by Dr. Subbaya Subramanian, Timothy K. Starr and Dr. Xianda Zhao
Viewed by 21600+ | Cited by 40+

Perspectives of Immunotherapy in Tumors of the Gastrointestinal Tract
by Dr. Gianluca Masi
Viewed by 17500+ | Cited by 45+

Immunotherapy of Triple-Negative Breast Cancer
by Dr. Claudia De Lorenzo and Dr. Laura Cerchia
Viewed by 21800+ | Cited by 40+

Cancer Immunotherapy and Immune-Related Adverse Events
by Dr. Shaheen Khan
Viewed by 33900+ | Cited by 110+

Oncolytic Viruses as Cancer Immunotherapy Agents
by Dr. Masataka Suzuki
Viewed by 22100+ | Cited by 70+

Immunotherapy for Solid Tumors
by Dr. Elizabeth Fabre
Viewed by 11800+ | Cited by 60+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

14 November 2023
Cancers | Highly Cited Special Issues on Clinical Research of Cancer in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on clinical research of cancer. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Clinical Perspective and Translational Oncology of Liquid Biopsy
Edited by Dr. Juan Jesús Cruz
Viewed by 24100 + | Cited by 70+

Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
Edited by Dr. Constantin N. Baxevanis
Viewed by 30800+ | Cited by 80+

Clinical Use of PARP Inhibitors in Cancer – From Bench to Bedside and Back Again
Edited by Prof. Dr. Isabella Faraoni
Viewed by 34300+ | Cited by 70+

Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer
Edited by Prof. Dr. Stephane Dedieu
Viewed by 22500+ | Cited by 60+

Latest Basic, Translational and Clinical Advancements in HER2-Positive Breast Cancer
Edited by Dr. Serenella Pupa and Dr. Elda Tagliabue
Viewed by 28400+ | Cited by 100+

Ewing Sarcoma: Basic Biology, Clinical Challenges and Future Perspectives
Edited by Prof. Dr. Stefan Burdach,  Prof. Dr. Uta Dirksen and Prof. Dr. Poul H. Sorensen
Viewed by 15600+ | Cited by 20+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

13 November 2023
Cancers | Highly Cited Special Issues on Cancer Drug Development in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer drug development. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors
Edited by Prof. Dr. Chiara Riganti, Dr. M. Helena Vasconcelos and Prof. Dr. Catherine Passirani
Viewed by 38700+ | Cited by 160+
Tumor Models and Drug Targeting In Vitro
Edited by Dr. Sascha Kopp and Dr. Marcus Krüger
Viewed by 18700+ | Cited by 30+
The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance
Edited by Dr. Bi-Dar Wang and Prof. Dr. Luciane R Cavalli
Viewed by 20900+ | Cited by 80+
Cancer Stem Cells (CSCs) in Drug Resistance and Their Therapeutic Implications in Cancer Treatment
Edited by Dr. Peter Van Veldhuizen
Viewed by 18000+ | Cited by 50+
Recent Advances in Drug Therapy for Glioblastoma
Edited by Dr. Juan Manuel Sepúlveda-Sánchez
Viewed by 17000+ | Cited by 30+
microRNA and Oxidative Drugs in Cancer Therapy and Prevention
Edited by Prof. Dr. Alberto Izzotti and Prof. Dr. Ming You
Viewed by 17300+ | Cited by 30+